[{"template":"NNP : DT NN IN CD","text":"['Exercise**: - A study with 64', '(TEAM)**: - A trial with 395', 'Depression**: - A study with 104', 'Immunizations**: - A study with 61', 'Depression**: - A trial with 345', 'Prednisone**: - A study with 147', 'Improvement**: - A study with five', 'Puncture**: - A study with 50', 'Diabetes**: - A trial with 329', 'Patients**: - A trial with 80', 'Print**: - A study with 10', 'Pain**: - A study with 117', 'Intervention**: - A study with 300', 'UTIs**: - A study with 84', 'Draws**: - A study with 100', 'Disorders**: - A trial with 1,004', 'Aggression**: - A study with 60', 'Interventions**: - A study with 400', 'Physicians**: - A trial with 120', 'Pain**: - A study with 30', 'Program**: - A study with 520', 'Intervention**: - A study with 198', '(BE)**: - A study with 324', 'Feeding:** - A study of 21', 'Ciprofloxacin**: - A study with 400', 'Patients**: - A study with 100', 'Treatment**: - A trial with 157', 'Training**: - A study with 40', 'Psychosis**: - A study of 327', 'Fever**: - A study with 52', 'Intervention**: - A trial with 211', 'Patients**: - A trial with 405', 'Approaches**: - A trial with 64', 'Women**: - A trial with 240', 'Paracetamol**: - A study with 80', 'Adults**: - A trial with 1,801', 'IVF:** - A study with 259', 'Mobilization**: - A study with 336', 'Ciprofloxacin**: - A study with 497', 'Patients**: - A study with 37', 'Intervention**: - A study with 78', 'Rico**: - A study with 179', 'Patients**: - A study with 40', '(Alpha-Tocopherol)**: - A study with 289', 'Depression**: - A trial with 533', 'Conditions**: - A trial with 214', 'Disorder**: - A trial with 115', 'Patients**: - A trial with 136', 'Magnifiers**: - A study with 39', 'Function**: - A trial with 91', 'Sulfate**: - A trial on 105', 'Americans**: - A study with 4228', 'Training**: - A study with 35', 'Disorders**: - A trial with 205', 'Adolescents**: - A trial with 152', 'Depression**: - A trial with 230', 'Induction**: - A study on 54', 'Adolescents**: - A trial with 418', 'Psychotherapy**: - A trial with 600', 'Utilizers**: - A trial with 407', 'Depression**: - A trial with 223', 'Depression**: - A trial with 302', 'Abuse**: - A trial with 120', '(m-CIMT)**: - A study with 30', 'Progression**: - A study on 222', 'Acetaminophen**: - A study with 73', 'Sulfate**: - A study on 64', 'Aspirations**: - A study with 30', 'Points**: - A study with 60', 'Care**: - A trial with 265', 'Depression**: - A trial with 613', 'Organization**: - A study with 7,077', 'Patients**: - A trial with 249', 'MPS**: - A study with 53', 'Depression**: - A trial with 153', 'Assistants**: - A trial with 626', 'Patients**: - A trial with 393', 'CCTVs**: - A study with 22', 'Depression**: - A trial with 188', 'Pain**: - A study with 149', 'Biofeedback**: - A study with 40', 'Depression**: - A study with 577', 'Product**: - A trial with 59', '(TCQ)**: - A study with 206', 'Patients**: - A study with 52', 'Mothers**: - A study with 497', 'Patients**: - A study with 35', 'Patients**: - A trial with 387', 'Depression**: - A trial with 1,801', 'Depression**: - A trial with 267', 'Patients**: - A trial with 175', 'Program**: - A study with 715', 'Drinking**: - A trial with 97', 'Depression**: - A trial with 405', 'Disorders**: - A trial with 191', 'Levels**: - A study of 35', 'Rehabilitation**: - A trial with 101', 'Varicella**: - A study with 72', 'Mobility**: - A study with 26', 'Pain**: - A trial with 218', 'Walking**: - A trial with 91', 'Prophylaxis**: - A study with 140', 'Intervention**: - A study with 424', 'Functions:** - A study on 72', 'Diabetes**: - A study with 291', '(DCI):** - A study with 283', '(DBTP)**: - A study with 30', 'Depression**: - A study with 74', 'Pharmacists**: - A trial with 125', 'Sampling**: - A study with 100', 'Balance**: - A study with 20', 'Immunizations**: - A study with 39', 'Experiences**: - Another study with 127', 'Trimethoprim-Sulfamethoxazole**: - A study with 117', 'Patients**: - A study with 39', 'Depression**: - A study with 506', 'Rinse**: - A trial with 57', 'MPS**: - A study with 119', 'Depression**: - A trial with 598', 'Methyldopa**: - A study on 33', 'Prevention**: - A study with 522', 'CSP\/MTX\/Prednisolone**: - A trial with 41', 'Acceptability**: - A study with 84', 'Intervention**: - A study with 123', 'Magnifiers**: - A study with 70', 'MP**: - A study with 108', 'Prophylaxis**: - A study with 537', 'Immunizations**: - A study with 92', 'Rehabilitation**: - A study with 20', 'Aids**: - A study with 20', 'Prophylaxis**: - A study with 83', 'Recruits**: - A study with 2,157', 'Depression**: - A trial with 217', 'Intervention**: - A study with 542', 'Acitretin**: - A study with 21', 'Care**: - A trial with 354', 'Practice**: - A study with 30', 'Feeding:** - A study of 44', 'Disorder**: - A trial with 232', 'Patients**: - A study with 479', 'Enema**: - A study with 40', 'Sodium**: - A study with 63', 'Venipuncture**: - A study with 43', 'Puncture**: - A study with 45', 'Physiotherapy**: - A trial with 120', 'Bobath**: - A study with 61', 'Pain**: - A trial with 196', 'Patients**: - A study with 339', 'Depression**: - A trial with 386', 'Adults**: - A trial with 138', '(COA)**: - A study with 34', 'Appliances**: - A study with 47', 'Syndrome**: - A study with 40', 'Immunizations**: - A study with 200', 'Immunizations**: - A study with 42', 'Trimethoprim-Sulfamethoxazole**: - A study with 110', 'Function**: - A study with 58', 'Care**: - A study with 1047', 'Types**: - A study with 300', 'Piperacillin\/Tazobactam**: - A study with 111', 'Veterans**: - A trial with 268', 'Care**: - A study with 120', 'Acid**: - A study with 44', 'MPS**: - A study with 40']"},{"template":"NNP IN NNP NNP : NN","text":"['Trial on Transfusion Strategies**: - **Objective**:', 'Program for Executive Deficits**: - **Participants**:', 'Set with Sodium Hypochlorite**: - **Study', 'Advice in General Practice**: - **Participants**:', 'Protocol for Dialysis Catheters**: - **Study', '(GEn) for Migraine Prophylaxis - **Design**:', 'Relaxation for Combat-Related PTSD**: - EMDR', 'Imipramine for Painful Polyneuropathy - **Objective**:', 'Reduction in Overweight Adults - **Objective:**', 'Tablets in Neuropathic Bladder**: - **Participants**:', 'Treadmill on Functional Tasks**: - **Study', 'Treatment for Rheumatoid Shoulder - **Study', '(APC) vs. Unfractionated Heparin**: - **Study', 'Salt in Elderly Veterans - **Objective:**', 'Maintenance in Perimenopausal Women - **Objective:**', 'Program for VAP Prevention**: - **Study', 'Intervention for African-American Women**: - **Objective**:', 'TMP\/SMX in Hematological Malignancies**: - Ofloxacin', '(LBD) in Cytopenic Patients:** - **Objective:**', 'Agonist in Poor Responders** - **Objective:**', 'Living with AIDS (PLWA)**: - **Participants**:', 'Impact of Tobacco Marketing**: - Receptivity', 'Lidocaine in Eyelid Surgery**: - **Study', 'Service for Ambulatory Care**: - **Study', 'Beta in Cervical Cancer**: - **Study', 'Steel vs. NiTi Archwires**: - **Study', 'Outcomes of Shoulder Arthroplasty - **Study', 'Lidocaine in Ear Surgery**: - **Study', 'Collar in PTFE Bypass - **Objective**:', 'Alfa in Chemotherapy-Induced Anemia**: - **Study', 'Alfa in Nonplatinum Chemotherapy**: - **Study', 'Therapy for Anxiety Disorders**: - **Study', 'Maprotiline for Painful Polyneuropathy - **Objective**:', 'Analgesia in Tooth Extraction**: - **Study', 'Cooling in Awake Patients**: - **Study', 'Protocol in Low Responders** - **Objective:**', 'Study on Outpatient Commitment:** - **Participants:**', 'Alfa in Lung Cancer**: - **Study', 'Amitriptyline for Postherpetic Neuralgia - **Objective**:', 'Duodenoscopy in Acute GP**: - **Participants**:', 'Intervention for Diabetes Risk**: - **Participants**:', 'Triage for Same-Day Appointments**: - **Study', 'Counseling in Healthy Adults - **Objective:**', '(AD) with Psychotic Symptoms - **Study', 'Transfer in Younger Women**: - **Study', '(BWSTT) for Long-Term Benefit**: - **Study', 'Therapy for Mild Preeclampsia:** - **Study', 'Interventions on Gait Parameters**: - **Study', 'Supplementation in PAD Patients**: - **Study', 'Outcomes in AMA Patients**: - **Study', 'Risperidone in Dementia-Related Psychosis - **Study', 'Alfa in Pediatric Cancer**: - **Study', 'Irrigation for Long-Term Catheters**: - **Study', 'Anemia of Cancer (AOC)**: - **Study', 'Ibuprofen in Orthodontic Pain**: - **Study', 'Management in Postoperative Care**: - **Objective**:', 'Heparin in Acute Leukemia**: - **Study', 'Partners of Bipolar Patients**: - **Study', 'Dressing for Pain Relief**: - **Study', 'Ultrasound in Preterm PROM:** - **Objective:**', 'OC for Colon Cancer - **Duration**:', 'Citalopram for Diabetic Neuropathy - **Objective**:', 'Diphenhydramine in Hematology\/Oncology Patients**: - **Participants**:', 'Carcinoma without Surgical Staging)**: - **Participants**:', 'Grafts at Immediate Implants:** - **Study', 'Study on Rectal Adenocarcinoma**: - **Participants**:', 'Carbamazepine for Diabetic Polyneuropathy - **Objective**:', 'Placebo in Acute Mania**: - **Study', 'Amoxicillin-Clavulanate for Acute Rhinosinusitis - **Objective:**', 'Prednisolone for Infectious Mononucleosis:** - **Objective:**', 'Fluoxetine in Major Depression**: - **Objective**:', 'Protocol in Poor Responders** - **Objective:**', 'Management in Military Personnel - **Objective:**', 'Ciprofloxacin after IV Ciprofloxacin:** - **Participants:**', 'Cold with Specific Bacteria - **Objective:**', 'E in Generalized Malignancy - **Objective**:', 'Lidocaine in Traumatic Lacerations**: - **Study', 'Clamping in Cirrhotic Patients - **Study', 'Lidocaine for IV Catheterization**: - **Study', 'Restoration in Esthetic Zones:** - **Study', 'Software in Behavioral Programs - **Objective:**', 'Lidocaine in Various Surgeries**: - **Study', 'Block at Midfemoral Level**: - **Objective**:', 'Program for Low-Income Families**: - **Objective**:', 'Lidocaine in Cardiac Catheterization**: - **Study', 'Regimens in Severe Pre-eclampsia:** - **Study', 'Levels in Severe Preeclampsia:** - **Study', 'Repair in RA Patients - **Study', 'SIL in HIV-Positive Women - **Objective**:', 'Trial on Postoperative Bacteremia**: - **Participants**:', 'Disc vs. Circumferential Fusion:** - **Participants:**', 'Surgery for LAD Lesions**: - Comparison', 'Consultations on GP Workload**: - **Study', 'Block at Popliteal Fossa**: - **Objective**:', 'Advice for Diabetes Risk**: - **Participants**:', 'PTFE with Vein Cuff - **Objective**:', 'Therapy for Relapse Prevention**: - **Study', 'Table in Cochrane Reviews**: - **Objective**:', 'Cuff in Femoral-Popliteal Bypass - **Objective**:', '(RA) for CIN II\/III - **Objective**:', 'Children with Autistic Disorder** - **Design:**', '(NET) for Sudanese Refugees**: - NET', 'GnRHa in Low Responders** - **Objective:**', 'Occlusion in Cirrhotic Patients - **Study', 'Infection with Purulent Rhinorrhea - **Objective:**', 'NiTi vs. Single-Stranded NiTi**: - **Study', 'Desipramine for Diabetic Neuropathy - **Objective**:', 'Protocols in Emergency Room**: - **Study', 'Follow-Up for Warfarin Knowledge**: - **Objective**:', 'Hippurate After Gynecologic Surgery**: - **Participants**:', 'Smokers in New Zealand**: - **Objective**:', 'Class for Locomotor Function**: - **Design**:', 'Beta in Hematologic Malignancies**: - **Study', 'Trial on Brief Intervention**: - **Participants**:', 'Amoxicillin for Acute Rhinosinusitis - **Objective:**', 'Diet in AML Patients:** - **Objective:**', 'Alfa in Breast Cancer**: - **Study', 'Radiographs in Emergency Settings**: - Study', 'Bacteriuria in Neurogenic Bladder**: - **Study', 'Lidocaine for Simple Lacerations**: - **Study', 'Program with Support Groups**: - **Participants**:', 'Acupressure with Lavender Oil**: - **Participants**:', 'Loss in Primary Care - **Objective:**', 'Efficacy of Oral Prednisolone - **Objective**:', '(MA) in Cancer-Associated Wasting - **Objective**:', 'Mianserin for Diabetic Neuropathy - **Objective**:', 'Wort for Painful Polyneuropathy - **Objective**:', 'Archwires in Resolving Crowding**: - **Study', 'Messaging for Maori Smokers**: - **Objective**:', 'Hyperstimulation in Poor Responders** - **Objective:**', 'Bypass with Vein Cuff - **Objective**:', 'Reduction in Surgical ICU**: - **Study', 'Alfa in Lymphoproliferative Malignancies**: - **Study', 'Reduction through Compliance Auditing**: - **Study', 'Pathology in Acute LBP**: - Study', 'Amoxicillin for Sinusitis-Type Symptoms - **Objective:**', 'E in Alcoholic Hepatitis**: - **Objective**:', 'Salbutamol in Severe Asthma:** - **Efficacy:**', 'Venlafaxine for Neuropathic Pain - **Objective**:', 'Placement with Immediate Provisionalization:** - **Study', 'Placebo in Bipolar Mania**: - **Study', 'Prosthesis vs. Non-Surgical Treatment:** - **Participants:**', 'Program with Behavioral E-Counseling - **Objective:**', 'Cooling in Ischemic Stroke**: - **Study']"},{"template":"NNP NNP : NN NNP NNP","text":"['Popliteal Fossa**: - **Objective**: Compare US', 'Catheter Care**: - **Study Design**: Randomized', 'Cancer (SCLC)**: - **Study Design**: Randomized,', '(CS) Systems**: - **Study Design**: Prospective', 'Standard Management**: - **Study Design**: Multiple', 'Adverse Events**: - **Hypoglycemia Incidence**: No', 'Eye Drops - **Study Design**: Randomized', 'Iliaca Block**: - **Objective**: Compare US', 'Ear Surgery**: - **Study Design**: Randomized,', 'System Insertion**: - **Study Design**: Randomized,', 'Breast Cancer**: - **Study Design**: Randomized', 'Motor Training**: - **Study Design**: Crossover', 'Long-Term Catheters**: - **Study Design**: Randomized', 'Eyelid Surgery**: - **Study Design**: Prospective,', 'Pediatric Cancer**: - **Study Design**: Randomized,', 'Perphenazine Enanthate**: - **Study Design**: Double-blind,', 'Standard System**: - **Study Design**: Matched', '(Y) Systems**: - **Study Design**: Multicenter', 'Cirrhotic Patients - **Study Design**: Cirrhotic', 'Plexus Anesthesia**: - **Objective**: Compare US', 'Nerve Blockade**: - **Study Design**: Prospective,', 'Ophthalmic Solution - **Study Design**: Double-masked', 'Hematologic Malignancies**: - **Study Design**: Randomized', 'Emergency Room**: - **Study Design**: Randomized', 'Awake Patients**: - **Study Design**: Case-control', 'Dialysis Catheters**: - **Study Design**: Prospective', 'Ambulatory Care**: - **Study Design**: Randomized', 'Bipolar Patients**: - **Study Design**: Partners', 'Clamping (IC) - **Study Design**: Noncirrhotic', 'Echocardiographic Outcomes**: - **Blood Flow Variability**:', 'Glycemic Control - **HbA1c Levels**: Most', 'Resistance Training - **Study Design**: Randomized', 'Catheter Placement**: - **Study Design**: Double-blind,', 'Gait Parameters**: - **Study Design**: Randomized,', 'Certolizumab Pegol - **Study Design**: Randomized,', 'Life Study)**: - **Study Design**: Randomized', 'Chemotherapy (MFL)**: - **Study Design**: Randomized', 'Nerve Block**: - **Objective**: Compare US', 'Severe Asthma:** - **Efficacy:** Salmeterol (50', 'Surgical ICU**: - **Study Design**: Pre-', 'Traumatic Lacerations**: - **Study Design**: Randomized', 'Severe Preeclampsia:** - **Study Design:** Women', 'Ischemic Intervals - **Study Design**: Patients', 'Primary Care**: - **Study Design**: Block', 'Needle Insertion**: - **Study Design**: Randomized,', 'Reduce Falls**: - **Study Design**: Randomized', 'Prevent Blockage**: - **Study Design**: Multisite', 'Y-set Systems**: - **Study Design**: Randomized', 'Poor Responders** - **Objective:** Compare GnRH', 'Corticomotor Excitability**: - **Study Design**: Cohort', 'Midfemoral Level**: - **Objective**: Compare US', 'Methylphenidate (MPH-IR)**: - **Study Design**: Double-blind,', 'Catheter Insertion**: - **Study Design**: Double-blind,', 'Compression (IPC)**: - **Study Design**: Randomized,', 'Anxiety Disorders**: - **Study Design**: Randomized,', '(BRAVE Study)**: - **Study Design**: Open-label,', 'Neck Cancer**: - **Study Design**: Randomized,', 'Ophthalmic Solution) - **Study Design**: Multicenter,', 'Nerve Blocks**: - **Study Design**: Randomized,', '(r-UK) Study**: - **Design**: Phase II,', 'Functional Outcomes**: - **Study Design**: Prospective', 'Lung Cancer**: - **Study Design**: Phase', 'Betamethasone (Postpartum)**: - **Study Design**: Prospective,', 'VAP Prevention**: - **Study Design**: Pre-', 'Ophthalmic Ointment - **Study Design**: Randomized,', 'Supportive Care**: - **Study Design**: Randomized', 'Nonplatinum Chemotherapy**: - **Study Design**: Randomized,', 'Cervical Cancer**: - **Study Design**: Two-stage,', 'Plexus Block**: - **Objective**: Compare US', 'Integrative Approaches**: - **Study Design**: Randomized', 'Bloodstream Infections**: - **Study Design**: Pre-', 'Physical Therapy - **Study Design**: Randomized', 'African-American Women**: - **Objective**: Reduce IPV', 'Functional Tasks**: - **Study Design**: Randomized', 'Control (Antepartum)**: - **Study Design**: Prospective,', 'Sodium Hypochlorite**: - **Study Design**: Controlled', 'Shoulder Replacement - **Study Population**: Various', 'Gold Thiomalate)**: - **Study Design**: Placebo-controlled,', 'Cancer (AOC)**: - **Study Design**: Randomized', 'Placebo (Antepartum)**: - **Study Design**: Prospective,', 'Injectable Anesthetics**: - **Study Design**: Prospective,', 'Neurodevelopmental Exercises**: - **Study Design**: Controlled', 'Key Findings - **Preschool Children**: ADCs', 'Liver Resections - **Study Design**: Patients', 'Additional Studies: - **Metaproterenol Delivery:** No', 'PAD Patients**: - **Study Design**: PAD', 'Bag Systems**: - **Study Design**: Prospective', 'Tunnel Decompression**: - **Study Design**: Randomized', 'Ischemic Stroke**: - **Study Design**: Randomized', 'Acid Gel - **Study Design**: Double-blind', 'Operating Theatre**: - **Study Design**: Double-blind,', 'Cardiac Arrest**: - **Overall Survival**: No', 'Cardiac Catheterization**: - **Study Design**: Blinded,', '(BY) Systems**: - **Study Design**: Single-center', '(Multiple Injection)**: - **Objective**: Compare US', 'Chemotherapy-Induced Anemia**: - **Study Design**: Randomized,', 'Fluticasone Propionate:** - **Efficacy:** Ciclesonide (both', 'Exclusion (HVE) - **Study Design**: Noncirrhotic', 'Lymphoproliferative Malignancies**: - **Study Design**: Randomized,', 'Tunnel Surgery**: - **Study Design**: Randomized', 'Anxiety Disorders**: - **Study Design**: Double-blind,', 'Neurogenic Bladder**: - **Study Design**: Randomized,', 'Long-Term Benefit**: - **Study Design**: Randomized', 'Exclusion (MTHVE) - **Study Design**: Patients', 'Unfractionated Heparin**: - **Study Design**: Randomized,', 'Compliance Auditing**: - **Study Design**: Pre-', 'Betamethasone (Antepartum)**: - **Study Design**: Prospective,', 'Same-Day Appointments**: - **Study Design**: Interrupted', 'Neuromuscular Stimulation - **Study Design**: Double-blind,', 'Pedicular Clamping - **Study Design**: Patients', 'US Guidance)**: - **Objective**: Compare US', 'Dental Procedures**: - **Study Design**: A', 'Simple Lacerations**: - **Study Design**: Prospective,', 'Acute Stroke**: - **Study Design**: Single-blind,', 'Mild Preeclampsia:** - **Study Design:** Women', '(U) Systems**: - **Study Design**: Randomized', 'Replacement (THR)**: - **Reoperation Rates**: THR', 'Stimulation (TS)**: - **Study Design**: Randomized', 'GP Workload**: - **Study Design**: Randomized', 'Onset HELLP)**: - **Study Design**: Randomized,', 'Anxiety Disorder**: - **Study Design**: Randomized,', 'Gait Retraining - **Study Design**: Randomized', '(Double Injection)**: - **Objective**: Compare US', 'Various Surgeries**: - **Study Design**: Double-blind,', '(Second Study)**: - **Study Design**: Randomized,', 'Insulin Dose - **Insulin Requirements**: CSII', 'IV Catheterization**: - **Study Design**: Double-blind,', 'Acute Leukemia**: - **Study Design**: Prospective,', 'CA-BSI Reduction**: - **Study Design**: Multi-institutional,']"},{"template":"NN IN CD NNS VBD IN","text":"['study with 2019 women found that', 'study with 65 adults found that', 'trial with 329 patients found that', 'study with 217 patients found that', 'trial with 90 patients showed that', 'trial with 533 patients found that', 'study with 60 women found that', 'analysis of 1030 patients showed that', 'trial with 600 patients found that', 'trial with 302 patients found that', 'study with nine patients demonstrated that', 'study of 24 preschoolers found that', 'program with 45 patients found that', 'trial with 251 patients showed that', 'study with 560 adults found that', 'study with 61 patients indicated that', 'study with 84 girls found that', 'study with 55 patients found that', 'trial with 217 patients found that', 'trial with 208 patients found that', 'study with 506 mothers found that', 'trial with 215 adolescents found that', 'trial with 97 veterans showed that', 'trial with 63 inpatients found that', 'trial with 942 patients found that', 'home over three months showed that', 'study with 150 outpatients found that', 'study with 479 patients found that', 'trial with 22 patients found that', 'study with 120 patients found that', 'study with 283 patients suggested that', 'study with 542 women found that', 'study with 69 patients showed that', 'study with 50 patients found that', 'trial with 265 patients found that', 'study with 28 patients found that', 'trial with 114 patients found that', 'trial with 393 patients found that', 'study with 104 patients found that', 'trial with 232 patients found that', 'study with 109 children found that', 'study with 300 girls found that', 'trial with 200 women found that', 'study with 40 patients found that', 'study with 108 patients found that', 'study with 12 patients suggested that', 'trial with 152 adolescents found that', 'study with 33 women showed that', 'study with 123 adolescents found that', 'trial with 214 patients found that', 'study with 126 women showed that', 'study with 121 patients found that', 'trial with 1,801 patients found that', 'trial with 387 patients found that', 'study with 291 patients found that', 'trial of 40 infants showed that', 'trial with 240 women found that', 'study of 100 women found that', 'study with 4228 patients found that', 'trial with 11 patients showed that', 'trial with 211 patients found that', 'study with 73 children found that', 'study with 34 women showed that', 'trial with 753 neonates found that', 'comparison with 80 patients confirmed that', 'trial with 115 patients found that', 'study of 288 students found that', 'trial with 10 patients showed that', 'trial with 138 patients found that', 'study with 201 outpatients showed that', 'trial with 80 patients found that', 'study of 67 patients found that', 'study with 117 children found that', 'study of 50 women found that', 'trial with 64 patients found that', 'trial with 48 women found that', 'trial with 125 patients found that', 'study with 100 patients found that', 'study with 520 patients found that', 'study with 117 patients found that', 'study with 60 patients found that', 'study with 63 patients found that', 'study with 167 patients found that', 'study with 63 patients showed that', 'placebo for 8 days showed that', 'trial with 50 women found that', 'trial with 345 women found that', 'trial with 613 patients found that', 'trial with 223 patients found that', 'study with 242 patients demonstrated that', 'study with 36 women demonstrated that', 'trial with 396 women showed that', 'trial with 405 patients found that', 'trial with 554 patients demonstrated that', 'trial with 1,275 patients found that', 'study with 39 children found that', 'trial with 407 patients found that', 'trial with 21 patients divided into', 'study with 194 patients found that', 'trial with 418 adolescents found that', 'study of 60 women found that', 'study with 74 patients found that', 'study with 101 patients demonstrated that', 'trial with 190 patients showed that', 'trial with 598 patients found that', 'study with 7,077 women showed that', 'trial with 2382 participants found that', 'study with 114 patients showed that', 'study with 62 patients found that', 'trial with 84 women found that', 'study with 28 adults found that', 'trial with 154 participants showed that', 'study with 1378 patients found that', 'trial with 626 patients found that', 'study with 38 patients found that', 'trial with 10 patients indicated that', 'trial with 386 patients found that', 'trial with 1,004 patients found that', 'trial with 39 women found that', 'trial with 409 women showed that', 'trial with 100 women found that', 'study with 12 patients showed that', 'study with 79 patients found that', 'trial with 191 patients found that', 'study with 200 women found that', 'study with 190 patients found that']"},{"template":"DT JJ NN IN JJ NN","text":"['No significant difference in overall survival', 'a limited advantage over cranberry extract', 'a viable option for primary screening,', 'a significant increase in intraocular pressure', 'No significant difference in mental status', 'no significant difference in ovarian response', 'A 21\/7-day regimen of norgestimate\/ethinyl estradiol', 'A significant sex by genotype interaction', 'the conventional protocol in poor responders.', 'a severe infection in cirrhotic patients,', 'a slight increase in contraceptive use', 'no significant difference in median survival,', 'No significant effect of patient vaccination', 'a significant decrease in uterine, leiomyoma,', 'a significant reduction in mean amplitude', 'no significant difference in immediate efficacy', 'an educational intervention on contraceptive compliance', 'No overall effect of sweet taste', 'the primary endpoint of sustained disability', 'a similar incidence of adverse events.', 'the common cold in various populations,', 'a steroid-sparing agent in severe asthma.', 'a significant increase in urinary estrogen', 'No significant development of antimicrobial resistance', 'a non-significant effect among overweight women.', 'a non-significant reduction in 24-hour blood', 'no significant difference in myopia progression', 'a 12-week study of treatment-resistant patients,', 'a 20-week period, though grip strength', 'No significant improvement in liver function', 'a progressive disease in many patients.', 'a strong correlation between detectable drug', 'the clinical significance of antioxidant therapy', 'a 12-day course of inhaled beclomethasone', 'The unexpected effect of educational intervention', 'a CVD-prevention program on lifestyle factors.', 'no significant difference in steroid consumption', 'a significant reduction in overweight prevalence', 'no significant difference between interferon beta-1a', 'a slight reduction in depressive symptoms,', 'a disulfiram regimen among discharged alcohol', 'no significant impact on mortality, duration', 'no significant difference in overall evaluation', 'a maternal-child program with comprehensive support', 'a short course of oral prednisolone', 'a fast-track protocol on postoperative morbidity', 'No objective change in social behavior', 'a significant increase in clinical pregnancy', 'a significant increase in child abuse', 'a three-day course of oral ciprofloxacin,', 'no significant difference in incident depression', 'No significant effect on visual acuity,', 'a significant effect on neonatal mortality.', 'a first episode of biliary colic', 'A significant improvement in disease-free survival', 'no significant effect on neurological development', 'a viable alternative for colorectal cancer', 'the mixed effectiveness of various health', 'a protective effect on upper respiratory', 'an Internet-based program for weight loss', 'a protective strategy against such injury.', 'The incremental cost per additional QALY', 'a \u226520% improvement in pulmonary function', 'no significant difference in fever duration', 'no significant difference in health-related quality', 'the toxic accumulation of beta-amyloid (Abeta).', 'No significant difference in apnea incidence', 'the first choice for severe infections,', 'no significant difference in axial length', 'no significant impairment in immune response', 'The 30-microg dose of interferon beta-1a', 'a well-tolerated option for long-term use.', 'the 8-day course with traditional packaging.', 'a significant reduction in soluble thrombomodulin', 'no significant difference in overall mortality', 'no significant difference in weight gain', 'The high rate of histologic regression', 'no significant difference in self-reported pain', 'a significant improvement in long-term survival', 'no significant difference in leukoplakia reduction', 'no significant effect on night-wetting frequency', 'A significant difference in serum albumin', 'a significant increase in plasma folate', 'a significant decline in preclinical pregnancy', 'a modest reduction in nocturnal asthma', 'no significant difference in symptom improvement', 'a single session of motivational interviewing', 'a fast-track protocol after open bowel', 'a significant reduction in colorectal adenomas', 'an effective dose of all-trans-retinoic acid', 'a weight decrease of 4.3-4.5 kg', 'No significant benefit in non-rotavirus diarrhea.', 'the high rate of virological failure', 'a significant influence of physical activity', 'a viable alternative for umbilical cord', 'a significant increase in mean heart', 'no significant difference in tic exacerbation', 'a 12-week course of oral prednisolone', 'a full course of antenatal corticosteroids.', 'a significant rise in serum potassium', 'a viable option for single-tooth replacement', 'a significant reduction in ovarian hyperstimulation', 'an adjunctive treatment for bipolar disorder,', 'no significant suppression of urinary cortisol', 'no significant difference in anxiety, satisfaction,', 'a critical window for early intervention', 'a beneficial effect on prostanoid metabolism', 'a low frequency of adverse events.', 'no clear evidence of superior efficacy', 'a significant increase in contraceptive uptake', 'no significant difference in neurological complication', 'a standard treatment for primary prophylaxis', 'a common infection in immunocompromised patients,', 'the clinical course of transient tachypnea', 'no significant difference in early weaning', 'a significant predictor of adverse outcomes.', 'the practical advantage of once-weekly dosing.', 'a fatal condition with limited treatment']"},{"template":"NNP NNP IN NNP NNP :","text":"['IVF Outcomes in AMA Patients**: -', 'IIIB Carcinoma without Surgical Staging)**: -', 'Acetate (MA) in Cancer-Associated Wasting -', 'Circuit Class for Locomotor Function**: -', 'Circuit Class for Chronic Stroke**: -', 'Sodium Reduction in Overweight Adults -', 'Commercial Lidocaine in Ear Surgery**: -', 'Model Programs for Homeless Adults**: -', 'Commercial Software in Behavioral Programs -', 'Home-Visit Intervention for Medication Adherence**: -', 'C\u00f4me Device for Postural Rehabilitation**: -', 'Weight Loss in Primary Care -', 'Management (ICM) for Upper-Extremity Disorders**: -', 'Training Interventions on Gait Parameters**: -', 'Weight Management in Military Personnel -', 'Y-shaped Set with Sodium Hypochlorite**: -', 'Aerobic Exercise for HIV-Infected Adults**: -', 'Telephone Calls for ART Adherence**: -', 'Living Advice for Diabetes Risk**: -', 'Management Program for High Utilizers**: -', 'Endovaginal Ultrasound in Preterm PROM:** -', 'PSA Levels in Afro-Caribbean Men**: -', 'Dementia (AD) with Psychotic Symptoms -', 'Common Cold with Specific Bacteria -', 'Stainless Steel vs. NiTi Archwires**: -', 'Substance Misuse in Early Psychosis**: -', 'Methenamine Hippurate After Gynecologic Surgery**: -', 'Optimal Treatment for Rheumatoid Shoulder -', 'Telephone Consultations on GP Workload**: -', 'Artificial Disc vs. Circumferential Fusion:** -', 'Vitamin E in Generalized Malignancy -', 'Therapy (NET) for Sudanese Refugees**: -', 'Collaborative Care for Postpartum Depression**: -', 'Inhalation (TSI) in Young Children**: -', 'Pathway (ICP) for Stroke Rehabilitation:** -', 'Nerve Block at Midfemoral Level**: -', 'Spine Radiographs in Emergency Settings**: -', 'Serious Pathology in Acute LBP**: -', 'Persons Living with AIDS (PLWA)**: -', 'NiTi Archwires in Resolving Crowding**: -', 'Collaborative Care for Older Adults**: -', 'Collaborative Care for Hispanic Patients**: -', 'Telephone Triage for Same-Day Appointments**: -', 'Asymptomatic Bacteriuria in Antenatal Clinic**: -', 'Low-Grade SIL in HIV-Positive Women -', 'Training (BWSTT) for Long-Term Benefit**: -', 'Implant Placement with Immediate Provisionalization:** -', 'Superelastic NiTi vs. Single-Stranded NiTi**: -', 'Back Pain by Occupational Physicians**: -', 'Discharge Plan for Elderly Patients:** -', 'Acid (RA) for CIN II\/III -', 'PTFE Bypass with Vein Cuff -', 'Foam Dressing for Pain Relief**: -', 'GnRHa Protocol in Poor Responders** -', 'Safety Program for Low-Income Families**: -', 'Contingency Management in Community Settings**: -', 'Saline Irrigation for Long-Term Catheters**: -', 'Self-Regulation Program for Weight Maintenance -', 'Central Hospital of Hu\u00e9, Vietnam**: -', 'Collaborative Treatment for Chinese Americans**: -', 'Text Messaging for Maori Smokers**: -', 'Bone Grafts at Immediate Implants:** -', 'Strengthening Exercises for Knee OA**: -', 'Vein Collar in PTFE Bypass -', 'Cessation Program with Support Groups**: -', 'Weight Maintenance in Perimenopausal Women -', 'Randomized Study on Rectal Adenocarcinoma**: -', 'PUFA Supplementation in PAD Patients**: -', 'Prevention Integrated with Prenatal Care**: -', 'Knee Contractures in OA Patients**: -', 'Dietary Counseling in Healthy Adults -', 'GnRH-Antagonist Protocol in Poor Responders** -', 'Controlled Trial on Transfusion Strategies**: -', 'Different Magnifiers in Geriatric Patients**: -', 'Agonist Protocol in Low Responders** -', 'Telephone Support for ART Adherence**: -', 'Long Protocol in Poor Responders** -', 'MgSO\u2084 Therapy for Mild Preeclampsia:** -', 'Tract Infection with Purulent Rhinorrhea -', 'Care Management for Multiple Conditions**: -', 'Invasive Surgery for LAD Lesions**: -', \"John's Wort for Painful Polyneuropathy -\", 'Nerve Block at Popliteal Fossa**: -', 'Enacarbil (GEn) for Migraine Prophylaxis -', 'Unbuffered Lidocaine in Traumatic Lacerations**: -', 'Surface Cooling in Awake Patients**: -', 'Cranberry Tablets in Neuropathic Bladder**: -', 'Long-Term Outcomes of Shoulder Arthroplasty -', 'Collaborative Care for HIV Patients**: -', 'Prophylaxis Protocol for Dialysis Catheters**: -', 'Close Monitoring for Minor Depression**: -', 'Cuff Repair in RA Patients -', 'Discharge Planning for Elderly Patients:** -', 'Iron Gluconate in Hemodialysis Patients**: -', 'Phone Counseling for ART Adherence**: -', 'Therapy (CAP) vs. Psychoeducation (PE)**: -', 'Telephone Service for Ambulatory Care**: -', 'Telephone Support for Depressive Symptoms**: -', 'Potassium-Enriched Salt in Elderly Veterans -', 'Telecare Management for Cancer Patients**: -', 'Collaborative Care for Late-Life Depression**: -', '(TXA\u2082) Levels in Severe Preeclampsia:** -', 'Vein Cuff in Femoral-Popliteal Bypass -', 'Diet (LBD) in Cytopenic Patients:** -', 'Distraction Education for IV Insertion**: -', 'Raw Diet in AML Patients:** -', 'Inflow Occlusion in Cirrhotic Patients -', 'Collaborative Care for Cancer Patients**: -', 'Maori Smokers in New Zealand**: -', 'Ultrasound Therapy in Knee OA**: -', 'MgSO\u2084 Regimens in Severe Pre-eclampsia:** -', 'Telephone Protocols in Emergency Room**: -', 'Loss Program with Behavioral E-Counseling -', 'Pain Management in Postoperative Care**: -', 'C (APC) vs. Unfractionated Heparin**: -', 'People Living with HIV (YPLH)**: -', 'Book Preparation for Blood Sampling**: -', 'Excision (APE) vs. Coloanal Procedures:** -']"},{"template":"NN IN DT JJ NN IN","text":"['delivery with an intact perineum for', 'impact of a fast-track protocol on', 'disability, with no significant difference between', 'post-gingivectomy, with a 6-7% difference at', 'loss with no significant difference in', 'agonist at the glycine site of', 'filling of the pancreatic duct with', 'placebo, with a notable duration of', 'completion of a clinic visit within', 'loss in the first week without', 'effect on the mean number of', 'improvement in the pramipexole group, with', 'efficacy of a short course of', 'difference in the primary outcome between', 'difference in the overall risk of', 'avoidance of the supine position for', 'hMG on the first day of', 'mg\/day) over a mean follow-up of', 'addition of a 10-day course of', 'effect of a CVD-prevention program on', 'injection over a 20-week period, though', 'nimodipine as a standard treatment for', 'duration of the third stage of', 'response in the high-dose group for', 'phase versus the conventional protocol in', 'placebo in the short-term treatment of', 'duration of the second phase of', 'oxygen on the third day of', '(GEn) in the prophylactic treatment of', 'effectiveness of an educational intervention on', '(Syntometrine) in the active management of', 'months, with no significant difference between', 'disorder, with a particular focus on', 'safety in the prophylactic treatment of', 'g) with a 3-day course of', 'impact of a single dose of', 'cases), with a significant portion of', 'efficacy of a 2-minute infusion of', '(E-EPA) as an adjunct treatment in', 'placebo as the first step in', 'protocol with a halved dose during', 'tolerability as an add-on therapy in', 'abortion, with no significant difference in', 'formation of a hybrid layer, with', 'frequency, with no significant difference between', 'efficacy of a nortriptyline-fluphenazine combination in', '**Clobazam**: In a dose-ranging study with', 'severity, with no significant difference between', 'teeth, with no significant difference between', 'analgesia with a similar duration of', 'regression, with a mean survival of', 'completely, with no significant difference between', 'option for the rapid control of', 'compliance with a disulfiram regimen among', '<.01), with no significant difference between', 'ml\/kg over the first week, while', 'placebo for the same duration, with', 'pregnancy, with a significant risk of', 'groups, with no significant difference in', 'size of the velopharyngeal gap during', 'extraction of the primary canine with', 'azoospermia in a significant proportion of', 'management of the third stage of', 'years, with a main analysis over', 'activities, with no significant difference in', 'impairment from an elementary school in', 'improvement in the role-physical domain of', 'disease in the long term for', 'evidence for a small impact on', 'monitoring, with no clear evidence of', 'drainage of the pancreatic duct with', 'carbamazepine as a valuable alternative for', 'reduction in the labial segments, while', 'state with a high prevalence of', 'pain during the first stage of', 'effect of a 21-day supplementation with', 'difference in the combined endpoint of', 'potential as an alternative treatment for', 'effect on the primary endpoint of', 'hours, with a significant difference at', 'frusemide) on the clinical course of', 'size of the residual gap at', '(MTX) as a steroid-sparing agent in', 'patients, with no significant difference between', 'mechanism behind the hypotensive effect of', 'insulin during the first year of', 'failure in the high-volume group, with', '(DHE)**: In a small study with', 'colonization of the digestive tract with', 'safety of a fast-track protocol after', 'reduction in the relative hazard of', 'placebo via a subcutaneous pump after', 'women, with a notable increase within', 'functioning despite a significant decrease in', 'confidence, though no significant difference in', '(recFSH) during the luteal phase versus', 'patients, with an average age of']"},{"template":"NNP NNP IN NNP NNP NNP","text":"['Tramadol\/APAP Combination for Chronic Low Back', 'Discharge Planning by Admitting Department Personnel:**', 'Drug Combinations for Late-Stage Disease A', 'Immunoglobulin (IVIG) in Secondary Progressive Multiple', 'Cognitive Treatment vs. Non-Specific Mental Stimulation**:', \"Children's Hospital of Eastern Ontario Pain\", 'Safety Guidelines in Pediatric Oncology Patients:**', 'Cross-Over Trial of Four Insulin Regimens**:', 'Antenatal Care for Obese Women A', 'Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis', \"Donepezil Efficacy in Alzheimer's Disease ####\", 'Topical Steroids in Treating Acute Sinusitis', 'Nutrition (TPN) for Malnourished AIDS Patients**:', 'Plus Cisplatin vs. S-1 Alone**: S-1', '(APAP) Combination for Chronic Lower Back', 'Prevention Interventions for Mexican-American Women**: A', 'Superelastic Ni-Ti vs. Triple-Stranded Steel Archwires**:', 'High-Dose Steroids in Small Intestine CD:**', 'Luteal Phase in Long-Protocol GnRH Agonist', 'Local Anesthesia in Carotid Endarterectomy Several', 'Tramadol Monotherapy for Chronic Low Back', 'Occlusion (IPO) with Different Ischemic Intervals', 'Inhalation (TSI) in Young CF Patients**:', 'Iron Sucrose in Peritoneal Dialysis (PD)', 'Treatment Protocol in Skilled Nursing Facility**:', 'Reprocessing (EMDR) for Female Sexual Assault', 'Therapy (PRT) vs. Cyclophosphamide-Doxorubicin-Cisplatin (CAP) Chemotherapy**:', '### Summary of Calcium Supplementation Studies', 'Oral Iron in Non-Dialysis CKD Patients**:', 'Artificial Disc vs. Anterior Lumbar Interbody', 'Care Management for Latino Medicaid Patients**:', 'LABA Addition vs. ICS Dose Doubling**:', 'Protection Education for Rheumatoid Arthritis**: A', 'RT Combined with Chemotherapy (Cisplatin, Epirubicin,', 'Computer-Tailored Feedback vs. Human E-Mail Counseling', '(AP) View in Lumbar Spine Radiography**:', 'Povidone Iodine vs. Povidone Iodine Alone**:', 'Health Interventions for Rural HIV-Infected Persons**:', 'Lifestyle Counseling for GDM Prevention Lifestyle', 'Long-Term Outcomes in UK MRC CLASICC', 'Off-Pump Surgery for Proximal LAD Lesions**:', 'Calorie Restriction in Obese Pregnant Women', 'Multicenter Study on Initial Chemotherapy (MFL)**:', 'Interferon Beta-1a in Poor Responders **Objective:**', 'Diet (NHD) vs. Low-Bacterial Diet (LBD)', 'Lifestyle Intervention in Obese Pregnant Women', 'Global Assessment of Change, Principal Investigator', 'Dietary Counseling in Public Health Service', 'Warmed Lidocaine in Carpal Tunnel Decompression**:', '(DHS) Model in Urban Indian Health', 'Aerobic Training in Overweight Pregnant Women', 'Group Psychotherapy for Metastatic Breast Cancer', 'Graded Activity for Low Back Pain**:', 'Primary Care for Problem Drinking**: A', 'EPA-EE Supplementation in Weight-Losing Cancer Patients', 'Study (Stenting vs. Internal Mammary Artery)**:', 'Implant Placement with Acid-Etched Surfaces (Osseotite):**', 'Skills Training vs. School Reintegration**: A', 'Nutrition Education in Pregnant Adolescents A', 'Phenytoin Powder vs. Normal Saline**: A', 'Carotene Study in US Physicians**: A', 'Step Recovery vs. Behavioral Skills Training', 'Methenamine Hippurate in Uterovaginal Prolapse Surgery**:', 'Brief Intervention in Northern Territory Indigenous', 'Clinical Trials on Multiple Sclerosis Treatments', 'Fraction V in Small Cell Lung', 'Irradiation (WAI) vs. Doxorubicin-Cisplatin (AP) Chemotherapy**:', 'Interviewing (MI) vs. Educational Treatment (ET)**:', \"Anti-TNF Therapies for Crohn's Disease ####\", 'World Federation of Neurological Surgeons (WFNS)', 'Interferon Beta-1b in Primary Progressive Multiple', 'Carotene Study in US Physicians**: No', 'Naltrexone Efficacy in Treating Alcohol Dependence', 'E Study in Female Health Professionals**:', 'Low-Dose Atorvastatin with High-Dose Interferon Beta-1a', 'Management Training for HIV-Infected Gay Men**:', 'Sexual Behavior in Older HIV-Infected Adults**:', 'Stimulation Protocols in Poor Responders **Study', 'Chronic Pain in Spinal Cord Injury', 'Decision Aid in SPAF III Trial**:', 'Stimulation (TENS) for Chronic Neck Pain**:', 'Length Measurement in Threatened Preterm Labor:**', 'Long-Term Outcomes of Total Shoulder Arthroplasty', 'Regeneration (GTR) with Expanded Polytetrafluoroethylene (ePTFE)', 'Nursing Intervention for Pediatric HIV Patients**:', 'Case Management for Musculoskeletal Disorders (MSDs)**:', 'Exchange Strategies in Public Health (Canada)**:', 'Photocoagulation (GLP) for Cystoid Macular Edema', 'Relaxation Training for Sexual Aggression Victims**:', 'EPA Supplement vs. Megestrol Acetate (MA)', 'Foot Orthoses for Cavus Foot Pain**:', 'Prevention Program in Norway **Objective:** Evaluate', 'Polymyxin B in Acute Nonlymphocytic Leukemia**:', 'Acetate (GA) in Relapsing-Remitting Multiple Sclerosis', 'Colectomy (OC) for Colorectal Cancer ####', 'Gamma Nail vs. Medoff Sliding Plate**:', 'Clamp\/Release Regime for Intermittent Portal Clamping', 'Behavioral Coping for Bone Marrow Aspirations**:', 'Fatty Acids in Cachectic Pancreatic Cancer', 'Manual Therapy for Acute Cervical Pain**:', 'Twin Bag vs. Ultra Y-set Systems**:', 'Pain Relief in Acute Exudative Pharyngitis:**', 'Fall Prevention in Taiwan **Objective:** Determine', 'Marginal Defects with Anorganic Bovine Bone:**', 'Life (QoL) in Colorectal Cancer (CRC)', 'C Study in US Male Physicians**:', 'Group Techniques in Hospitalized Schizophrenic Clients', 'Nortriptyline-Fluphenazine Combination for Painful Diabetic Polyneuropathy', 'Fraction V in Non-Small Cell Lung', 'Cuff Repair in Rheumatoid Arthritis Patients', 'Outpatient Department of Port Moresby General', 'Topical Budesonide in Acute Maxillary Sinusitis', 'Developmental Interventions for Very Preterm Infants', 'Nicotine Patch in Serious Mental Illness', 'Global Assessment of Change, Patient Analog']"},{"template":"NNP NNP : NN TO VB","text":"['Preterm Labor:** - **Objective:** To determine', 'III Trial**: - **Objective**: To assess', 'Diabetic Neuropathy - **Objective**: To study', 'Schizophrenic Clients - **Objective**: To assess', 'Maxillary Sinusitis - **Objective:** To compare', 'Precursor Study**: - **Objective**: To test', 'Supplementation Study**: - **Objective**: To test', 'Trial (1998-1999)** - **Objective:** To determine', 'Cancer Prevention**: - **Objective**: To test', 'Psychiatric Disorders**: - **Objective**: To assess', 'Tobacco Marketing**: - Receptivity to tobacco', 'Postherpetic Neuralgia - **Objective**: To determine', 'Ghent (Belgium)**: - **Objective**: To promote', 'Femoral-Popliteal Bypass - **Objective**: To determine', 'Mouth Syndrome - **Objective**: To evaluate', 'Facial Pain - **Objective**: To evaluate', 'Pain Conditions - **Objective**: To compare', '(TD) Study**: - **Objective**: To compare', 'Pilot Trial** - **Objective:** To assess', 'Restraint Use**: - **Objective**: To compare', 'Desipramine Trial** - **Objective:** To evaluate', 'Low-Income Families**: - **Objective**: To assess', 'Diabetic Polyneuropathy - **Objective**: To evaluate', 'Schizophrenia Study**: - **Objective**: To evaluate', 'Painful Polyneuropathy - **Objective**: To test', 'Hospital Initiative** - **Objective:** To assess', 'Mouth Pain - **Objective**: To evaluate', 'Sinusitis-Type Symptoms - **Objective:** To determine', 'HIV-Positive Women - **Objective**: To estimate', 'Postherpetic Neuralgia - **Objective**: To evaluate', 'Maxillary Sinusitis - **Objective:** To determine', 'Hepatitis C**: - **Objective**: To assess', 'York State**: - **Objective**: To evaluate', 'Cancer-Associated Wasting - **Objective**: To determine', 'Cancer Pain - **Objective**: To evaluate', 'Impairment Study**: - **Objective**: To determine', 'Warfarin Knowledge**: - **Objective**: To evaluate', 'Diabetic Polyneuropathy - **Objective**: To compare', 'BP Individuals - **Objective:** To test', 'Hepatitis B**: - **Objective**: To evaluate', 'Seat Campaign**: - **Objective**: To evaluate', 'Sensory Neuropathy - **Objective**: To evaluate', 'Sinusitis-Like Complaints - **Objective:** To assess', 'Preterm PROM:** - **Objective:** To assess', 'Diabetic Neuropathy - **Objective**: To compare', 'C Non-Responders**: - **Objective**: To determine', 'Purulent Rhinorrhea - **Objective:** To compare', 'Rhode Island**: - **Objective**: To evaluate', 'Cord Injury - **Objective**: To determine', 'Infectious Mononucleosis:** - **Objective:** To evaluate', 'Alcoholic Hepatitis**: - **Objective**: To assess', 'Drugs Study**: - **Objective**: To test', 'Healthy Adults - **Objective:** To assess', 'Reduction Therapy - **Objective**: To investigate', 'AML Patients:** - **Objective:** To evaluate', 'Postherpetic Neuralgia - **Objective**: To study', 'Blood Transfusion**: - **Objective**: To assess', 'Elderly Veterans - **Objective:** To examine', 'Transfusion Strategies**: - **Objective**: To compare', 'Bootheel Region**: - **Objective**: To examine', 'Acute Rhinosinusitis - **Objective:** To evaluate', 'Vein Cuff - **Objective**: To evaluate', '(SMAAF Study)**: - **Objective**: To compare', 'Paroxetine Trial** - **Objective:** To assess', 'Supplementation Studies**: - **Objective**: To investigate', 'Exudative Pharyngitis:** - **Objective:** To assess', 'Cancer Treatment - **Objective**: To evaluate', 'Health Program**: - **Objective**: To accelerate', 'Oral-Facial Pain - **Objective**: To evaluate', 'Makler Cannula** - **Objective:** To compare', 'Zoster Pain - **Objective**: To evaluate', 'Neuropathic Pain - **Objective**: To investigate', 'Poststroke Pain - **Objective**: To investigate', 'Cancer Patients - **Objective**: To compare', 'Vein Cuff - **Objective**: To compare', 'Portal Hypertension**: - **Objective**: To evaluate', 'Mental Illness - **Objective**: To compare', 'Anticoagulant Therapy**: - **Objective**: To compare', 'Peripheral Neuropathy - **Objective**: To evaluate', 'Steroid Treatment - **Objective**: To evaluate', 'Cytopenic Patients:** - **Objective:** To compare', 'Postherpetic Neuralgia - **Objective**: To compare', 'Therapy Intervention - **Objective**: To compare', 'Monitoring (AM)**: - **Objective**: To evaluate', 'Cancer Patients - **Objective**: To assess', 'Nicotine Patch - **Objective**: To determine', 'West Virginia**: - **Objective**: To promote', 'Major Depression**: - **Objective**: To determine', 'Controlled Trial** - **Objective:** To evaluate', 'Generalized Malignancy - **Objective**: To investigate', 'CIN II\/III - **Objective**: To determine', 'Acute Rhinosinusitis - **Objective:** To determine', 'South Carolina**: - **Objective**: To evaluate', 'Oral Prednisolone - **Objective**: To evaluate', 'Advance Directives** - **Objective:** To evaluate', 'Diabetic Neuropathy - **Objective**: To evaluate', 'Center, Japan** - **Objective:** To evaluate', 'Specific Bacteria - **Objective:** To assess', 'Oxidative Status**: - **Objective**: To assess', 'Anticoagulation Clinics**: - **Objective**: To determine', 'Overweight Adults - **Objective:** To test', 'Management Program**: - **Objective**: To reduce', '(FEP) Study**: - **Objective**: To assess', 'Oncology Patients:** - **Objective:** To compare', 'Program (Iran)**: - **Objective**: To assess', 'Painful Polyneuropathy - **Objective**: To compare', 'Crisis Plans** - **Objective:** To investigate', 'PTFE Bypass - **Objective**: To determine']"},{"template":"NNP NNP : DT NN IN","text":"['Geriatric Patients**: - A study with', 'At-Risk Drinking**: - A trial with', 'Military Recruits**: - A study with', 'Trigger Points**: - A study with', 'Postpartum Depression**: - A study with', 'HIV Patients**: - A trial with', 'Video Intervention**: - A study with', 'Ischemia (DCI):** - A study with', 'Upper-Extremity Disorders**: - A trial with', 'Hemodialysis Patients**: - A study with', 'Postnatal Depression**: - A trial with', 'Neuropsychological Functions:** - A study on', 'Hispanic Patients**: - A trial with', 'Needle Pain**: - A study with', 'Oral Rinse**: - A trial with', 'Pharmacy Service:** - A study in', 'Minor Depression**: - A trial with', 'Transference Training**: - A study with', 'Rehabilitation Approaches**: - A trial with', 'Alcohol Abuse**: - A trial with', 'Poststroke Depression**: - A trial with', 'Chemotherapy Patients**: - The addition of', 'Multidisciplinary Treatment**: - A trial with', 'Blood Draws**: - A study with', 'HIV-Prevention Interventions**: - A study with', 'Levonorgestrel Implants**: - The combination of', 'Labor Duration**: - A study on', 'Lumbar Puncture**: - A study with', 'Multiple Conditions**: - A trial with', 'Physician Acceptability**: - A study with', 'Adolescent Mothers**: - A study with', 'Puerto Rico**: - A study with', 'Respiratory Biofeedback**: - A study with', 'E (Alpha-Tocopherol)**: - A study with', 'Prenatal Care**: - A study with', 'Large Print**: - A study with', 'Sex Intervention**: - A study with', 'Optical Magnifiers**: - A study with', 'Nasogastric Feeding:** - A study of', 'Arm Function**: - A trial with', 'Latino Patients**: - A study with', 'Maintenance Organization**: - A study with', 'Disease Progression**: - A study on', 'Late-Life Depression**: - A trial with', 'High-Risk Women**: - A study along', 'Low-Vision Aids**: - A study with', 'Depression Improvement**: - A study with', 'High Utilizers**: - A trial with', 'Arthritis (JIA)**: - A study with', 'Functional Appliances**: - A study with', 'Postural Rehabilitation**: - A study with', 'Management Model:** - A trial at', 'Osteoarthritis (COA)**: - A study with', 'Qigong (TCQ)**: - A study with', 'Cephalometric Changes**: - A study on', 'Post-CABG Depression**: - A trial with', 'Recurrent UTIs**: - A study with', 'Low-Income Women**: - A trial with', 'Behavioral Intervention**: - A study with', 'Acute Depression**: - A trial with', 'Therapy (m-CIMT)**: - A study with', 'Blood Sampling**: - A study with', 'Task Practice**: - A study with', 'Chinese Americans**: - A study with', 'Management (TEAM)**: - A trial with', 'Magnesium Sulfate**: - A study on', 'Whiplash Syndrome**: - A study with', 'Back Pain**: - A trial with', 'Discharge-Planning Intervention:** - A study in', 'Neck Pain**: - A trial with', 'Muscle Training**: - A study with', 'Marrow Aspirations**: - A study with', 'Cervical Pain**: - A study with', 'Care Patients**: - A trial with', 'Clinical Pharmacists**: - A trial with', 'Older Adults**: - A trial with', 'Care Assistants**: - A trial with', 'HIV Prevention**: - A study with', 'Tea Product**: - A trial with', 'Indanyl Sodium**: - A study with', 'Cannula Types**: - A study with', 'Occupational Physicians**: - A trial with', 'CRF Patients**: - A study with', 'Promotion Intervention**: - A study with', 'Leg Rehabilitation**: - A trial with', 'Depressed Adolescents**: - A trial with', 'Prevention Program**: - A study with', 'Immunization Pain**: - A study with', 'Stand Magnifiers**: - A study with', 'Magnesium Sulfate**: - A trial on', 'CKD Patients**: - A study with', 'Granulocytopenic Patients**: - The addition of', 'Model-Tailored Intervention**: - A study with', 'Anxiety Disorders**: - A trial with', 'Labor Induction**: - A study on', 'Depression Care**: - A study with', 'Risk-Reduction Intervention**: - A study with', 'Urban Patients**: - A study with', 'Depression Care**: - A trial with', 'Consult-Liaison Care**: - A trial with', 'Cardiac Patients**: - A trial with', 'Depression Intervention**: - A trial with', 'Norethisterone Enanthate**: - The combination of', 'Program (DBTP)**: - A study with', 'Epilepsy Patients**: - A trial with', 'Povidone-Iodine Enema**: - A study with', 'Hemodialysis Patients**: - A trial with', 'Care Plan:** - A study in', 'Cancer Patients**: - A trial with', 'Panic Disorder**: - A trial with']"},{"template":"NNP NNP NNP : NN NNP","text":"['Intramuscular Gold Thiomalate)**: - **Study Design**:', 'Acute Cerebral Ischemia**: - **Design**: Randomized,', 'Different Ischemic Intervals - **Study Design**:', 'Norplant System Insertion**: - **Study Design**:', 'Cup Resurfacing Hemiarthroplasty - **Study Population**:', 'Intermittent Pedicular Clamping - **Study Design**:', 'General Hospital Study**: - **Objective**: Study', 'Triple-Stranded Steel Archwires**: - **Study Design**:', 'Bromide Delivery Study**: - **Objective**: Evaluate', 'Digital Nerve Blocks**: - **Study Design**:', 'Polymyxin-Bacitracin Ophthalmic Ointment - **Study Design**:', 'Fenoterol Combination Study**: - **Design**: Randomized,', 'Weight Loss Program - **Objective:** Compare', 'Anesthetic Eyedrops Trial**: - **Design**: Randomized,', 'Social Anxiety Disorder**: - **Study Design**:', 'Chloramphenicol Eye Drops - **Study Design**:', 'Intermittent Clamping (IC) - **Study Design**:', 'Minor Liver Resections - **Study Design**:', 'CATIE Studies Overview - **Design Challenges**:', 'Pneumatic Compression (IPC)**: - **Study Design**:', 'IV Catheter Insertion**: - **Study Design**:', 'Urinary Catheter Care**: - **Study Design**:', 'Carpal Tunnel Surgery**: - **Study Design**:', 'Anesthetic Operating Theatre**: - **Study Design**:', 'UVXD (U) Systems**: - **Study Design**:', 'Brachial Plexus Blocks**: - **Objective**: Compare', 'Study (Qu\u00e9bec, Canada)**: - **Objective**: Evaluate', 'Twin Bag Systems**: - **Study Design**:', 'Vascular Exclusion (HVE) - **Study Design**:', 'Y-set (Y) Systems**: - **Study Design**:', 'Program (FAME Program)**: - **Design**: Prospective,', 'Previous Colorectal Cancer**: - **Design**: Randomized,', 'Press-Fit Humeral Stems - **Study Population**:', 'Familial Adenomatous Polyposis**: - **Design**: Randomized,', 'Urokinase (r-UK) Study**: - **Design**: Phase', 'National Guard Study**: - **Objective**: Compare', 'Shoulder Arthroplasty (TSA) - **Study Population**:', 'Full-Coverage Stabilization Splint:** - **Study:** Compared', 'Block (Multiple Injection)**: - **Objective**: Compare', 'Human E-Mail Counseling - **Objective:** Compare', 'Weight Gain Comparison - **Objective**: Compare', 'Out-of-Hours Primary Care**: - **Study Design**:', 'Humeral Head Replacement - **Study Population**:', 'Surface Replacement Arthroplasty - **Study Population**:', 'Acid-Etched Surfaces (Osseotite):** - **Study Design:**', 'Multistranded Steel Archwires**: - **Study Design**:', 'Intermittent Portal Clamping - **Study Design**:', 'Weight Loss Program - **Objective:** Evaluate', 'Disease #### CDP571 - **Study Design**:', 'Pulp Therapy (IPT)**: - **Objective**: Determine', 'Sensorimotor Integrative Approaches**: - **Study Design**:', 'Pediatric Dental Procedures**: - **Study Design**:', 'Best Supportive Care**: - **Study Design**:', 'Brachial Plexus Block**: - **Objective**: Compare', 'Urokinase Infusion Study**: - **Design**: Randomized', 'Hip Replacement (THR)**: - **Reoperation Rates**:', 'Intensive Physical Therapy - **Study Design**:', 'Epidural Needle Insertion**: - **Study Design**:', 'Sciatic Nerve Block**: - **Objective**: Compare', 'Placebo (Second Study)**: - **Study Design**:', 'Primary Bloodstream Infections**: - **Study Design**:', 'Controlled Trial (2002):** - **Objective:** Evaluate', 'Periapical Infected Sites:** - **Study Design:**', 'Occlusal Splint Therapy:** - **Study:** Compared', 'Total Shoulder Replacement - **Study Population**:', 'Skilled Nursing Facility**: - **Participants**: MS', 'Against Colorectal Adenomas**: - **Design**: Randomized,', 'Noncarious Primary Dentin**: - **Objective**: Evaluate', 'Improving Functional Outcomes**: - **Study Design**:', '### SELEDO Study - **Design**: Randomized,', 'Cancer (BRAVE Study)**: - **Study Design**:', 'Norfloxacin Ophthalmic Solution - **Study Design**:', 'Usual Psychiatric Treatment**: - **Study Design**:', 'Four Injectable Anesthetics**: - **Study Design**:', 'Fusidic Acid Gel - **Study Design**:', 'Weight Loss Interventions - **Objective:** Compare', 'Weight Loss Programs - **Objective:** Evaluate', 'Fully Compliant Patients**: - **Study Design**:', 'Initial Chemotherapy (MFL)**: - **Study Design**:', 'Epidural Catheter Placement**: - **Study Design**:', 'Psychoeducational Treatment (FFT)**: - **Study Design**:', 'Total Shoulder Replacements - **Study Population**:', 'Y (BY) Systems**: - **Study Design**:', 'Block (Double Injection)**: - **Objective**: Compare', 'Ultra Y-set Systems**: - **Study Design**:', 'Anorganic Bovine Bone:** - **Study Design:**', 'Intermittent Vascular Occlusion - **Study Design**:', 'Pregnant Hispanic Women**: - **Objective**: Evaluate', 'In-Person Weight Maintenance - **Objective:** Evaluate', 'Carpal Tunnel Decompression**: - **Study Design**:', 'Loss Maintenance Interventions - **Objective:** Compare', 'Total Shoulder Arthroplasties - **Study Population**:', 'Lung Cancer (SCLC)**: - **Study Design**:', 'Block (Success Rate)**: - **Objective**: Determine', 'Public Health (Canada)**: - **Objective**: Evaluate', '(HIP) Computer Program**: - **Objective**: Improve', 'Moxifloxacin Ophthalmic Solution) - **Study Design**:', 'Digital Nerve Blockade**: - **Study Design**:', 'Surface Replacement Hemiarthroplasty - **Study Population**:', 'Cup Surface Replacement - **Study Population**:', 'Lymphoma Investigation Study**: - **Objective**: Compare', 'Vascular Exclusion (MTHVE) - **Study Design**:', 'GnRH Agonist Regimen** - **Objective:** Compare', 'I-III Colon Cancer - **Duration**: January']"},{"template":"JJ NN IN DT JJ NN","text":"['long protocol with a halved dose', 'porcine insulin during the first year', 'mean duration of the third stage', 'potential harm, while the third study', 'weight loss in the first week', 'significant improvement in the experimental group', '\u226520% improvement in the visual analog', 'event-free survival in the heparin-plus-alteplase group', 'active management of the third stage', 'colorectal cancer over a 5-year follow-up.', 'symptom severity, with no significant difference', 'asthma severity in the experimental group', 'pT1bNoMo carcinoma of the uterine cervix', 'sensory loss in the medial thigh', 'controlled trial in a geriatric hospital', 'adverse effect on the mean number', 'sagittal position of the upper molars.', 'schizoaffective disorder, with a particular focus', 'effective option for the rapid control', '10-day course of the antibiotic loracarbef,', 'further investigation as a potential maintenance', 'complete filling of the pancreatic duct', 'transient tachypnea of the newborn (TTN).', 'posteroanterior mobilization on the painful side', 'significant difference in the combined endpoint', 'decision-making confidence, though no significant difference', 'significant improvement in the neuropathy disability', 'patient tolerance of the antibiotic regimens.', 'net effect of a CVD-prevention program', 'consolidated summary of the key findings:', 'antibiotic use in the r-metHuG-CSF group.', 'glucocorticoid administration on the inflammatory response', 'random assignment in a double-blind, crossover', 'sexual functioning despite a significant decrease', 'secondary analysis of a clinical trial', 'submaximal bronchodilation with the initial doses.', '(40 mg\/day) as an add-on therapy', 'significant difference in the entire study', 'observational study in a medical ICU.', 'significant efficacy beyond the initial treatment', 'operative time of the hand-assisted approach.', 'overall survival over a 36-month period.', '6-48 months, with no significant difference', 'mean area under the concentration-time curve', 'total score during the \"on\" period', 'survival advantage for the surgery-only group', 'visual impairment from an elementary school', 'luteal phase versus the conventional protocol', 'verbal learning in the cognitive intervention', 'quick response, with the open bite', '(EG), extraction of the primary canine', 'permanent teeth, with no significant difference', 'visual feedback for both tongue placement', 'primary closure of the common bile', 'potential benefit in the first treatment', 'normal activities, with no significant difference', 'significant difference in the primary outcome', 'vitrectomy, peeling of any epiretinal membrane,', 'final period with the preferred mode.', 'hybrid layer, with the experimental group', 'complete resection of all macroscopic disease', 'dynamic balance in the trained group', 'mean size of the velopharyngeal gap', 'acid (E-EPA) as an adjunct treatment', 'saline placebo via a subcutaneous pump', 'significant improvement in the pramipexole group,', 'sexual functioning between the quetiapine switch', 'significant difference in the mean time', 'significant improvement in the role-physical domain', 'plasma exchange in an open trial.', 'steroid injection over a 20-week period,', 'outpatient commitment (beyond the initial court', 'nociceptive activation of the pituitary-adrenal axis', 'inherited disease among the white population,', 'acute sinusitis in the primary care', 'Post-hoc analysis of a 28-week double-blind', 'dual blockade with an angiotensin-converting enzyme', 'significant difference in the mean pain', 'practical significance of these intervention-related changes.', 'chemotherapy-alone group, with no significant difference', 'slight increase in the required dose', 'significant difference in the overall risk', 'partial regression, with a mean survival', 'positive symptoms, with no significant safety', 'required oxygen on the third day', 'complete abortion, with no significant difference', 'Weak evidence for a small impact', 'weight loss with no significant difference', 'overall duration of the painful crisis,', 'observational study in a surgical ICU.', 'vertical jump with all orthotic conditions.', '**Dihydroergotamine (DHE)**: In a small study', 'partial agonist at the glycine site', 'ergometrine (Syntometrine) in the active management', '(CO validated) of the brief intervention']"},{"template":": DT NN IN CD NNS","text":"['- A study with 50 children', '- A trial with 59 patients', '- A study with 111 patients', '- A trial with 265 patients', '- A study with 60 patients', '- A study with 149 children', '- A trial with 267 patients', '- A trial with 115 patients', '- A study with 100 children', '- A study with 108 patients', '- A study with 520 patients', '- A trial with 386 patients', '- A study with 537 patients', '- Another study with 201 outpatients', '- A trial on 105 women', '- A study with 72 children', '- Another study with 127 women', '- A trial with 407 patients', '- A trial with 214 patients', '- A trial with 626 patients', '- A study with 300 subjects', '- A trial with 58 patients', '- Another study with 125 patients', '- A study on 64 women', '- A trial with 533 patients', '- A trial with 223 patients', '- A study with 119 subjects', '- A study with 117 children', '- A study with 40 patients', '- A study with 43 children', '- A study with 37 patients', '- A study with 4228 patients', '- A study with 506 mothers', '- A trial with 600 patients', '- A study on 33 women', '- A trial with 329 patients', '- A trial with 418 adolescents', '- A study with 63 patients', '- A study with 47 adolescents', '- A study with 73 children', '- A study with 20 patients', '- A study with 30 patients', '- A study with 60 inmates', '- A study with 44 patients', '- A study with 291 patients', '- A study on 54 women', '- A trial with 232 patients', '- A study with 542 women', '- A trial with 598 patients', '- A study with 52 children', '- A trial with 57 patients', '- A study with 40 subjects', '- A trial with 138 patients', '- A study with 83 patients', '- A study with 84 women', '- A study with 61 children', '- A trial with 120 workers', '- A study with 92 children', '- A study with 577 patients', '- A trial with 240 women', '- A study with 53 subjects', '- A trial with 152 adolescents', '- A study with 39 subjects', '- A study with 21 patients', '- A comparison of 20 micrograms', '- A study with 200 children', '- A study with 283 patients', '- A study with 80 children', '- A trial with 345 women', '- A trial with 268 patients', '- A study with 84 girls', '- A trial with 302 patients', '- A study with 123 adolescents', '- A trial with 405 patients', '- A trial with 1,801 patients', '- A trial with 136 patients', '- A trial with 218 patients', '- A study on 222 women', '- A study with 147 patients', '- A trial with 387 patients', '- A trial with 196 participants', '- A study with 39 children', '- A trial with 97 veterans', '- A trial with 41 patients', '- A trial with 217 patients', '- A cohort of 3373 12-year-olds', '- A trial with 211 patients', '- A study with 400 patients', '- A study with 7,077 women', '- A trial with 393 patients', '- A study with 479 patients', '- A trial with 125 patients', '- A study with 70 subjects', '- A trial with 1,004 patients', '- A study with 74 patients', '- A study with 22 subjects', '- A study with 120 patients', '- A trial with 191 patients', '- A study with 104 patients', '- A study with 117 patients', '- A study with 140 patients', '- A trial with 613 patients', '- A trial with 80 patients', '- A study with 497 patients', '- A study with 110 patients']"},{"template":"NNP IN NNP NNP NNP :","text":"['(WAI) vs. Doxorubicin-Cisplatin (AP) Chemotherapy**: -', 'Intervention for Pediatric HIV Patients**: -', 'PTFE with Distal Vein Cuff -', 'Imipramine for Painful Diabetic Neuropathy -', 'Intervention for Nonsmoking Support Persons**: -', 'Management for Latino Medicaid Patients**: -', 'Management for Musculoskeletal Disorders (MSDs)**: -', 'Treatment for Female Assault Victims**: -', 'E in Chronic Hepatitis B**: -', 'Iron in Non-Dialysis CKD Patients**: -', 'Bag vs. Ultra Y-set Systems**: -', 'Amitriptyline for Neuropathic Cancer Pain -', 'Study on Chronic Nonfluent Aphasia**: -', 'Addition vs. ICS Dose Doubling**: -', 'Treatment for Childhood Abuse Survivors**: -', 'Lidocaine for Digital Nerve Blocks**: -', 'B in Acute Nonlymphocytic Leukemia**: -', 'Lidocaine for IV Catheter Insertion**: -', 'Cream for Debridement Pain Relief**: -', 'Desipramine for Painful Diabetic Neuropathy -', 'Amitriptyline for Various Pain Conditions -', 'Treatment vs. Non-Specific Mental Stimulation**: -', 'Venlafaxine for Painful Diabetic Neuropathy -', 'Study at Liaquat University (2007)**: -', 'Guidelines in Pediatric Oncology Patients:** -', 'Coping for Bone Marrow Aspirations**: -', 'Training for Sexual Aggression Victims**: -', 'Placement with Acid-Etched Surfaces (Osseotite):** -', 'Cemented vs. Press-Fit Humeral Stems -', 'Amitriptyline for Central Poststroke Pain -', '(TPN) for Malnourished AIDS Patients**: -', '(PRT) vs. Cyclophosphamide-Doxorubicin-Cisplatin (CAP) Chemotherapy**: -', 'Interviewing for Outpatient Treatment Adherence**: -', 'CBT for Primary Care Patients**: -', 'Treatment for Addiction Recovery (STAR)**: -', 'Planning by Admitting Department Personnel:** -', 'Pain in Spinal Cord Injury -', 'Sulfate vs. No Magnesium Sulfate**: -', 'Cancer in Back Pain Patients**: -', 'Lidocaine for Digital Nerve Blockade**: -', '(TSI) in Young CF Patients**: -', 'Psychotherapy for Rural HIV-Infected Persons**: -', 'Study on Deep-Seated Tumors (1985-1988)**: -', 'Interventions for Rural HIV-Infected Persons**: -', 'Ni-Ti vs. Triple-Stranded Steel Archwires**: -', 'Study on Initial Chemotherapy (MFL)**: -', 'Patients with Previous Colorectal Cancer**: -', 'Antibiotics for Acute Maxillary Sinusitis -', 'Lidocaine for Norplant System Insertion**: -', 'Hippurate in Uterovaginal Prolapse Surgery**: -', 'Lidocaine in Carpal Tunnel Decompression**: -', 'Aid in SPAF III Trial**: -', 'Amitriptyline for Chronic Oral-Facial Pain -', 'Initiative for Primary Bloodstream Infections**: -', 'Feedback vs. Human E-Mail Counseling -', 'Budesonide in Acute Maxillary Sinusitis -', 'Amitriptyline for Painful Diabetic Neuropathy -', 'Efficacy in Cleft Children (Taiwan)**: -', 'Physiotherapy for Long-Term Mobility Problems**: -', 'Venlafaxine for Atypical Facial Pain -', 'Clamping in Minor Liver Resections -', 'BWSTT in Improving Functional Outcomes**: -', 'Iron in Pediatric Hemodialysis Patients**: -', 'Strategies in Public Health (Canada)**: -', '(TENS) for Chronic Neck Pain**: -', 'Combination for Painful Diabetic Polyneuropathy -', 'Patch in Serious Mental Illness -', 'Activity for Low Back Pain**: -', '(Stenting vs. Internal Mammary Artery)**: -', 'Plate vs. Full-Coverage Stabilization Splint:** -', 'Surgery for Proximal LAD Lesions**: -', 'Trial of Four Insulin Regimens**: -', 'Amantadine in Cocaine-Abusing Methadone Patients**: -', '(MI) vs. Educational Treatment (ET)**: -', 'Protocol in Skilled Nursing Facility**: -', 'Psychotherapy for Male Vietnam Veterans**: -', 'Defects with Anorganic Bovine Bone:** -', 'System in Group Treatment Programs**: -', 'TMP\/SMX in Bone Marrow Transplantation**: -', 'Orthoses for Cavus Foot Pain**: -', 'Techniques in Hospitalized Schizophrenic Clients -', 'Therapy for Acute Cervical Pain**: -', 'ER for Social Anxiety Disorder**: -', 'Antigenicity in Non-Insulin-Dependent Diabetic Subjects**: -', 'Doxycycline for Acute Sinusitis-Like Complaints -', 'Amitriptyline for HIV-Related Peripheral Neuropathy -', 'Behavior in Older HIV-Infected Adults**: -', 'SSRIs for Burning Mouth Syndrome -', 'Iron in Pre-Dialysis CRF Patients**: -', 'Measurement in Threatened Preterm Labor:** -', 'View in Lumbar Spine Radiography**: -', 'Steroids in Small Intestine CD:** -', 'Lidocaine for Epidural Catheter Placement**: -', '(IPO) with Different Ischemic Intervals -', 'Consultation in Out-of-Hours Primary Care**: -', '(CB) vs. Discussion-Type (DISC) Group**: -', 'Iron in ESA-Naive CKD Patients**: -', 'Lidocaine for Epidural Needle Insertion**: -', 'Regime for Intermittent Portal Clamping -', 'Analgesia in Pediatric Tooth Extractions**: -', 'Study on Acute Cerebral Ischemia**: -', 'Management by Health Care Assistants**: -', 'Relief in Acute Exudative Pharyngitis:** -', '(B) vs. Y-set (Y) Systems**: -', 'Lidocaine in Carpal Tunnel Surgery**: -', 'Supplementation in Weight-Losing Cancer Patients -']"},{"template":"NNP : NN TO VB DT","text":"['Doxycycline - **Objective**: To assess the', 'Veterans - **Objective:** To examine the', 'Campaign**: - **Objective**: To evaluate the', 'Malignancy - **Objective**: To investigate the', 'Syndrome - **Objective**: To evaluate the', 'C**: - **Objective**: To assess the', 'Families**: - **Objective**: To assess the', 'Rhinosinusitis - **Objective:** To evaluate the', 'Initiative** - **Objective:** To assess the', 'Complaints - **Objective:** To assess the', 'Sinusitis - **Objective:** To determine the', 'Neuralgia - **Objective**: To evaluate the', 'Pain - **Objective**: To investigate the', 'Intervention - **Objective**: To compare an', 'Adults - **Objective:** To test the', 'Polyneuropathy - **Objective**: To test the', 'Polyneuropathy - **Objective**: To evaluate the', 'Cannula** - **Objective:** To compare the', 'Pain - **Objective**: To evaluate the', 'Transfusion**: - **Objective**: To assess the', 'Rhinosinusitis - **Objective:** To determine the', 'Hypertension - **Objective:** To determine the', 'Mononucleosis:** - **Objective:** To evaluate the', 'Therapy - **Objective**: To investigate the', 'Netherlands** - **Objective:** To assess the', 'II\/III - **Objective**: To determine an', 'Individuals - **Objective:** To test the', '(Iran)**: - **Objective**: To assess the', 'Injury - **Objective**: To determine the', 'Schizophrenia - **Objective**: To investigate the', 'Study**: - **Objective**: To investigate the', 'Use**: - **Objective**: To compare the', 'Polyneuropathy - **Objective**: To compare the', 'Neuropathy - **Objective**: To study the', 'Japan** - **Objective:** To evaluate the', 'Schizophrenia - **Objective**: To determine the', 'Trial** - **Objective:** To evaluate the', 'Status**: - **Objective**: To assess the', 'Montreal**: - **Objective**: To evaluate a', 'Hypertension**: - **Objective**: To evaluate the', 'Trial** - **Objective:** To assess the', 'Island**: - **Objective**: To evaluate a', 'Neuralgia - **Objective**: To compare the', 'Adults - **Objective:** To assess the', 'Patients - **Objective**: To compare the', 'PROM:** - **Objective:** To assess the', 'Alcoholics**: - **Objective**: To determine the', 'Clients - **Objective**: To assess a', 'Aspirin**: - **Objective**: To assess a', 'Patch - **Objective**: To determine the', 'Studies**: - **Objective**: To investigate the', 'Rhinorrhea - **Objective:** To compare the', 'Trial**: - **Objective**: To assess the', 'Study**: - **Objective**: To test the', 'Patients**: - **Objective**: To compare the', 'Prednisolone - **Objective**: To evaluate the', 'Study**: - **Objective**: To compare the', 'Disorders**: - **Objective**: To assess the', 'Patients:** - **Objective:** To compare the', 'Study:** - **Objective:** To evaluate the', 'CU**: - **Objective**: To assess the', 'Bacteria - **Objective:** To assess the', 'Treatment - **Objective**: To evaluate the', 'Neuralgia - **Objective**: To study the', 'Reduction - **Objective**: To investigate the', 'Study:** - **Objective:** To assess the', 'State**: - **Objective**: To evaluate a', 'Carolina**: - **Objective**: To evaluate a', 'NVAF**: - **Objective**: To test the', 'Conditions - **Objective**: To compare the', 'Neuropathy - **Objective**: To compare the', 'Patients:** - **Objective:** To evaluate the', 'Pharyngitis:** - **Objective:** To assess the', 'Study**: - **Objective**: To assess the', 'Schizophrenia - **Objective**: To examine the', '(AM)**: - **Objective**: To evaluate the', 'II\/III - **Objective**: To determine the', 'Neuropathy - **Objective**: To evaluate the', 'PTL:** - **Objective:** To estimate the', 'Women - **Objective**: To estimate the', 'Cuff - **Objective**: To evaluate the', 'Injury - **Objective**: To evaluate the', 'Hepatitis**: - **Objective**: To assess the']"},{"template":"JJ NNS IN JJ NN NN","text":"['different analgesics for post-episiotomy pain relief', 'pregnant women with fetal growth retardation', 'Ninety-one patients with neurosis, personality disorder,', 'internet-based interventions with enhanced engagement strategies.', 'risky behaviors among diverse youth populations.', 'elderly patients with rheumatoid arthritis (RA)', 'various treatments for psoriatic arthritis (PsA).', 'squamous cells of undetermined significance (ASCUS)', 'clinical practices in various healthcare settings.', 'Significant improvements in physical fitness, strength,', 'significant improvements in total symptom scores,', 'multiple strategies for optimal health outcomes.', 'standard assessments of parental health, intelligence,', 'community-wide changes in sexual health behaviors.', 'nephropathy patients with nephrotic range albuminuria', 'beneficial effects on respiratory muscle strength,', 'significant differences in urinary tract infection', 'premenopausal women with symptomatic uterine leiomyomas.', 'significant reductions in 24-hour mean glucose', 'valuable data for future sample size', 'substantial savings in short-term hospital costs.', 'significant changes in inflammatory mediators, albumin,', 'significant improvements in early continence recovery.', 'potential benefits of specialized care strategies,', 'significant differences in self-esteem, body cathexis,', 'significant differences in spirometric measures, hospitalizations,', 'premenopausal women with asymptomatic uterine leiomyomas.', 'significant reductions in 24-hour sodium excretion.', 'Significant improvements in secondary disease activity', 'significant differences in implant stability, gingival', 'significant improvements in upper limb function.', 'Afro-Caribbean men with elevated prostate cancer', 'significant predictors of adolescent smoking initiation.', 'young adults with different foot types.', \"significant differences in women's abstinence rates.\", 'single doses of racemic ketoprofen (12.5', 'mental disorders in public primary care', 'significant gains in sexual choices, safety,', 'significant differences in other side effects.', 'specific bacteria in upper respiratory tract', 'reliable methods like oral contraceptive pills.', 'additional benefits over radical surgery alone,', 'preterm infants with perforated necrotizing enterocolitis.', 'various treatments for chronic pelvic pain', 'overall differences between trauma-focused group therapy', 'elderly residents in long-term care facilities.', 'Significant reductions in vertical defect height', 'psychological treatments in primary care settings,', 'acute relapses of multiple sclerosis (MS).', 'pharmacological treatments with behavioral interventions, contingency', 'significant changes in glomerular filtration rate', '<4 weeks of prior zidovudine therapy.', 'sustained reductions in vertebral fracture risk.', 'significant differences in neutropenia prevention, hospitalization', 'prevent infections across different patient populations.', 'bacterial counts in partial removal group,', 'significant differences in marginal bone resorption,', 'particular benefits in specific patient subgroups.', '\u226412 months of prior zidovudine treatment.', 'significant improvements in elbow extension, symptom', 'high doses of fish oil improve', 'psychological variables across various age groups,', 'pulmonary parameters despite improved reflux symptoms.', 'significant differences in postoperative liver function', 'significant differences in physical activity knowledge,', 'significant differences in organ failure score,', 'significant benefits over prolonged translaryngeal intubation.', 'basic activities of daily living (ADLs).', 'aftercare sessions for male alcohol treatment', 'potential benefits from additional postoperative doses.', 'Thirty-nine patients with right liver lobe', 'significant differences in total bed days.', 'significant differences in other alcohol consumption', 'adults, individuals with mental health issues,', 'significant differences in complications, hospital stay,', 'psychotherapeutic treatments for posttraumatic stress disorder', 'significant improvements in global symptom severity', 'superior results in ulcer size reduction', 'long-term effects of permanent vena cava', 'remote areas with limited healthcare resources.', 'Significant improvements in attention, information processing,', 'modest improvements in depression, cannabis use,', 'potential benefits of various discharge planning', 'different treatments for hepatocellular carcinoma (HCC)', 'physical outcomes across different age groups,', 'various medications on menstrual blood loss', 'Significant improvements in physical activity, systolic']"},{"template":"JJ NN NN CC JJ NN","text":"['diarrhea, drug allergy, and catheter-related cellulitis.', 'Similar morbidity, mortality, and en bloc', 'nausea, fatigue, headache, and sleep disorders.', 'lateral rearfoot post, and neutral rearfoot', 'notable weight gain or cardiovascular issues.', 'exacerbations, health status, and physiological indices.', 'antigen-extracted allogeneic bone and microfibrillar collagen', 'partial thromboplastin time and thrombin time', 'low sensitivity (47.3%) but high specificity', 'difficulties, future perspective, and stoma-related problems.', 'patients, mexiletine (MXT) and tocainide (TCD)', 'dietary fat intake, and health-related quality', 'unfractionated heparin (UFH) or low-molecular-weight heparin', 'trauma-focused group therapy and present-centered comparison', 'intraoperative cell salvage, and postoperative autotransfusion', 'sacroiliac joint manipulation plus cervical spine', 'opioid craving intensity and self-reported opioid', 'pain, depression, anxiety, and improved sleep', 'palmitic acid release, or palmitate oxidation', 'multiple sclerosis (PPMS) or transitional MS.', 'significant pain reduction and improved movement', '(6-minute walk test), and health-related quality', 'anxiety, paranoia, anger\/hostility, and interpersonal sensitivity', 'symptoms, mood, cognition, or global impression', 'intraovarian androgen levels, and reduced estradiol', 'bronchopulmonary dysplasia (BPD) and acute air', 'perception, alignment efficiency, and clinical effectiveness.', 'expert team leadership and local support', 'depression, cannabis use, and general functioning.', 'sedation, psychomotor impairment, and patient acceptance,', 'low birth weight and preterm delivery', 'surgical success rate or visual outcomes.', 'vital capacity (FVC) and specific conductance', 'affective pain, disability, or overall affect.', 'lean body mass, and subjective health', 'congestive heart failure, and bronchopulmonary dysplasia', 'various discharge planning and transitional care', 'radical prostatectomy (RP) and transurethral resection', 'severe tantrums, aggression, or self-injurious behavior.', 'macular degeneration (AMD) and other low-vision', 'internal fixation (IF) and arthroplasty (hemiarthroplasty', 'sustained disability progression and clinical relapse', 'interpersonal sensitivity, anger\/hostility, and overall aggression', 'physical activity, systolic and diastolic blood', 'general health promotion, and usual care.', 'acute gallstone pancreatitis and biliopancreatic obstruction.', 'consistent condom use and reduced chlamydia', 'usage, hospital days, or clinical symptoms.', 'fusidic acid gel and oral oxytetracycline', 'adolescents, college students, and military personnel.', 'acceptance, retention rates, or opioid consumption.', 'viral load, transaminases, and oxidative status.', 'operative time, recovery, and technical challenges,', 'analysis, visuo-motor speed, and verbal abstracting', 'relapse-free survival (RFS) or overall survival', 'hypertensive disorders, preeclampsia, and fetal growth.', 'complications, hospital stay, or pathological staging.', 'Early symptom recognition and prompt treatment', 'scores, ambulation speed, and stride length', 'infections, hospital stay, and patient discomfort,', 'local tumor control or overall survival.', 'improved insulin sensitivity and reduced plasma', 'immediate placement (IP) and delayed placement', 'intraventricular hemorrhage (IVH), and arterial pH', 'Significant pain relief and functional improvement.', 'Good pain relief and functional improvement', 'crestal bone changes, and clinical outcomes.', 'mm diameter metal and flexible plastic', 'Significant pain relief and patient satisfaction.', 'significant pain reduction and improved quality', 'operative time, cost, and postoperative pain.', 'general anesthesia (GA) and spinal anesthesia', 'reduced sodium intake and weight loss', 'ovary syndrome (PCOS) and idiopathic hirsutism.', 'motor-nerve conduction velocity, and sensory-nerve action', 'insufficient pain relief, and overall medication', 'levels, side effects, and patient satisfaction.', 'neuralgia, tension headache, and postherpetic neuralgia.', 'neurosis, personality disorder, or adjustment reaction', 'high contraceptive use and low pregnancy', 'intraventricular hemorrhage (IVH) and late-onset sepsis', 'biliary infection, bacteremia, and intraoperative bleeding.', 'strength, balance, gait, and functional performance.', 'gastro-oesophageal reflux (GOR) and bronchial asthma,', 'individual case prognosis and patient-specific factors.', 'self-reported tobacco abstinence and reduced nicotine', 'increased muscle strength and reduced pain', 'hepatic laboratory values, and histologic progression', 'dietary sodium reduction and weight loss', 'impact labor progression or fetal health.', 'progression-free survival (PFS) and overall survival', 'therapeutic approach (thoracic and sacroiliac joint', 'live birth rate, and multiple birth', 'good performance status and normal hemoglobin', 'advanced erosive, collapse, and mutilating-type shoulders.']"},{"template":"NNP NNP NNP IN NNP NNP","text":"['Weight Loss Program with Behavioral E-Counseling', \"Alzheimer's Dementia (AD) with Psychotic Symptoms\", 'Low-Glycemic Index Diet for GDM A', 'Insurance Case Management for Musculoskeletal Disorders', 'Cognitive Behavioral Intervention for Gay Men**:', 'Postpartum MgSO\u2084 Therapy for Mild Preeclampsia:**', 'Optimal Clamp\/Release Regime for Intermittent Portal', 'Treadmill Training (BWSTT) for Long-Term Benefit**:', 'Tissue Regeneration (GTR) with Expanded Polytetrafluoroethylene', 'Delayed Implant Placement with Immediate Provisionalization:**', 'Gabapentin Enacarbil (GEn) for Migraine Prophylaxis', 'Investigator Global Assessment of Change, Patient', 'Muscle Strengthening Exercises for Knee OA**:', 'Rehearsal Therapy (IRT) for Chronic Nightmares', 'Hepatic Inflow Occlusion in Cirrhotic Patients', 'Megestrol Acetate (MA) in Cancer-Associated Wasting', 'Short GnRHa Protocol in Poor Responders**', 'Interposition Vein Cuff in Femoral-Popliteal Bypass', 'Cognitive Behavioral Coping for Bone Marrow', 'Eclectic Psychotherapy (BEP) for Police Officers', 'Cervical Length Measurement in Threatened Preterm', 'Long-term Opioid Therapy for Back Pain', 'Laser Photocoagulation (GLP) for Cystoid Macular', 'Radiation Therapy (PRT) vs. Cyclophosphamide-Doxorubicin-Cisplatin (CAP)', 'Auricular Acupoint Stimulation for Myopia Control**', 'Autogenous Bone Grafts at Immediate Implants:**', 'Randomized Controlled Trial on Transfusion Strategies**:', 'Respiratory Tract Infection with Purulent Rhinorrhea', 'Phone Text Messaging for Maori Smokers**:', 'Parenteral Nutrition (TPN) for Malnourished AIDS', 'Open Colectomy (OC) for Colorectal Cancer', 'Depression Care Management for Latino Medicaid', 'Nerve Stimulation (TENS) for Chronic Neck', 'A\u2082 (TXA\u2082) Levels in Severe Preeclampsia:**', '#### Calorie Restriction in Obese Pregnant', 'National Clinical Guidance on Childhood Surgery', 'New York City for Latino GBM**:', 'Protein C (APC) vs. Unfractionated Heparin**:', 'Rotator Cuff Repair in RA Patients', 'Pressure (PEP) Mask vs. Postural Drainage', 'Mother Care (KMC) for Low-Birth-Weight Infants', 'Speed-Dependent Treadmill Training on Postural Instability', \"St. John's Wort for Painful Polyneuropathy\", 'Fish Oil Capsules in Advanced Cancer', 'Glatiramer Acetate (GA) in Relapsing-Remitting Multiple', 'Minimally Invasive Surgery for LAD Lesions**:', 'Exposure Therapy (NET) for Sudanese Refugees**:', 'Ormond Street Measurement of Infant Feeding,', 'Early Developmental Interventions for Very Preterm', 'Care Pathway (ICP) for Stroke Rehabilitation:**', 'Style Modification Program for Physical Activity', 'Intravenous Immunoglobulin (IVIG) in Secondary Progressive', 'Tai Chi Program for Fall Prevention', 'Case Management (ICM) for Upper-Extremity Disorders**:', '(IV) MgSO\u2084 Regimens in Severe Pre-eclampsia:**', 'Low Back Pain by Occupational Physicians**:', 'Institute Withdrawal Assessment of Alcohol Scale,', 'Smokers (DHS) Model in Urban Indian', 'Behavioral Group Techniques in Hospitalized Schizophrenic', 'Zinc Oxide Tape with Povidone Iodine', 'Opioid Dependence Treatment with Depot Naltrexone', 'Physical Activity Counseling in Pregnancy A', 'Tramadol\/Acetaminophen (APAP) Combination for Chronic Lower', 'Coaxial Superelastic NiTi vs. Single-Stranded NiTi**:', 'Food Safety Guidelines in Pediatric Oncology', 'Rotator Cuff Repair in Rheumatoid Arthritis', 'Standard Long Protocol in Poor Responders**', 'Group Drug Counseling for Bipolar Disorder', 'Delayed Implant Placement with Acid-Etched Surfaces', 'Hospital Diet (NHD) vs. Low-Bacterial Diet', 'Psychosis Therapy (CAP) vs. Psychoeducation (PE)**:', 'Index (LGI) Diet in Pregnancy A', 'Adapted Collaborative Care for Hispanic Patients**:', 'Alcohol Dependence Treatment with Long-Acting Naltrexone', 'N-3 Fatty Acids in Cachectic Pancreatic', 'Femoro-Crural PTFE Bypass with Vein Cuff', 'Different Training Interventions on Gait Parameters**:', 'Cystoid Macular Edema after BRVO **Design', 'Social Model Programs for Homeless Adults**:', 'Saint C\u00f4me Device for Postural Rehabilitation**:', 'Risky Sexual Behavior in Older HIV-Infected', 'All-Trans-Retinoic Acid (RA) for CIN II\/III', 'Group III: Combination of L1 (75', 'Low-Bacterial Diet (LBD) in Cytopenic Patients:**', 'Progressive Relaxation Training for Sexual Aggression', 'Pedicle Occlusion (IPO) with Different Ischemic', 'Adult Outpatient Department of Port Moresby', 'Young People Living with HIV (YPLH)**:', 'Summary #### Quality of Life (QoL)', 'Multidisciplinary Antenatal Care for Obese Women', 'Lumbosacral Spine Radiographs in Emergency Settings**:', 'High-Dose Interferon Beta-1a in Poor Responders']"},{"template":"IN JJ NN CC JJ NN","text":"['in acute hemorrhage and portal hypertension.', 'between systematic detection and usual care', 'with biliary colic or acute gallbladder', 'with fluid-air exchange and intraocular gas', 'for maternal age and infant birthweight,', 'with nutritional support, and IGF-related treatments.', 'for placebo, p=0.041) and improved seizure', 'of weight loss and reduced sodium', 'in metabolic fitness and psychological variables,', 'during single-leg squat and lateral stepdown,', 'of perioperative hypertension and postoperative hypotension', 'for weight loss and weight-gain prevention.', 'in preterm delivery and neonatal respiratory', 'in patient morbidity or technical difficulty', 'between analgesic efficacy and antidepressant effects.', 'of chronic schizophrenia and other psychoses.', 'in postural performance and reduced neck', 'of postoperative recovery and diagnostic accuracy,', 'with alpha(1)-AT deficiency and moderate emphysema', 'that brisk walking and salt restriction', 'on open reduction and internal fixation', 'of oral carbamazepine and intravenous lidocaine', 'between active management and usual care.', 'in implant integration or crestal bone', 'in bacterial eradication and clinical signs.', 'with selegiline (deprenyl) and other medications.', 'with pulse ultrasound and intraarticular hyaluronan,', 'of physical endurance and slight improvement', 'in long-term effectiveness and physician compliance.', 'of antidepressant action and improved treatment', 'of mechanical ventilation, or long-term outcomes.', 'in patient recruitment or physician cooperation,', 'in overall mortality or bleeding-related mortality', 'through visual inspection and photographic records.', 'of active drug and psychological treatment', 'on paranoid, hallucinatory-desintegrative, and catatonic syndromes.', 'in acute, continuation, and prophylactic phases,', 'of local heat or cold therapy', 'like relapse-free survival and distant metastasis', 'for placental insufficiency and fetal growth', 'in exertional dyspnea and physical function,', 'on progression-free survival and overall survival.', 'in overall survival or progression-free survival.', 'after sleep onset, and early morning', 'in clinical resolution and bacterial eradication', 'of gastrointestinal function, and lowering complication', 'into immediate replacement and immediate restoration', 'with antibiotic ointment and mydriatic alone', 'without strict supervision, and future research', 'in quiescent disease, and long-term use', 'in hospital stay or organ failure', 'in social functioning and reduced burden', 'on progression-free survival and overall survival', 'between collaborative care and usual care.', 'of psychosocial therapy, and patient characteristics.', 'in maternal blood and amniotic fluid.', 'without adverse maternal or neonatal effects.', 'by radical hysterectomy and pelvic lymphadenectomy.', 'between peritoneal closure and non-closure groups.', 'with fluid restriction and effective analgesia', 'in visual acuity or visual function', 'that aerobic exercise and physical activity', 'with advanced gastric and colorectal cancer,', 'by oxidative stress and mitochondrial impairment,', 'in anxiety, satisfaction, or overall experience', 'of fast-track (FT) or multimodal optimization', 'in functional independence and upper extremity', 'of statistical significance and practical efficacy.', 'like human milk and salicylic sugar', 'in aerobic capacity and functional performance.', 'in physical function or arterial stiffness', 'in pediatric dental and orthodontic procedures.', 'with autistic disorder and severe tantrums,', 'of decompressive surgery and steroid injection', 'than rigid ones, and early postoperative', 'with ligament reconstruction and tendon interposition', 'of pre-eclampsia (74.1%) and fetal growth', 'on fetal growth and placental function.', 'of vaginal cleansing and urethral catheterization', 'in myopia progression or axial length', 'on sensory integration and neurodevelopmental therapy', 'as fever, pain, and abdominal tenderness.', 'in vascular obstruction and pulmonary artery', 'in postural control and neglect tests,', 'on uterine size and menstrual cycle', 'with anticonvulsant therapy and reduced seizure', 'with advanced disease or specific risk', 'of surgical staging and postoperative radiation', 'under careful monitoring and appropriate dosage', 'in specific scenarios, but individual patient']"},{"template":"IN NNP NNP : NN NNP","text":"['with Sodium Hypochlorite**: - **Study Design**:', 'in Behavioral Programs - **Objective:** Compare', 'for Dialysis Catheters**: - **Study Design**:', 'vs. NiTi Archwires**: - **Study Design**:', 'through Compliance Auditing**: - **Study Design**:', 'in Acute Stroke**: - **Study Design**:', 'for IV Catheterization**: - **Study Design**:', 'in Emergency Room**: - **Study Design**:', 'for Rheumatoid Shoulder - **Study Population**:', 'in Neurogenic Bladder**: - **Study Design**:', 'vs. Single-Stranded NiTi**: - **Study Design**:', 'in Eyelid Surgery**: - **Study Design**:', 'in Cirrhotic Patients - **Study Design**:', 'on GP Workload**: - **Study Design**:', 'of Three Archwires**: - **Study Design**:', 'for Long-Term Benefit**: - **Study Design**:', 'in Low Responders** - **Objective:** Evaluate', 'at Popliteal Fossa**: - **Objective**: Compare', 'in Poor Responders** - **Objective:** Compare', 'in Poor Responders** - **Objective:** Evaluate', 'in RA Patients - **Study Population**:', 'vs. Fluticasone Propionate:** - **Efficacy:** Ciclesonide', 'with Autistic Disorder** - **Design:** Multisite,', 'in Perimenopausal Women - **Objective:** Compare', 'in Cervical Cancer**: - **Study Design**:', 'for Simple Lacerations**: - **Study Design**:', 'for Mild Preeclampsia:** - **Study Design:**', 'in PAD Patients**: - **Study Design**:', 'in Esthetic Zones:** - **Study Design:**', 'for African-American Women**: - **Objective**: Reduce', 'in Severe Pre-eclampsia:** - **Study Design:**', 'with Immediate Provisionalization:** - **Study Design:**', 'for Relapse Prevention**: - **Study Design**:', 'with Behavioral E-Counseling - **Objective:** Compare', 'on Functional Tasks**: - **Study Design**:', 'in Surgical ICU**: - **Study Design**:', 'for Ambulatory Care**: - **Study Design**:', 'in Traumatic Lacerations**: - **Study Design**:', 'in Cardiac Catheterization**: - **Study Design**:', 'vs. Unfractionated Heparin**: - **Study Design**:', 'in Parenteral Nutrition**: - **Design**: Randomized,', 'of Shoulder Arthroplasty - **Study Population**:', 'for Maori Smokers**: - **Objective**: Determine', 'at Immediate Implants:** - **Study Design:**', 'for Migraine Prophylaxis - **Design**: Randomized,', 'in Breast Cancer**: - **Study Design**:', 'for Same-Day Appointments**: - **Study Design**:', 'in Lymphoproliferative Malignancies**: - **Study Design**:', 'in New Zealand**: - **Objective**: Evaluate', 'in Ear Surgery**: - **Study Design**:', 'in Resolving Crowding**: - **Study Design**:', 'of Life Study)**: - **Study Design**:', 'at Midfemoral Level**: - **Objective**: Compare', 'for Locomotor Function**: - **Design**: Randomized', 'for Long-Term Catheters**: - **Study Design**:', 'in Chemotherapy-Induced Anemia**: - **Study Design**:', 'for Colon Cancer - **Duration**: January', 'for VAP Prevention**: - **Study Design**:', 'in Awake Patients**: - **Study Design**:', 'in Low Responders** - **Objective:** Investigate', 'in Obesity Intervention - **Objective:** Describe', 'in Various Surgeries**: - **Study Design**:', 'in Lung Cancer**: - **Study Design**:', 'of Cancer (AOC)**: - **Study Design**:', 'in Ischemic Stroke**: - **Study Design**:', 'in Postoperative Care**: - **Objective**: Assess', 'on Gait Parameters**: - **Study Design**:', 'in Hematologic Malignancies**: - **Study Design**:', 'in Nonplatinum Chemotherapy**: - **Study Design**:', 'in Acute Leukemia**: - **Study Design**:', 'in Severe Preeclampsia:** - **Study Design:**', 'of Bipolar Patients**: - **Study Design**:', 'in Severe Asthma:** - **Efficacy:** Salmeterol', 'in Pediatric Cancer**: - **Study Design**:', 'in Military Personnel - **Objective:** Evaluate', 'for Anxiety Disorders**: - **Study Design**:']"},{"template":": NN TO VB DT NN","text":"['- **Objective**: To compare the efficacy', '- **Objective**: To investigate the effectiveness', '- **Objective**: To evaluate the safety', '- **Objective**: To assess the impact', '- **Objective**: To evaluate the effectiveness', '- **Objective**: To examine the effect', '- **Objective:** To compare the efficacy', '- **Objective**: To determine the effect', '- **Objective**: To evaluate the quality', '- **Objective**: To determine the efficacy', '- **Objective:** To assess the feasibility', '- **Objective:** To evaluate the efficacy', '- **Objective**: To determine the feasibility', '- **Objective:** To assess the impact', '- **Objective:** To assess the efficacy', '- **Objective**: To examine the efficacy', '- **Objective**: To estimate the efficacy', '- **Objective:** To assess the effect', '- **Objective:** To evaluate the effect', '- **Objective**: To assess the role', '- **Objective**: To evaluate a state', '- **Objective**: To observe the effect', '- **Objective**: To investigate the feasibility', '- **Objective**: To evaluate the benefit', '- **Objective**: To evaluate the efficacy', '- **Objective:** To assess the role', '- **Objective:** To evaluate the effectiveness', '- **Objective:** To determine the effectiveness', '- **Objective**: To assess the effect', '- **Objective**: To assess the feasibility,', '- **Objective**: To determine the utility', '- **Objective**: To compare the effectiveness', '- **Objective:** To assess the effectiveness', '- **Objective**: To test the effect', '- **Objective**: To test the efficacy', '- **Objective**: To examine the benefit', '- **Objective:** To estimate the effect', '- **Objective**: To evaluate the effect', '- **Objective**: To investigate the effect', '- **Objective:** To compare the safety', '- **Objective**: To assess a smoking', '- **Objective**: To investigate the association']"},{"template":"IN NNP NNP NNP : NN","text":"['for Digital Nerve Blocks**: - **Study', 'in Minor Liver Resections - **Study', 'for Additional Oxytocic Injections:** - Syntometrine', 'vs. Human E-Mail Counseling - **Objective:**', 'for HIV-Related Peripheral Neuropathy - **Objective**:', 'for Painful Diabetic Polyneuropathy - **Objective**:', 'vs. Press-Fit Humeral Stems - **Study', 'in Group Treatment Programs**: - **Participants**:', 'with Distal Vein Cuff - **Objective**:', 'vs. Triple-Stranded Steel Archwires**: - **Study', 'for Central Poststroke Pain - **Objective**:', 'in Carpal Tunnel Decompression**: - **Study', 'vs. Cyclophosphamide-Doxorubicin-Cisplatin (CAP) Chemotherapy**: - **Participants**:', 'with Different Ischemic Intervals - **Study', 'for Sexual Aggression Victims**: - Self-exposure', 'for Various Pain Conditions - **Objective**:', 'in Pediatric Tooth Extractions**: - **Study', 'in SPAF III Trial**: - **Objective**:', 'for Traumatized Young Women**: - EMDR', 'on Acute Cerebral Ischemia**: - **Design**:', 'in Non-Insulin-Dependent Diabetic Subjects**: - **Participants**:', 'for Acute Maxillary Sinusitis - **Objective:**', 'in Chronic Hepatitis C**: - **Objective**:', 'for IV Catheter Insertion**: - **Study', 'on Deep-Seated Tumors (1985-1988)**: - **Participants**:', 'for Epidural Catheter Placement**: - **Study', 'for Neuropathic Cancer Pain - **Objective**:', 'for Acute Sinusitis-Like Complaints - **Objective:**', 'in Skilled Nursing Facility**: - **Participants**:', 'vs. Non-Specific Mental Stimulation**: - **Participants**:', 'in Serious Mental Illness - **Objective**:', 'on Initial Chemotherapy (MFL)**: - **Study', 'of Four Injectable Anesthetics**: - **Study', 'vs. Ultra Y-set Systems**: - **Study', 'with Acid-Etched Surfaces (Osseotite):** - **Study', 'with Previous Colorectal Cancer**: - **Design**:', 'for Epidural Needle Insertion**: - **Study', 'in Acute Exudative Pharyngitis:** - **Objective:**', 'for Urinary Catheter Care**: - **Study', 'in High-Normal BP Individuals - **Objective:**', 'in Acute Nonlymphocytic Leukemia**: - Ciprofloxacin', 'in Spinal Cord Injury - **Objective**:', 'in Fully Compliant Patients**: - **Study', 'for Digital Nerve Blockade**: - **Study', 'for Norplant System Insertion**: - **Study', 'in Back Pain Patients**: - Evaluation', 'in Threatened Preterm Labor:** - **Objective:**', 'in Small Intestine CD:** - **Participants:**', 'for Pediatric HIV Patients**: - **Participants**:', 'in Out-of-Hours Primary Care**: - **Study', 'in Carpal Tunnel Surgery**: - **Study', 'for Atypical Facial Pain - **Objective**:', 'in Public Health (Canada)**: - **Objective**:', 'in Chronic Hepatitis B**: - **Objective**:', 'in Improving Functional Outcomes**: - **Study', 'for Primary Bloodstream Infections**: - **Study', 'in Acute Maxillary Sinusitis - **Objective:**', 'vs. Y-set (Y) Systems**: - **Study', 'for Social Anxiety Disorder**: - **Study', 'with Anorganic Bovine Bone:** - **Study', 'for Debridement Pain Relief**: - **Study', 'with Specific Adjuvant Exercise**: - **Participants**:', 'at Liaquat University (2007)**: - **Participants**:', 'for Burning Mouth Syndrome - **Objective**:', 'in Familial Adenomatous Polyposis**: - **Design**:', 'for Painful Diabetic Neuropathy - **Objective**:', 'vs. Educational Treatment (ET)**: - Thirty', 'for Nonsmoking Support Persons**: - **Participants**:', 'in Uterovaginal Prolapse Surgery**: - **Participants**:', 'for Intermittent Portal Clamping - **Study', 'for Malnourished AIDS Patients**: - **Participants**:', 'for Chronic Oral-Facial Pain - **Objective**:', 'in Pediatric Oncology Patients:** - **Objective:**', 'vs. Doxorubicin-Cisplatin (AP) Chemotherapy**: - **Participants**:', 'in Pediatric Dental Procedures**: - **Study', 'in Hospitalized Schizophrenic Clients - **Objective**:', 'in Weight-Losing Cancer Patients - **Objective**:', 'vs. Full-Coverage Stabilization Splint:** - **Study:**', 'of Four Insulin Regimens**: - **Participants**:']"},{"template":"DT NN IN CD NNS VBD","text":"['A trial with 211 patients found', 'A trial with 125 patients found', 'Another study with 90 women assessed', 'A study with 542 women found', 'A trial with 196 participants assessed', 'A study with 53 subjects found', 'A trial with 268 patients found', 'A study with 117 patients found', 'A study with 117 children found', 'A trial with 115 patients found', 'Another study with 125 patients showed', 'A study with 110 patients found', 'A trial with 152 adolescents found', 'Another study with 34 women showed', 'A study with 111 patients found', 'A trial with 240 women found', 'A study with 100 patients found', 'A trial with 138 patients found', 'A trial with 418 adolescents found', 'A study with 283 patients suggested', 'Another study with 30 patients showed', 'A study with 577 patients found', 'A trial with 57 patients used', 'A trial with 223 patients found', 'A study with 506 mothers found', 'A study with 84 women assessed', 'A trial with 407 patients found', 'A trial with 267 patients found', 'A cohort of 3373 12-year-olds was', 'A trial with 329 patients found', 'A study with 291 patients found', 'A trial with 191 patients found', 'A study with 147 patients explored', 'A total of 55 neonates were', 'A study with 39 children found', 'A trial with 386 patients found', 'A trial with 626 patients found', 'A study with 40 patients found', 'A trial with 405 patients found', 'A study with 74 patients found', 'A trial with 1,801 patients found', 'Another study with 60 patients found', 'A trial with 80 patients found', 'A trial with 232 patients found', 'A study with 63 patients showed', 'A total of 141 patients were', 'A study with 30 patients found', 'A study with 73 children found', 'the home over three months showed', 'Another study with 201 outpatients showed', 'A trial with 97 veterans showed', 'A trial with 533 patients found', 'A study with 7,077 women showed', 'A trial with 387 patients found', 'A trial with 613 patients found', 'A trial with 598 patients found', 'A total of 110 patients were', 'A trial with 393 patients found', 'Another study with 194 patients found', 'A total of 56 patients were', 'the second, while 37 patients received', 'A study with 120 patients found', 'A study with 84 girls found', 'A total of 18,816 participants were', 'A trial with 1,004 patients found', 'A study with 104 patients found', 'Another study with 127 women evaluated', 'A study with 520 patients found', 'A trial with 59 patients used', 'A study with 123 adolescents found', 'A trial with 302 patients found', 'A total of 218 patients were', 'A study with 52 children aged', 'A trial with 600 patients found', 'A study of 24 preschoolers found', 'A trial with 217 patients found', 'A trial with 345 women found', 'Another study with 126 women showed', 'A trial with 214 patients found', 'A study with 479 patients found', 'A study with 4228 patients found', 'A trial with 265 patients found']"},{"template":"NNP NNP NN IN CD NNS","text":"['Design**: Randomized study with 84 patients', 'Design**: Randomized study with 82 patients.', 'Children**: A study with 109 children', 'Misoprostol**: A study with 200 women', 'Suppositories**: A study with 63 patients', 'Myopia A study with 48 myopic', 'Phase II trial with 114 patients', 'Screw**: A study with 400 patients', 'Design**: Comparative study with 34 patients.', 'Selegiline (15 mg\/day for 3 weeks)', 'Nursing**: A study with 114 patients', 'Adults**: A study with 175 adults', 'Paste**: A study with 66 patients', 'Design**: Randomized trial with 75 patients.', 'Program**: A study with 242 patients', 'LLETZ**: A study of 50 women', 'Plate**: A study with 217 patients', 'Midazolam**: A study with 45 outpatients', 'Design**: Randomized study with 63 patients', 'Nail**: A study with 206 patients', 'Depression**: A trial with 63 inpatients', 'Design**: Randomized study with 30 patients.', 'Design**: Randomized study with 61 patients', 'Interventions**: A study with 152 students', 'Design**: Open study with 10 patients', 'ART-123 (0.06 mg\/kg for 30 min', 'Cyclopentolate) A study with 96 patients', 'Care**: A study of 890 patients', 'DHS**: A study with 110 patients', 'Disclosure**: A study with 48 women', 'California**: A trial with 1985 women', 'Design**: Randomized trial with 285 patients.', 'Malaria**: A study with 79 patients', 'Design**: Randomized trial with 349 patients', 'DHS**: A study with 121 patients', 'Therapy**: A trial with 66 women', 'Program**: A study with 28 patients', 'Screw**: A study with 100 patients', 'Nail**: A study with 108 patients', 'Measures**: A study with 223 patients', 'Kenya**: A trial with 1813 women', 'Patients**: A trial with 90 patients', 'Nigeria**: A trial with 1485 women', 'Nail**: A study with 210 patients', 'Nail**: A study with 80 patients', 'Routes**: A study with 28 adults', 'Screw**: A study with 210 patients', 'Opioids**: A study with 150 outpatients', 'Trial)**: A study with 560 adults', 'PPMS A study with 50 subjects', 'Sclerosis A study with 60 patients', 'Adults**: A study with 65 adults', 'Design**: Randomized study with 20 patients.', 'LLETZ**: A trial with 396 women', 'Design**: Randomized trial with 354 patients.', 'Pirenzepine A study with 353 children', 'Patients**: A study with 50 patients', 'Anesthesia**: A trial with 100 women', 'LLETZ**: A trial with 200 women', 'Design**: Randomized study with 100 patients.', 'Percussion**: A study with 51 participants', 'Sclerosis A study with 42 patients', 'Students**: A study of 288 students', 'Clinic**: A trial with 300 women', 'Design**: Randomized study with 21 patients.', 'Children**: A study with 103 children', 'Bifocals**: A study with 240 children', 'Fluconazole**: A study of 73 patients', 'Coagulator**: A study of 100 women', 'Adhesiolysis**: A study with 100 patients', 'Sclerosis A study with 98 patients', 'LLETZ**: A study of 60 women', 'Rankin Scale score at 3 months', 'Design**: Randomized study with 64 patients.', 'Design**: Case-control study with 17 patients', 'Comparison**: A study with 167 patients', 'Design**: Matched trial with 40 patients', 'Design**: Controlled study with 62 patients.', 'Clinics**: A trial with 251 patients', 'DHS**: A study with 190 patients', 'Vaporization**: A study of 63 women']"},{"template":"NN TO VB DT NN IN","text":"['**Objective**: To estimate the efficacy of', '**Objective**: To investigate the association between', '**Objective**: To determine the utility of', '**Objective**: To assess the role of', '**Objective**: To assess the effect of', '**Objective:** To determine the effectiveness of', '**Objective**: To compare the effectiveness of', 'evidence to support the effectiveness of', '**Objective:** To compare the efficacy of', '**Objective:** To compare the safety of', 'study to evaluate the provision of', '(RCT) to evaluate the impact of', '**Objective**: To determine the effect of', '**Objective**: To evaluate the effect of', '**Objective**: To examine the effect of', '**Objective:** To estimate the effect of', '**Objective:** To assess the effectiveness of', '**Objective**: To evaluate the effectiveness of', 'hypertension to investigate the mechanism behind', '**Objective**: To test the efficacy of', '**Objective**: To evaluate the benefit of', '**Objective**: To investigate the effectiveness of', '**Objective**: To determine the efficacy of', 'inability to show an advantage for', '**Objective**: To evaluate the efficacy of', '**Objective**: To test the effect of', 'insertion to reduce the risk of', '**Objective:** To assess the role of', '**Objective**: To assess the impact of', '**Objective:** To assess the effect of', '**Objective:** To evaluate the efficacy of', '**Objective:** To assess the impact of', '**Objective:** To assess the efficacy of', '**Objective**: To observe the effect of', '**Objective:** To evaluate the effect of', 'trial to evaluate the effectiveness of', '**Objective**: To compare the efficacy of', '**Objective**: To examine the benefit of', '**Objective**: To examine the efficacy of', '**Objective**: To investigate the effect of', '**Objective**: To evaluate the quality of', '**Objective:** To evaluate the effectiveness of']"},{"template":": NN CD NNS IN JJ","text":"['- **Participants**: 180 patients with occluded', '- **Participants:** 24 children with active', '- **Participants**: 45 patients with acute', '- **Participants**: 24 adults with nociceptive', '- **Participants**: 122 patients with idiopathic', '- **Participants**: 540 patients with high-risk', '- **Participants**: 30 patients with early', '- **Participants**: 26 patients with transfusional', '- **Participants:** 2 patients with passive', '- **Participants**: 156 patients with high-risk', '- **Participants**: 42 patients with typhoid', '- **Participants**: 103 patients with acute', '- **Participants**: 33 women with spasmodic', '- **Participants**: 56 patients with acute', '- **Participants**: 54 patients with idiopathic', '- **Participants**: 25 subjects with chronic', '- **Participants**: 51 patients with chronic', '- **Participants:** 17 children with active', '- **Participants**: 120 patients with critical', '- **Participants**: 17 patients with early', '- **Method**: 60 patients with generalized', '- **Participants**: 107 adults with uncomplicated', '- **Participants:** 298 patients with symptomatic', '- **Participants**: 144 patients with thalassemia', '- **Participants**: 47 patients with typical', '- **Participants**: 47 patients with uncomplicated', '- **Participants:** 397 patients with macular', '- **Participants**: 288 cases of culture-proven', '- **Participants**: 158 patients with soft', '- **Participants**: 122 patients with mild-to-moderate', '- **Participants**: 19 children with severe', '- **Completion**: 57 patients on clopenthixol', '- **Participants:** 500 patients with acute', '- **Participants**: 48 patients with refractory', '- **Participants:** 108 patients with acute', '- **Participants**: 100 patients with chronic', '- **Participants**: 26 patients with insulin-antibody-mediated', '- **Participants**: 123 adults with uncomplicated', '- **Participants**: 89 persons with neurogenic', '- **Participants:** 20 patients with moderate-to-severe', '- **Participants**: 121 patients with acute', '- **Participants**: 116 patients with early', '- **Participants**: 128 children with social', '- **Participants:** 11 patients with severe,', '- **Participants**: 523 patients with migraines,', '- **Participants**: 18 men with idiopathic', '- **Participants**: 60 patients with severe', '- **Participants**: 345 patients with high-risk', '- **Participants**: 94 patients with reduced', '- **Participants**: 108 children with suspected', '- **Participants**: 74 children with generalized', '- **Participants**: 50 adults with uncomplicated', '- **Participants**: 59 patients with peripheral', '- **Participants:** 3207 patients with symptomatic', '- **Participants**: 290 patients with recurrent', '- **Participants**: 73 adults with long-term', '- **Participants**: 146 patients with chronic', '- **Participants:** 400 patients with proximal-vein', '- **Participants**: 30 children with overanxious', '- **Participants**: 149 patients with occluded', '- **Participants:** 45 patients with severe', '- **Method**: 127 patients with major', '- **Participants**: 40 men with high-grade', '- **Participants**: 45 patients without para-aortic', '- **Participants**: 70 infants with central', '- **Participants**: 32 patients with acute', '- **Participants**: 385 patients with endometrioid', '- **Method**: 40 subjects with symptomatic', '- **Participants**: 20 men with chronic', '- **Participants**: 284 patients with acute', '- **Participants:** 1001 patients with symptomatic', '- **Participants**: 20 patients with chronic', '- **Method**: 123 patients with acute', '- **Participants**: 40 patients without aortic', '- **Participants**: 181 adults with acute', '- **Participants**: 238 patients with acute', '- **Participants:** 201 patients with proximal', '- **Participants**: 63 patients with migraines,', '- **Participants**: 30 patients with idiopathic', '- **Participants:** 364 patients with moderate-to-severe', '- **Participants**: 235 children with uncomplicated', '- **Intervention**: Three months of aerobic', '- **Participants**: 8 children with moderate']"},{"template":"DT JJ NN VBZ JJ NNS","text":"['The provided text comprises multiple studies', 'The provided text summarizes several studies', 'The provided text discusses various studies', 'The provided text discusses multiple studies', 'The provided text summarizes multiple studies', 'The provided text contains multiple studies', 'The provided text summarizes various studies']"},{"template":"NNP IN NNP NNP : DT","text":"['Care for Postpartum Depression**: - A', 'Management for Cancer Patients**: - A', 'Care for HIV Patients**: - A', 'Testing for TB Patients**: - A', 'CBT for Latino Patients**: - A', 'Contractures in OA Patients**: - A', 'Care for Latino Patients**: - A', 'Calls for ART Adherence**: - An', 'Amoxicillin in Neutropenic Episodes**: - No', 'Counseling for ART Adherence**: - A', '(ICM) for Upper-Extremity Disorders**: - A', 'Care for Acute Depression**: - A', 'Treatment for Chinese Americans**: - A', 'Care for Cardiac Patients**: - A', 'Integrated with Prenatal Care**: - A', 'Care for Cancer Patients**: - A', 'Pain by Occupational Physicians**: - A', 'Effect of Depression Intervention**: - A', 'Preparation for Blood Sampling**: - A', 'Reality for Lumbar Puncture**: - A', 'Sulfate for Disease Progression**: - A', 'Living with HIV (YPLH)**: - A', 'Magnifiers in Geriatric Patients**: - A', 'Care for Post-CABG Depression**: - A', 'Plan for Elderly Patients:** - A', 'Depression in Veterans Affairs**: - A', 'Program for High Utilizers**: - A', 'Distraction for Immunization Pain**: - A', 'Depression in Low-Income Women**: - A', 'Therapy in Knee OA**: - A', 'Care for Anxiety Disorders**: - A', 'Planning for Elderly Patients:** - A', 'Prevention for Adolescent Mothers**: - A', 'Care for Postnatal Depression**: - A', 'Intervention for Asian Women**: - An', '(ICP) for Stroke Rehabilitation:** - A', 'Device for Postural Rehabilitation**: - A', 'Depression in Puerto Rico**: - A', 'Care for Anxiety Disorders**: - The', 'Study of Functional Appliances**: - A', 'Methotrexate in Steroid-Dependent IBD:** - A', 'Support for ART Adherence**: - A', 'Women with Acute UTI**: - A', 'Monitoring for Minor Depression**: - A', 'Placebo for Severe Preeclampsia**: - A', 'Phenytoin for Labor Induction**: - A', 'Program for Older Adults**: - A', 'Trial in Dialysis Patients**: - A', 'Viloxazine in Dysthymic Patients**: - A', 'Intervention for Arm Function**: - A', 'Ferumoxytol in Hemodialysis Patients**: - A', 'CABG in Multivessel Disease**: - A', 'Depression in Rural Patients**: - A', 'Pefloxacin in Granulocytopenic Patients**: - The', 'Care with Clinical Pharmacists**: - A', 'Support for Depressive Symptoms**: - A', 'Iron in Hemodialysis Patients**: - A', 'Care for Panic Disorder**: - A', 'Care for Depressed Adolescents**: - A', 'Placebo in Atypical Depression**: - A', 'Sodium for Impulsive Aggression**: - A', \"Remission in Crohn's Disease:** - A\", 'Care for Older Adults**: - A', 'Hypnosis for Lumbar Puncture**: - A', 'Placebo in Dysthymic Disorder**: - A', 'Activity with Off-the-Shelf Orthotics**: - An', 'Distraction for Blood Draws**: - A', 'Management for Multiple Conditions**: - A', 'Care for Late-Life Depression**: - A', 'Gluconate in Hemodialysis Patients**: - A', 'Depression in Epilepsy Patients**: - A', 'Care vs. Consult-Liaison Care**: - A', 'Care for Hispanic Patients**: - A', 'Athletes with Cavus Feet**: - A', 'Class for Chronic Stroke**: - A', 'Naltrexone in Alcohol Dependence**: - A', 'Intervention for Older Women**: - A', 'Cream for Needle Pain**: - A', 'Teams for Depression Improvement**: - A']"},{"template":"NN VBD DT JJ NN IN","text":"['acid showed a significant increase in', 'group received a hypnotic induction at', 'therapy had a positive effect on', 'indoramin found no significant effect on', 'study evaluated a combined regimen of', 'support played a crucial role in', 'amitriptyline experienced a significant increase in', 'rate showed no significant difference between', 'pseudoephedrine showed a significant reduction in', '(CIMT) was a significant predictor of', \"group had an 'excess' number of\", 'analysis indicated a significant decrease in', 'compliance was the significant predictor of', 'rhLH showed a significant reduction in', 'mg\/kg showed a clinical response at', 'group had a median survival of', 'removal showed no significant difference in', 'raloxifene had no significant effect on', 'study found a slight increase in', 'study found no significant reduction in', 'group experienced a significant reduction in', 'group showed a quick response, with', 'study noted a significant reduction in', 'study showed a significant reduction in', 'study was a 2-year follow-up of', 'study showed a slight reduction in', 'study reported a non-significant reduction in', 'endpoint was a \u226520% improvement in', 'azithromycin found no significant difference in', 'study found no significant benefit of', 'outcome was the active quality of', 'group had a mean follow-up of', 'wort showed no significant effect on', 'study explored the potential efficacy of', 'ANOVA indicated no significant improvement in', 'treatment showed a significant decrease in', 'study showed no significant improvement in', 'treatment showed no beneficial effect on', 'triflusal reduced the combined incidence of', 'group showed a significant increase in', 'treatment was a viable alternative for', 'Cinacalcet showed a dose-proportional increase in', 'participant completed a full course of', 'trial found no significant difference in', 'year) showed a significant reduction in', 'group showed a non-significant decrease in', 'group showed a significant reduction in', 'Thymopentin showed a non-significant reduction in', 'analysis showed no significant difference between', 'study evaluated a new spacer for', 'death showed no significant difference between', 'activity had a negative effect on', 'outcome was the combined incidence of', 'cinromide showed no significant difference between', 'study found no significant difference in', 'study evaluated the clinical value of', 'trial found no significant benefit of', 'ranitidine showed a modest reduction in', 'outcome was the combined rate of', 'event) showed no significant difference between', 'group underwent a 15-week intervention, while', 'study found a significant reduction in', 'therapy showed no significant effect on', 'weekly) found no significant reduction in', 'group had a shorter duration of', 'evaluation found no significant difference between', 'study found no significant difference between', 'trimethoprim had a limited advantage over', 'Results showed a significant reduction in']"},{"template":"CD JJ NNP NNP IN NNP","text":"['7: Web-Based Weight Loss in Primary', '6: Internet-Based Weight Management in Military', '75 mg\/day (Group HD) of Naftopidil.']"},{"template":"NN IN CD NNS VBD DT","text":"['review of 491 patients showed a', 'study with 577 patients found no', 'trial with 240 infants showed a', 'trial with 267 patients found no', 'study with 48 eyes found no', 'study with 206 patients found no', 'trial with 19 patients found both', 'Study of 1172 patients found a', 'study with 210 patients found no', 'trial with 76 patients found no', 'study with 576 children found no', 'trial with 688 patients assessed the', 'pH at 6 hours showed no', 'trial with 176 patients assessed a', 'study in 120 patients confirmed the', 'response at 8 weeks maintained the', 'study with 116 neonates found no', 'study with 84 women assessed the', 'trial with 1813 women found a', 'trial with 300 women found no', 'trial with 200 infants found no', 'trial with 2416 infants found no', 'study with 15 children found no', 'trial with 416 patients showed both', 'trial with 3526 patients found no', 'placebo for 2 years found no', 'study with 240 children found no', 'study with 33 patients found no', 'trial with 196 participants assessed the', 'follow-up of 331 women showed no', 'study with 10 patients found no', 'study with 147 patients explored the', 'trial with 37 children found no', 'trial with 57 patients used a', 'trial with 59 patients used a', 'trial with 1485 women found no', 'trial with 12 patients reported a', 'trial with 24 subjects showed a', 'study with 175 adults found no', 'trial with 23 women found no', 'trial with 80 infants found no', 'study with 353 children evaluated the', 'trial with 150 infants found a', 'study with 11 patients found no', 'group of 18 patients received no', 'trial with 251 patients assessed the', 'study with 12 patients found a', 'trial with 225 participants assessed the', 'trial with 154 participants assessed the', 'study with 42 patients found no', 'study with 100 patients found no', 'trial with 102 neonates found a', 'study with 101 volunteers found a', 'trial with 268 patients found no', 'trial with 58 patients assessed the', 'study of 186 patients found no', 'study with 10 subjects found a', 'study with 24 children found no', 'study with 125 patients showed a', 'trial with 69 patients showed a', 'study of 63 women found no', 'study with 400 patients showed no', 'study with 80 patients found no', 'study with 62 patients found no', 'study with 110 patients found no', 'study with 110 patients found both', 'trial with 265 patients showed both', 'study with 588 neonates showed a', 'trial with 66 women assessed the', 'study with 111 patients found no', 'study with 123 patients found no', 'study with 160 adults found no', 'study with 103 children found no', 'trial with 14 patients found a', 'trial with 24 patients showed a']"},{"template":"JJ NN CC JJ NN NN","text":"['autistic disorder and severe tantrums, aggression,', 'functional independence and upper extremity function,', 'other statin and disease-modifying drug combinations.', 'physical function and reduced depression severity', 'antidepressant adherence and depressive symptom outcomes.', 'home-based exercise, and usual care groups.', 'recurrence-free interval and overall survival (OS)', 'rigid ones, and early postoperative breast', 'disease-free survival and reduced lymphocyte level', 'appendectomy (LA) and open appendectomy (OA)', 'preterm delivery and neonatal respiratory distress', 'implant integration or crestal bone movement.', 'lactic dehydrogenase and alanine aminotransferase levels.', 'biophysical scores, and umbilical artery blood', 'antenatal care, and other primary care', 'output, frequency, and oral rehydration solution', 'ischemic injury and reduced blood loss.', 'dry eyes, and long symptom duration.', 'nutritional supplementation, and early ambulation, show', 'chlorhexidine solution or sterile water placebo.', 'anticonvulsant therapy and reduced seizure frequency', 'spinal-epidural (CSE), and intradural-epidural analgesia (IEA).', 'fluid-air exchange and intraocular gas tamponade.', 'startle reactivity, and improved executive function.', 'short-term efficacy but rapid relapse post-treatment.', 'sleep onset, and early morning awakening,', 'non-invasive, effective, and well-tolerated treatment option,', 'single-leg squat and lateral stepdown, regardless', 'high attrition and potential self-selection bias.', 'vascular obstruction and pulmonary artery pressure', 'titrated-dose oxycodone and sustained-release morphine sulfate', 'physical activity or gestational weight gain.', 'immediate replacement and immediate restoration groups.', 'fallopian-tube carcinoma, or primary peritoneal carcinoma).', 'subjective benefit, or skin temperature response', 'environmental adjustments, and secondary prevention measures.', 'placebo, p=0.041) and improved seizure severity', 'levodopa dosage and reduced motor fluctuations.', 'molar relationships, and reduced malocclusion severity.', '(CC, n=40) or selective clamping (SC,', 'cultural considerations, and integrated service delivery', 'pulmonary function, and improved inflammatory parameters.', 'satisfactory gastrointestinal and cardiovascular tolerability profile.', 'anesthetic volume and improved block quality', 'epidemic outbreak but delayed cord separation.', 'careful monitoring and appropriate dosage adjustments.', 'biliary colic or acute gallbladder disease.', '24-hour half-life, and minimal drug interactions.', 'delusional disorder and antipsychotic-induced erectile dysfunction.', 'postural performance and reduced neck pain,', 'myocardial reinfarction, or non-fatal cerebrovascular event)', 'below-knee (FemPopBK) or femoro-distal (FemDist) bypass.', 'motivational interviewing, and cognitive behavior therapy', 'contraceptive use and reduced pregnancy incidence.', 'placental insufficiency and fetal growth restriction', 'major depression and generalized anxiety disorder', 'pneumatic compression, and electrical stimulation show', 'tear stability, and meibomian gland function.', 'arthroplasty (hemiarthroplasty and total hip replacement,', 'relapse-free survival and distant metastasis rates,', 'weight loss and waist circumference reduction.', 'pre-eclampsia (74.1%) and fetal growth restriction', 'same procedure plus individualized velopharyngeal surgery.', 'weight loss and reduced sodium intake', 'chlorhexidine solution or sterile saline placebo', 'low-dose (32%), and high-dose (36%) groups.', 'overall survival, or complete response rates.', 'weight gain and other side effects.', 'human milk and salicylic sugar powder', 'cardiovascular fitness and reduced blood pressure', 'extensive components, and additional community resources.', 'advanced disease or specific risk factors.', 'myopia progression or axial length increase']"},{"template":"NNS VBD DT JJ NN IN","text":"['children found no significant difference in', 'schools showed a positive effect on', 'groups saw a weight decrease of', 'results showed a significant improvement in', 'patients showed a significant reduction in', 'studies highlight the complex balance between', 'women found a significant difference in', 'groups showed a significant decrease in', 'patients found no additional benefit for', 'results showed no significant difference in', 'women showed no significant difference in', 'studies found no significant effect of', 'levels performed an equal number of', 'regimens found no significant difference in', 'patients found a high prevalence of', 'adults found no significant difference in', 'patients reported an improved sense of', 'patients had a serious cause of', 'patients had a >50% reduction in', 'subgroups showed a clear benefit from', 'groups showed a significant reduction in', 'results showed no significant effect of', 'studies found no significant difference in', 'infants found a significant reduction in', 'patients experienced a >50% reduction in', 'years found no significant difference in', 'patients found no significant effect of', 'studies noted a slight increase in', 'Results showed no significant difference in', 'children found no significant effect of', 'women found no significant difference in', 'patients found a favorable effect of', 'regimen showed no significant advantage over', 'students showed a significant increase in', 'patients found no significant difference between', 'consultations were an acceptable alternative for', 'studies highlight the differential efficacy of', 'infants found no nosocomial sepsis in', 'analyses revealed a significant reduction in', 'adults found no overall efficacy of', 'infants showed a significant reduction in', 'infants found no significant reduction in', 'patients completed the 2-month study, with', 'treatments had a low frequency of', 'neonates showed a significant reduction in', 'results suggested no dramatic improvement with', 'others found no significant benefit over', 'patients found no significant difference in', 'analyses suggested a potential benefit in', 'patients evaluated a task-oriented intervention for', 'studies highlight the mixed effectiveness of', 'Results showed a significant improvement in', 'men tested an Internet-delivered intervention for', 'results showed a significant decrease in', 'methods included a 10-day course of', 'patients received a 3-month course of', 'patients received an intravenous injection of', 'pharmacists had a favorable effect on', 'Results showed a significant reduction in', 'eyes found no significant difference in']"},{"template":"IN DT JJ NN IN NN","text":"['with a notable duration of analgesia', 'of a 2-minute infusion of rt-PA', 'with no prior history of apnea.', 'with a significant risk of progression', 'during the initial phase of training,', 'of the pancreatic duct with contrast', 'during the first year of treatment.', 'from an improved definition of thrombocytopenia.', 'with no significant difference in complications.', 'by a single-blind phase with placebo', 'in a slight reduction in grip', 'with no significant difference between groups.', 'with no significant difference between them.', 'as an alternative treatment for psychosis', 'in a significant number of patients,', 'in the overall risk of transfusion', 'of the second phase of induction', 'with a parental history of diabetes.', 'that a 7-day course of mifepristone', 'in the primary outcome of death', 'in the short-term treatment of autism', 'with no significant difference in weight', 'as an add-on treatment in chronic,', 'for the symptomatic treatment of mild', 'with no significant impact on anxiety', 'with no significant difference in outcomes.', 'in the acute phase of depression.', 'in the third stage of labor', 'in a small reduction in body', 'although no meaningful change in rheumatologic', 'as a valuable alternative for mild', 'in the prophylactic treatment of migraines.', 'though no significant difference in health', 'by a high rate of hypotrophy', 'during the first stage of labor.', 'with a single dose of gonadotropins).', 'of the third stage of labor.', 'that the standard level of education', 'despite no significant difference in rehospitalization', 'from the third day of life.', 'for a small impact on fruit', 'in the primary quality of life', 'with no significant difference in complication', 'for the rapid control of acute', 'with no significant difference between devices.', 'with a halved dose during stimulation', 'as an alternative therapy for refractory', 'with an extended duration of action.', 'in the primary endpoint between triflusal', 'in a small reduction in core', 'as a hemostatic treatment for trauma', 'in a significant proportion of men.', 'with no significant difference in pain', 'Therefore, the routine use of eye', 'with no significant difference in mortality', 'after a certain number of applications.', 'of the third stage of labor', 'that the actuarial probability of bleeding', 'despite a significant decrease in prolactin', 'in a significant reduction in drinking', 'of a single dose of cefuroxime', 'as the first step in treatment.', 'in the prophylactic treatment of migraines,', 'on the third day of life,', 'behind the hypotensive effect of spironolactone.', 'in the relative hazard of death', 'with a similar duration of action', 'during the final week of hospitalization', 'though the immediate need for contraception', 'with the daily dose of clonazepam']"},{"template":"VBD DT NN IN JJ NN","text":"['reported a reduction in homologous blood', 'evaluated the efficacy of prophylactic indomethacin', 'assessed the impact of community-based interventions,', 'was no increase in adverse events.', 'evaluated the impact of home-based contracting', 'highlight the effectiveness of various child', 'included the duration of supplemental oxygen', 'reduced the need for postoperative care.', 'accelerated the onset of antidepressant action', 'examined the impact of nutritional supplementation', 'reduced the severity of disturbed behavior,', 'investigated the efficacy of plasma exchange', 'prevented the progression of uterine leiomyomas', 'shunts, the need for surgical ligations,', 'investigated the effectiveness of antibiotic prophylaxis', 'evaluated the effectiveness of oral methotrexate', 'reduced the number of sexual partners.', 'reduced the risk of pre-eclampsia (74.1%)', 'delayed the need for levodopa therapy', 'assessed the impact of postnatal health', 'increased the frequency of ductal closure', 'confirmed the effectiveness of twice-daily diflunisal', 'highlight the need for further research', 'assessed the impact of postnatal home', 'reduced the recurrence of gingival overgrowth', 'assessed the efficacy of custom foot', 'requirement, the period of tachypnea, time', 'saw an increase in grip strength.', 'reduced the risk of prolonged labor.', 'Compared a beta-blocker with sympathomimetic activity', 'reduced the incidence of severe omphalitis', 'assessed the impact of nurse intervention', 'highlight the effectiveness of triple therapy', 'emphasized the need for thorough evaluation', 'experienced an increase in urinary pH.', 'received a combination of compliance-improving strategies,', 'showed no effect on cardiovascular endpoints,', 'highlight the importance of clinic features,', 'highlight the importance of careful monitoring', 'evaluated the impact of secondary cytoreductive', 'reduced the risk of sustained disability', 'lowered the risk of cardiovascular events,', 'demonstrated a reduction in tic severity.', 'investigated the role of visual feedback', 'found a reduction in preterm delivery', 'tested the impact of supportive telephone', 'reduced the need for additional medication', 'highlight the effectiveness of various water', 'highlight the effectiveness of various brief', 'highlight the need for careful consideration', 'highlight the importance of adequate sample', 'evaluated the addition of adhesive zinc', 'reduced the need for supplemental anesthesia.', 'increased the number of collected oocytes.', 'reduced the incidence of febrile episodes,', 'Reduced the incidence of antibiotic-associated diarrhea.', 'noted a reduction in symptomatic hypoglycemia', 'highlighted the importance of comprehensive approaches.', 'showed a reduction in impaired brain', 'attenuated the decrease of eicosapentaenoic acid', 'was the need for erythrocyte transfusion', 'shortened the duration of purulent rhinorrhea', 'indicated a decrease in tic frequency', 'evaluated the impact of clinic-based counseling', 'reduced the need for intraoperative shunting.', 'reduced the need for oxytocin augmentation', 'Shortened the duration of watery diarrhea,', 'showed some reduction in preterm delivery', 'increased the likelihood of successful return', 'showed some improvement in tic severity.', 'evaluated the effect of postnatal home', 'delayed the initiation of levodopa therapy', 'reduced the need for homologous blood', 'found no difference in cesarean section', 'explored the plasticity of neuropsychological function']"},{"template":"NNP IN NNP NNP NNP NNP","text":"['Acids in Cachectic Pancreatic Cancer Patients', 'Counseling in Public Health Service Dietary', 'Intervention in Obese Pregnant Women A', 'Mexiletine for HIV-Associated Painful Sensory Neuropathy', 'Assessment of Change, Patient Analog Pain', 'Summary of Smokeless Tobacco Cessation Studies', 'Study in US Male Physicians**: A', 'PTCA for Isolated Proximal LAD Lesions**:', 'Game for Preventing Adolescent Pregnancy**: A', 'Intervention in Small US Cities**: Popular', 'High-Dose vs. Low-Dose Methylprednisolone (MP) (30', 'Nail vs. Medoff Sliding Plate**: A', 'Combined with Chemotherapy (Cisplatin, Epirubicin, Cyclophosphamide)**:', \"Methotrexate in Chronic Active Crohn's Disease:**\", 'Trials on Multiple Sclerosis Treatments ####', 'Disc vs. Anterior Lumbar Interbody Fusion:**', \"Scleroderma with Raynaud's Phenomenon Study**: Involving\", 'Treatment for Childhood Sexual Abuse Survivors**:', 'Amitriptyline for Neuropathic Pain Post-Breast Cancer', 'Study in Female Health Professionals**: No', 'Amitriptyline for Acute Herpes Zoster Pain', 'Beta in Metastatic Breast Cancer (BRAVE', 'Study in Familial Adenomatous Polyposis (FAP)**:', 'V in Non-Small Cell Lung Cancer**:', 'Beta-1b in Primary Progressive Multiple Sclerosis', 'Monotherapy for Chronic Low Back Pain', 'Psychotherapy for Metastatic Breast Cancer Patients**:', '(QoL) in Colorectal Cancer (CRC) Survivors', 'Study in US Male Physicians**: No', 'Department of Port Moresby General Hospital', 'OC in Stage I-III Colon Cancer', 'Care for Low-Income Latina Cancer Patients**:', 'Fixation vs. Total Hip Replacement (THR)**:', 'Amoxicillin for Acute Upper Respiratory Tract', 'Sucrose in Peritoneal Dialysis (PD) Patients**:', 'Model in Urban Indian Health Clinics**:', 'Alpha1 in Hepatocellular Carcinoma**: Combining TACE', '(IVIG) in Secondary Progressive Multiple Sclerosis', 'Iodine vs. Povidone Iodine Alone**: A', '(EMDR) for Female Sexual Assault Victims**:', 'Combination for Chronic Low Back Pain', 'Phase in Long-Protocol GnRH Agonist Regimen**', 'Treatment in Spinal Cord Injury Patients**:', 'Outcomes in UK MRC CLASICC Trial', 'Beta-1a in Relapsing-Remitting Multiple Sclerosis (RRMS)', 'Training in Overweight Pregnant Women Aerobic', 'V in Small Cell Lung Cancer**:', 'Study in Female Health Professionals**: A', '(GTR) with Expanded Polytetrafluoroethylene (ePTFE) Membranes**:', 'Efficacy in Treating Alcohol Dependence ####', '(OC) for Colorectal Cancer #### Study', 'Mobilization for Neck Pain #### Overview', 'Intervention in Northern Territory Indigenous Communities**:', 'Summary of Adolescent Smoking Cessation Interventions', 'Outcomes of Total Shoulder Arthroplasty (TSA)', 'Hospital of Eastern Ontario Pain Scale', 'Trazodone for Chronic Burning Mouth Pain', \"Efficacy in Alzheimer's Disease #### Overview\", 'Alfa in Small-Cell Lung Cancer (SCLC)**:', 'Video for Urban Adolescent Girls**: A', 'Intervention for Early Adolescent Females**: A', 'Venlafaxine for Neuropathic Pain Post-Breast Cancer', 'Combination for Chronic Lower Back Pain', 'Assessment of Change, Principal Investigator Global', 'Azathioprine in Chronic Progressive Multiple Sclerosis', 'Program for Child Abduction Prevention**: Kindergarten', 'Treatment for Comorbid Substance Abuse**: Adding', 'Study on Advanced Rectal Cancer (1984-1986)**:', \"Therapies for Crohn's Disease #### CDP571\", 'Steroids in Treating Acute Sinusitis ####', 'Repair in Rheumatoid Arthritis Patients ####', 'Interventions for Very Preterm Infants ####', 'Lidocaine in Local Anesthetic Operating Theatre**:', 'Methotrexate in Chronic Progressive Multiple Sclerosis', 'Summary of Typhoid Fever Treatment Studies', 'E in Chronic Hepatitis C Non-Responders**:', 'Cyclophosphamide in Chronic Progressive Multiple Sclerosis']"},{"template":"JJ NNP NNP IN NNP NNP","text":"['**Comprehensive Discharge Planning for Elderly Patients:**', '**Psycho-Educational Telephone Support for Depressive Symptoms**:', '**Parental Distraction Education for IV Insertion**:', '**Supportive-Expressive Group Psychotherapy for Metastatic Breast', '**Motivational Interviewing (MI) vs. Educational Treatment', '#### Interferon Beta-1a in PPMS A', '**Home-Based Aerobic Exercise for HIV-Infected Adults**:', 'Web-Based Weight Loss in Primary Care', '**Omega-3 PUFA Supplementation in PAD Patients**:', '**Sciatic Nerve Block at Popliteal Fossa**:', '**Thymosin Fraction V in Small Cell', '**Pediatric Telephone Protocols in Emergency Room**:', '**Prospective Randomized Study on Rectal Adenocarcinoma**:', 'Internet-Based Weight Management in Military Personnel', '**Task-Related Circuit Class for Chronic Stroke**:', '**School-Based Health Promotion in Leeds**: A', 'Sensitive Collaborative Treatment for Chinese Americans**:', '**Nordic Multicenter Study on Initial Chemotherapy', '#### Dietary Counseling in Public Health', '**General IVF Outcomes in AMA Patients**:', '**Within-Patient Cross-Over Trial of Four Insulin', '#### Interferon Beta-1a in Relapsing-Remitting Multiple', '**Primary Care Intervention for Suicidal Ideation', '**Sciatic Nerve Block at Midfemoral Level**:', '**Proactive Telephone Support for ART Adherence**:', 'Ovarian Stimulation Protocols in Poor Responders', '**Home-Based Nursing Intervention for Pediatric HIV', '**Home Safety Program for Low-Income Families**:', '#### Nutrition Education in Pregnant Adolescents', '**Selective Prevention Interventions for Mexican-American Women**:', '#### Lifestyle Intervention in Obese Pregnant', '**HIV Prevention Integrated with Prenatal Care**:', '**ADAPt-C Collaborative Care for Cancer Patients**:', '**Mental Health Interventions for Rural HIV-Infected', '**Thymosin Fraction V in Non-Small Cell', '**Whole-Abdominal Irradiation (WAI) vs. Doxorubicin-Cisplatin (AP)', '**Supportive Telephone Calls for ART Adherence**:', '#### Lifestyle Counseling for GDM Prevention', '**Twelve Step Recovery vs. Behavioral Skills', '**Brief Group Counseling for Homosexual API**:', '#### Internal Stent vs. No Stent', '**Evidence-Based Pain Management in Postoperative Care**:', '**CHARITE Artificial Disc vs. Anterior Lumbar', '#### Long-Term Outcomes of Shoulder Arthroplasty', '**Prophylactic Methenamine Hippurate After Gynecologic Surgery**:', '#### Physical Activity During Pregnancy A', '**Specific Cognitive Treatment vs. Non-Specific Mental', '**S-1 Plus Cisplatin vs. S-1 Alone**:', 'Fall-Fracture Prevention Program in Norway **Objective:**', '**Healthy Living Advice for Diabetes Risk**:', '**Prophylactic Methenamine Hippurate in Uterovaginal Prolapse', '**Anteroposterior (AP) View in Lumbar Spine', '**Sexual Abuse Prevention for Elementary Students**:', '**Televised Cessation Program with Support Groups**:', '**Stress Management Training for HIV-Infected Gay', '**Task-Related Circuit Class for Locomotor Function**:', '**Social Skills Training vs. School Reintegration**:', '**Telephone-Based Close Monitoring for Minor Depression**:', '#### External Stent vs. No Stent', '**Custom Foot Orthoses for Cavus Foot', '#### Optimal Treatment for Rheumatoid Shoulder', '**Topical Phenytoin Powder vs. Normal Saline**:', '**Ibuprofen-Releasing Foam Dressing for Pain Relief**:', '#### External Stent vs. Internal Stent', '**Internet-Based Health Care for Persons Living', '**Abdomino-Perineal Excision (APE) vs. Coloanal Procedures:**', '**Cognitive Trauma Therapy for Battered Women', '**Community-Based Home-Visit Intervention for Medication Adherence**:', '#### Interferon Beta-1b in Primary Progressive', '**Prize-Based Contingency Management in Community Settings**:', '#### Long-Term Outcomes of Total Shoulder', '**Ultra Twin Bag vs. Ultra Y-set']"},{"template":"JJ NN IN JJ NN IN","text":"['effective treatment for neuroleptic-induced akathisia in', 'significant difference in overall mortality between', 'sodium bicarbonate during neonatal resuscitation on', 'short course of oral prednisolone in', 'routine use of intraventricular streptokinase for', 'slight increase in contraceptive use among', 'iodide salt on thyroid size during', 'significant difference in steroid consumption between', 'unexpected effect of educational intervention on', 'significant difference in overall survival between', 'double-blind trial with blinded outcome adjudication,', 'significant impact on mortality, duration of', 'significant difference in complete improvement by', 'spontaneous ovulation versus hCG-triggered ovulation during', 'significant reduction in overweight prevalence in', 'first choice for severe infections, with', 'significant difference in immediate efficacy between', 'beneficial effect on prostanoid metabolism without', 'significant effect on night-wetting frequency in', 'significant difference in disease response among', 'significant difference in myopia progression between', 'High incidence of prolonged apnea with', 'significant difference in apnea incidence between', 'clinical course of transient tachypnea of', 'Significant increase in urinary iodine in', 'clear evidence of superior efficacy in', 'significant difference in weight gain between', 'fibrin deposition on vascular subendothelium, while', 'Significant reduction in goitre prevalence in', 'fast-track protocol on postoperative morbidity in', 'myopia progression between full correction for', 'judicious use of radiographic imaging in', '24-hour therapy for mild preeclampsia, with', 'limited advantage over cranberry extract in', 'intramuscular betamethasone for antepartum treatment of', 'significant effect of patient vaccination on', 'significant difference in health-related quality of', 'nasal resistance on isolated days, with', 'standard treatment for primary prophylaxis of', 'airway inflammation at various dosages, with', 'sensory block, with significant prolongation in', 'viable option for single-tooth replacement in', 'significant reduction in colorectal adenomas in', '1-year study with omega-3 supplementation in', 'weight decrease of 4.3-4.5 kg at', 'increased use of low-fat milk among', 'significant difference in ovarian response between', '12-week course of oral prednisolone on', 'significant difference in fever duration between', 'wet nebulization in acute asthma, with', 'significant impairment in immune response between', 'alcohol consumption among pregnant women, with', 'significant difference in median survival, although', 'high rate of virological failure in', 'significant difference in catheter encrustation among', 'diet (Flexical) via nasogastric tube for', 'clinical significance of antioxidant therapy in', 'further investigation of interferon beta-1b in', 'significant reduction in mean amplitude of', 'similar progression of joint destruction in', 'significant difference in symptom improvement between', 'beneficial effect on serious depression in', 'affected patients, with minimal deterioration in', 'significant improvement in subjective symptoms, with', 'slight reduction in depressive symptoms, while', 'effective procedure for palatal closure in']"},{"template":"IN NNP NNP : DT NN","text":"['in Epilepsy Patients**: - A trial', 'in Hemodialysis Patients**: - A study', 'for Cancer Patients**: - A trial', 'for Lumbar Puncture**: - A pilot', 'for Chinese Americans**: - A study', 'for Depressed Adolescents**: - A trial', 'in Rural Patients**: - A study', 'for Stroke Rehabilitation:** - A study', 'for Hispanic Patients**: - A trial', 'vs. Off-Pump Surgery**: - A study', 'for Asian Women**: - An intervention', 'for Panic Disorder**: - A trial', 'with Recurrent UTIs**: - A study', 'in Geriatric Patients**: - A study', 'for High-Risk Women**: - A study', 'for High Utilizers**: - A trial', 'for Poststroke Depression**: - A trial', 'for Multiple Conditions**: - A trial', 'in Asthmatic Children**: - A study', 'for Disease Progression**: - A study', 'of Depression Intervention**: - A trial', 'vs. Consult-Liaison Care**: - A trial', 'in Steroid-Dependent IBD:** - A study', 'for ART Adherence**: - An adherence', 'for Cancer Patients**: - A study', 'for Minor Depression**: - A trial', 'by Occupational Physicians**: - A trial', 'for Older Adults**: - A trial', 'with Respiratory Biofeedback**: - A study', 'for Post-CABG Depression**: - A trial', 'for Acute Depression**: - A trial', 'for Blood Draws**: - A study', 'for Needle Pain**: - A study', 'of Functional Appliances**: - A study', 'for Impulsive Aggression**: - A study', 'for Anxiety Disorders**: - A trial', 'for Arm Function**: - A trial', 'for Labor Induction**: - A study', 'for Cardiac Patients**: - A trial', 'with HIV (YPLH)**: - A study', 'for Blood Sampling**: - A study', 'for Postural Rehabilitation**: - A study', 'for Late-Life Depression**: - A trial', 'of Cannula Types**: - A study', 'for Postnatal Depression**: - A trial', 'in Chemotherapy Patients**: - The addition', 'for Latino Patients**: - A study', 'in Military Recruits**: - A study', 'for HIV Patients**: - A trial', 'in Multivessel Disease**: - A study', 'for Depression Improvement**: - A study', 'for Lumbar Puncture**: - A study', 'for Latino Patients**: - A pilot', 'for Postpartum Depression**: - A study', 'with Prenatal Care**: - A study', 'with Clinical Pharmacists**: - A trial', 'in Granulocytopenic Patients**: - The addition', 'for Adolescent Mothers**: - A study', 'for Depressive Symptoms**: - A study', 'for Chronic Stroke**: - A pilot', 'in Depression Care**: - A study', 'in Veterans Affairs**: - A study', 'for Upper-Extremity Disorders**: - A trial', 'for Immunization Pain**: - A study', 'in Low-Income Women**: - A trial', 'in Puerto Rico**: - A study']"},{"template":"NNP : NN NNP NNP NN","text":"['Drops - **Study Design**: Randomized double-blind', 'Placebo**: - **Study Design**: Randomized, double-blind', 'Decompression**: - **Study Design**: Randomized study', 'Systems**: - **Study Design**: Randomized study', 'Ointment - **Study Design**: Randomized, double-blind', 'Anesthesia**: - **Objective**: Compare US guidance', 'Care**: - **Study Design**: Randomized assignment', 'Floxuridine**: - **Study Design**: Randomized study', 'Blocks**: - **Objective**: Compare US guidance', 'Care**: - **Study Design**: Randomized control', 'Patients**: - **Study Design**: Case-control study', 'Stroke**: - **Study Design**: Single-blind, randomized,', 'Protocols**: - **Stop Protocol**: Early cessation', 'Hypochlorite**: - **Study Design**: Controlled study', 'Fluspirilene**: - **Study Design**: Comparative study', 'Level**: - **Objective**: Compare US guidance', 'Training**: - **Study Design**: Crossover study', 'Lacerations**: - **Study Design**: Randomized study', 'Surgery**: - **Study Design**: Randomized, double-blind', 'Placebo**: - **Study Design**: Double-blind trial', '(TS)**: - **Study Design**: Randomized trial', 'Acetaminophen**: - **Study Design**: Randomized trial', 'Treatments**: - **Human Milk**: A study', 'Women**: - **Objective**: Reduce IPV recurrence', 'Placebo**: - **Study Design**: Randomized double-blind', 'Recurrence**: - **Eradication Rates**: Triple therapy', 'Procedures**: - **Study Design**: A study', 'Stroke**: - **Study Design**: Randomized pilot', 'Approaches**: - **Study Design**: Randomized trial', 'Injection)**: - **Objective**: Compare US guidance', 'Outcomes**: - **Study Design**: Prospective crossover', 'Neonates**: - **Study Design**: Prospective interventional', 'Malignancies**: - **Study Design**: Randomized trial', 'Thrombolysis**: - **Study Design**: Open study', 'Physicians**: - **Study Design**: Randomized assignment', 'Fossa**: - **Objective**: Compare US guidance', '(MFL)**: - **Study Design**: Randomized study', 'Cancer**: - **Study Design**: Randomized trial', 'Reduction**: - **Study Design**: Randomized trial', 'Compliance**: - **Side Effects**: Triple therapy', 'Block**: - **Objective**: Compare US guidance', 'Outcomes:** - **Lead Levels:** One study', 'Surgery**: - **Study Design**: Randomized study', 'Solution - **Study Design**: Double-masked study.', 'Catheters**: - **Study Design**: Randomized crossover', 'Study)**: - **Study Design**: Randomized, double-blind', 'Guidance)**: - **Objective**: Compare US guidance', 'Responders** - **Objective:** Compare GnRH antagonist', 'System**: - **Study Design**: Matched trial', 'Insertion**: - **Study Design**: Randomized, double-blind', 'Encrustation**: - **Study Design**: Randomized crossover', 'Care**: - **Study Design**: Randomized study', 'Study)**: - **Study Design**: Randomized study', '(AOC)**: - **Study Design**: Randomized trial', 'Cancer**: - **Study Design**: Two-stage, adaptive-design', 'Benefits:** - **Bilirubin Metabolism:** One study', 'Thiomalate)**: - **Study Design**: Placebo-controlled, double-blind.', 'Appointments**: - **Study Design**: Interrupted time']"},{"template":"JJ NN IN JJ NN NN","text":"['significant suppression of urinary cortisol levels,', 'myopia progression with manageable side effects.', 'acute treatment of pediatric anxiety disorders.', 'sedative effect on dementia-related motor behavior,', 'little effect on skeletal change, alignment,', '\u226520% improvement in pulmonary function (FEV1)', 'spermatogenic suppression with acceptable side effects.', 'overall performance in live patient settings.', 'intraoperative hypothermia during cerebral aneurysm surgery', 'viable alternative for umbilical cord care,', 'procedure-related pain, with similar success rates.', 'significant increase in urinary estrogen excretion', 'viable alternative for colorectal cancer surgery.', '12-week study of treatment-resistant patients, quetiapine', 'transplacental passage of fetal blood cells.', 'significant increase in plasma folate levels,', 'significant reduction in ovarian hyperstimulation syndrome', 'foam, irrespective of initial pain levels.', 'fast-track protocol after open bowel resection.', 'canvas bags) on sexual risk behaviors.', 'effective dose of all-trans-retinoic acid (atRA)', 'significant difference in overall evaluation length', 'significant increase in mean heart rate.', 'primary endpoint of sustained disability progression.', 'fetoplacental growth, while reduced exercise volume', 'monoclonal gammopathy of undetermined significance (MGUS).', 'significant improvement in ventilator-associated pneumonia incidence', 'overall survival in non-small cell lung', 'significant increase in intraocular pressure (IOP).', 'significant improvement in intraosseous canine position.', 'significant rise in serum potassium levels,', 'early diagnosis of slow labor progress,', 'Continuous increase in urinary iodine excretion', 'non-significant reduction in 24-hour blood pressure', 'slight improvement in overall health subscale,', 'significant difference in axial length elongation', 'postoperative bacteremia in primary closure (3.3%)', 'erythrocyte transfusion during hip fracture surgery.', 'daily consumption of concentrated cranberry juice', 'similar study with omeprazole (40 mg', 'significant difference between active treatment (average', 'significant increase in child abuse knowledge', 'procedural pain, with similar success rates.', 'palatal closure in submucous cleft palate', 'preemptive analgesia in pediatric dental extractions.', 'weight loss in male shift workers.', 'significant reduction in soluble thrombomodulin (sTM)', 'analgesic efficacy in postoperative dental pain.', 'significant improvement in hematological tolerance, performance', 'physical function, while expiratory muscle training', 'long-term use of oral protein energy', 'significant difference in catheter life extension', 'vibratory detection threshold, motor-nerve conduction velocity,', 'in-person support for long-term weight maintenance.', 'significant reduction in unadjusted resident mortality,', 'complete excavation in permanent posterior teeth.', 'pulse treatment with long-term steroid therapy).', 'diabetic polyneuropathy, despite frequent side effects.', 'chronic pain in spinal cord injury.', 'postoperative morbidity in open colonic surgery.', 'disulfiram regimen among discharged alcohol patients.', 'intractable epilepsy across various age groups,', 'national action for non-communicable disease prevention.', 'fatal condition with limited treatment options.']"},{"template":"NN NN CC JJ NN NN","text":"['liver injury and intraoperative blood loss.', 'immature teratomas, and mixed germ cell', 'efficacy failure, and overall medication assessments.', 'induction duration or cesarean delivery rates.', 'dysplasia (BPD) and acute air leaks,', 'cholangiopancreatography (ERCP) and endoscopic sphincterotomy (ES),', 'cell count and prior treatment history.', 'seizure frequency, and phenytoin-induced gingival hyperplasia.', 'activity, systolic and diastolic blood pressure', 'rearfoot post, and neutral rearfoot post.', 'heparin (UFH) or low-molecular-weight heparin (LMWH)', 'life (QL), and reduced hospital\/nursing home', 'dipyridamole-thallium scintigraphy, and coronary artery calcification', 'scale (VAS) and other pain measurement', 'group therapy and present-centered comparison treatment.', 'dentin (control) and partial removal (experimental).', 'saline washout, and acidic washout solution', 'atropine sulfate, and atropine sulfate alone.', 'survival (PFS) and overall survival (OS)', 'depression severity, and general health status.', 'alcohol consumption and peak intoxication levels.', 'placebo arm and adequate sample size', 'skin infiltration and epidural needle insertion.', 'height (VDH) and horizontal defect depth', 'anesthesia (GA) and spinal anesthesia (SA)', 'diameter metal and flexible plastic cannulae', 'function scores, and physical functioning quality', 'household water and reduced diarrheal disease', 'visuo-motor speed, and verbal abstracting ability,', 'telephone consultation, and urgent care handling.', 'placebo, p=0.01) and total seizure frequency', 'ferritin (SF), and transferrin saturation (TSAT)', 'approach (thoracic and sacroiliac joint manipulation', \"family communication, and reduced adolescents' marijuana\", 'cigarette advertising and peer-led smoking prevention', 'seizure frequency and improving seizure severity', 'medication effects, and physical role limitations.', 'control, tablet, and liquid fluoride groups,', 'recurrent prolapse and external hemorrhoidal disease', 'vastus medialis and gluteus medius activity', 'effects, contraindications, and overall health status.', 'pain relief, and overall medication assessments.', 'hospital stay and improved patient satisfaction.', 'survival (RFS) or overall survival (OS)', 'muscle strength and functional performance measures.', 'beclomethasone (n=7) or systemic dexamethasone therapy', 'hospital stay, and adverse neurologic outcomes.', 'block quality and reduced execution time.', '(RF) ablation and percutaneous microwave coagulation', 'placebo arm and adequate sample size.', 'fitness, mobility, and paretic leg muscle', 'discussion group, and social support group.', 'health transition, and mental component summary.', 'joint manipulation plus cervical spine postisometric', 'depression symptomatology and mental health status', 'sevoflurane (GA) or spinal anesthesia (SA),', 'aeruginosa density, and decreased hospitalization risk', 'insulin sensitivity and reduced plasma insulin', 'performance status and normal hemoglobin levels.', 'tobacco abstinence and reduced nicotine withdrawal', 'birth rate, and multiple birth rate', 'biochemical, radiologic, and hepatic histologic features.', 'degeneration (AMD) and other low-vision conditions.', 'implantation failure, and good prognosis women.', 'morbidity, mortality, and en bloc resections.', 'substance use but similar mood disorder', 'placement (IP) and delayed placement (DP)', 'contraceptive use and low pregnancy incidence']"},{"template":"DT JJ NN IN NN NN","text":"['the routine use of eye patching', 'no significant difference in weight regain.', 'No significant retardation in disease progression', 'a beneficial effect on purulent rhinorrhea', 'a >50% reduction in seizure frequency', 'a favorable effect of borage oil', 'a task-oriented intervention for arm function.', 'no significant impact on breast cancer', 'a shorter duration of steroid use', 'the significant predictor of infection rate', 'no significant difference in complication rates,', 'No significant impact on disease progression', 'no significant benefit of eye patching', 'a safe method for pain relief', 'a significant complication in premature infants.', 'no significant difference in health status', 'no significant effect of cranberry concentrate', 'a stable dose of acetylcholinesterase inhibitors.', 'No significant difference in serum ferritin', 'the overall risk of transfusion reactions.', 'a slight reduction in grip strength,', 'a reliable measure of solute removal', 'the second phase of induction chemotherapy', 'a small reduction in body temperature', 'a valuable resource for road safety', 'a 24\/4-day regimen of drospirenone\/ethinyl estradiol.', 'no significant difference in safety knowledge', 'a small impact on fruit consumption.', 'the primary quality of life measure.', 'a >50% reduction in seizure frequency.', 'No significant difference in wound healing', 'a significant advantage over radiotherapy alone.', 'the combined effect of surgery type', 'a significant increase in casualty ward', 'No significant difference in disease progression', 'no significant difference in energy intake', 'a beneficial effect on disease progression', 'the potent influence of cigarette advertising', 'no significant difference in rehospitalization rates.', 'a small reduction in core body', 'the rapid control of acute agitation.', 'no observed benefit on disease progression', 'a significant increase in restraint use', 'no significant difference in pain reduction', 'a significant decrease in prolactin levels.', 'No significant difference in treatment response', 'a therapeutic window for plasma levels,', 'no significant difference in mortality rates.', 'no significant difference between cranberry juice', 'a significant effect on disability progression.', 'No significant difference in operation duration,', 'no significant difference in pain intensity', 'the specific influence of cigarette advertising.', 'a significant reduction in mortality (P<0.05)', 'an alternative therapy for refractory epilepsy', 'a significant reduction in pruritus intensity', 'a valuable strategy in blood management', 'no significant reduction in prednisolone requirements.', 'no significant reduction in recurrent pyelonephritis', 'no overall efficacy of borage oil,', 'no significant difference in abrasion size', 'no meaningful change in rheumatologic status', 'no significant difference in reepithelialization speed,', 'a significant reduction in breast cancer', 'No significant improvement in executive functioning.']"},{"template":"JJ NN VBZ JJ NNS VBG","text":"['provided text contains multiple studies comparing', 'provided text comprises multiple studies evaluating', 'provided text summarizes multiple studies evaluating', 'provided text summarizes multiple studies comparing', 'provided text discusses various studies examining', 'provided text summarizes various studies evaluating', 'provided text discusses multiple studies evaluating', 'provided text summarizes various studies comparing', 'provided text summarizes multiple studies investigating', 'provided text summarizes several studies investigating', 'provided text summarizes multiple studies examining', 'provided text summarizes several studies evaluating']"},{"template":"NN NN NN CC JJ NN","text":"['inspiratory flow [NPIF], and nasal biopsy)', 'weight gain, anorexia, and urinary incontinence', 'rates, pregnancy rates, or live birth', 'control, discussion group, and social support', 'radiographs, nasendoscopic findings, and patient complaints.', 'nasal endoscopic scoring, and nasal lavage', 'weight gain, somnolence, and dry mouth.', 'mood instability, aggression, and overall functioning.', 'treatment, depression severity, and general health', 'defect height (VDH) and horizontal defect', 'efficacy, patient comfort, and radiological outcomes,', 'pain, anxiety, bleeding, or overall acceptability', 'content, seizure frequency, and phenytoin-induced gingival', 'chloroquine alone, chloroquine plus 5-day primaquine,', 'medialis, vastus lateralis, and gluteus medius', 'time, blood loss, or functional outcomes.', 'melarsoprol, nifurtimox monotherapy, and melarsoprol-nifurtimox combination.', 'infiltration, haematoma block, and general anesthesia.', 'serum ferritin (SF), and transferrin saturation', 'periventricular leukomalacia (PVL), and other complications.', 'scale, excoriation, lichenification, or overall severity', 'foot pain, disability, and functional limitation', 'sinus node dysfunction and atrioventricular block.', 'partners, drug use, and emotional distress', 'functioning, efficacy failure, and overall medication', 'plus, exercise only, plus only (motivation),', 'emergency room visits, and increased immunization', 'recurrent implantation failure, and good prognosis', 'washout), saline washout, and acidic washout', 'dietitian, practice nurse, or diet leaflet.', 'relapse rates, survival, or disease-free survival.', 'leg extensor power and reduced disability.', 'hours, telephone consultation, and urgent care', 'knee arthroplasty (TKA), and cardiac surgeries.', 'pain, function scores, and physical functioning', 'lofexidine hydrochloride, sertraline, and surgical adhesiolysis', 'arch, crowding, sex, or social class,', 'retrograde cholangiopancreatography (ERCP) and endoscopic sphincterotomy', 'labor induction duration or cesarean delivery', 'acuity, contrast sensitivity, and patient satisfaction,', 'reduction, stress management, and nutritional supplements.', 'health visitor care or usual care.', 'lesion size reduction and histological improvement', 'side effects, contraindications, and overall health', 'body mass index or health-related quality', 'analog scale (VAS) and overall efficacy.', 'lung cancer risk and total mortality', 'factors, surgeon expertise, and available resources.', 'improvement, health education, and environmental health', 'duration, wound infection, or surgical complications.', 'executive function, attention, and verbal memory,', 'assessments, morning stiffness, and joint scores.', 'antioxidants, amino acids, and nimodipine (Alsamin)', 'clinical, biochemical, radiologic, and hepatic histologic', 'analogue scale (VAS) and other pain', 'gait parameters, balance, and functional performance', 'limb function, mobility, and postural control.', 'hospital stay duration, and maternal-infant attachment.', 'tumors, immature teratomas, and mixed germ', 'indices, inflammation markers, or adverse events.', 'family planning counseling and regular follow-up', 'relief, disability reduction, and patient satisfaction.', 'rates, relapse rates, or overall survival.', 'separation anxiety disorder, or social phobia.', 'cardiorespiratory fitness, mobility, and paretic leg', 'discouragement, medication effects, and physical role', 'materials**, **telephone counseling**, and **home visits**.', 'radio-frequency (RF) ablation and percutaneous microwave']"},{"template":"DT JJ NN IN DT NN","text":"['a hypnotic induction at the start', 'the other serving as a control.', 'a significant reduction in the risk', 'a significant reduction in the need', 'the overall course of the disease.', 'the first day of the cycle.', 'The technical difficulty for the surgeon', 'a significant advantage over the use', 'no significant difference between the groups.', 'a significant issue in the quinine', 'a significant reduction in the number', 'no significant difference between the guide-wire', 'no significant difference between the drug', 'no significant advantage of either treatment.', 'no significant difference in the incidence', 'a significant reduction in the frequency', 'no significant difference in the duration', 'an essential part of the management', 'no significant difference in the length', 'no significant change in the control', 'a crucial role in the success', 'the high-functioning level of the participants.', 'a useful tool for some patients,', 'the pancreatic duct with a stent', 'the short duration of the program', 'a significant increase in the rate', 'no significant effect on the proportion', 'a preferred choice in some settings.', 'no significant difference in the improvement', 'a 15-week intervention, while the control', 'No significant difference in the rate', 'a consolidated summary of the findings:', 'no significant difference between the treatment', 'the second year after the interlock', 'the residual gap at the velopharyngeal', 'no significant difference in the decline', 'no significant difference in the recurrence', 'The median survival for the surgery', 'a clinic visit within a month']"},{"template":"NNP NNP NNP NNP : NN","text":"['Primrose Oil (EPO) Studies:** - **Study', 'Nicotine Replacement Therapy Intervention - **Objective**:', 'Local Anesthetic Operating Theatre**: - **Study', \"Psychotherapy Mothers' Group (RPMG)**: - RPMG\", 'Chemotherapy (Cisplatin, Epirubicin, Cyclophosphamide)**: - **Participants**:', 'Female Sexual Assault Victims**: - EMDR', 'Enhanced Weight Loss Interventions - **Objective:**', 'Pain Post-Breast Cancer Treatment - **Objective**:', 'Anterior Lumbar Interbody Fusion:** - **Participants:**', 'II Total Shoulder Arthroplasties - **Study', 'Chi Minh City, Vietnam - **Participants**:', 'Acute Nonlymphoid Leukemia (ANLL)**: - TMP\/SMX', 'Hepatic Vascular Exclusion (HVE) - **Study', 'Oral Anticoagulation (SMAAF Study)**: - **Objective**:', 'Cachectic Pancreatic Cancer Patients - **Objective**:', 'Hemispherical Cup Resurfacing Hemiarthroplasty - **Study', 'Weight Loss Maintenance Interventions - **Objective:**', 'Health Nurses (75-84 years)**: - **Design**:', 'Randomized Controlled Trial (1998-1999)** - **Objective:**', 'II Total Shoulder Replacements - **Study', 'Chronic Hepatitis C Non-Responders**: - **Objective**:', 'Plexus Block (Success Rate)**: - **Objective**:', 'Research Programme #### Copyright - \u00a9', 'Hepatic Vascular Exclusion (MTHVE) - **Study', 'National Lymphoma Investigation Study**: - **Objective**:', 'Medical Long-Term Care Sites):** - **Setting:**', 'Agent Against Colorectal Adenomas**: - **Design**:', 'UK MRC CLASICC Trial - **Participants**:', 'Infraclavicular Brachial Plexus Blocks**: - **Objective**:', 'Self-Managed Oral Anticoagulant Therapy**: - **Objective**:', 'Uptake Efficiency Slope (OUES)**: - OUES', 'Randomized, Non-inferiority Controlled Trial** - **Objective:**', 'Total Shoulder Arthroplasty (TSA) - **Study', 'Spinal Cord Injury Patients**: - **Participants**:', 'Head Surface Replacement Hemiarthroplasty - **Study', 'Nottingham Total Shoulder Replacement - **Study', 'Behavioral Weight Loss Program - **Objective:**', 'UNICEF Baby-Friendly Hospital Initiative** - **Objective:**', \"Crohn's Disease #### CDP571 - **Study\", 'Breast Cancer (BRAVE Study)**: - **Study', 'Urban Indian Health Clinics**: - **Objective**:', 'Neomycin\/Polymyxin B\/Nalidixic Acid (NPN)**: - Ciprofloxacin', 'Long-Protocol GnRH Agonist Regimen** - **Objective:**', 'Vertebral Fracture Prevention Trial**: - **Participants**:', 'Chronic Burning Mouth Pain - **Objective**:', 'Acute Herpes Zoster Pain - **Objective**:', 'Advanced Rectal Cancer (1984-1986)**: - **Participants**:', 'Total Hip Replacement (THR)**: - **Reoperation', 'Indirect Pulp Therapy (IPT)**: - **Objective**:', '(0.5% Moxifloxacin Ophthalmic Solution) - **Study', 'Chronic Periapical Infected Sites:** - **Study', 'Plexus Block (Multiple Injection)**: - **Objective**:', 'Nerve Block (Double Injection)**: - **Objective**:', 'Exercise Program (FAME Program)**: - **Design**:', 'Stage I-III Colon Cancer - **Duration**:', '### CATIE Studies Overview - **Design', 'Advanced Rectal Carcinoma (T4N0M0)**: - **Participants**:', 'Pregnancy (HIP) Computer Program**: - **Objective**:', 'DUROM Cup Surface Replacement - **Study', 'HIV-Associated Painful Sensory Neuropathy - **Objective**:', 'Double-Blind, Controlled Trial (2002):** - **Objective:**', 'Nagasaki Medical Center, Japan** - **Objective:**', 'Northern Territory Indigenous Communities**: - **Objective**:', 'Small-Cell Lung Cancer (SCLC)**: - **Study']"},{"template":"DT NN IN JJ NN IN","text":"['the role of glutamatergic activation in', 'The increase in transplant-related mortality with', 'the effectiveness of antibiotic prophylaxis in', 'the necessity of peritoneal closure in', 'the impact of home-based contracting on', 'the efficacy of antiretroviral chemoprophylaxis in', 'the effect of transdermal nicotine on', 'the severity of disturbed behavior, with', 'the role of social support in', 'A study on early treatment with', 'the complexity of sexual dysfunction in', 'the absence of surfactant therapy in', 'the liver from ischemia-reperfusion injury during', 'the effect of amoxicillin-potassium clavulanate on', 'the risk of mother-to-child transmission of', 'the administration of sodium bicarbonate during', 'The necessity of tendon interposition for', 'a preference over random mobilization in', 'the need for ventriculoperitoneal shunt in', 'the efficacy of plasma exchange in', 'the role of continuous monitoring in', 'the effect of iodinated salt on', 'the necessity of antibiotic treatment in', 'The study on adhesive zinc oxide', 'The efficacy of antibiotic prophylaxis in', 'the efficacy of preemptive analgesia in', 'the importance of careful monitoring for', 'the importance of personal ownership of', 'the role of visual feedback in', 'the role of folate supplementation in', 'any domain of sexual functioning despite', 'the management of preterm labor by', 'the necessity of routine drainage in', 'The incidence of manual removal of', 'the impact of clinic-based counseling in', 'the incidence of vertebral fractures, with', 'No change in thyroid size in', 'this condition, although high-level evidence for', 'the efficacy of preoperative acetaminophen in', 'the impact of nutritional supplementation on', 'the incidence of severe omphalitis by', 'the incidence of maternal infection in', 'some degree of neurobehavioral plasticity in', 'the need for further research with', 'the need for careful consideration of', 'the impact of nurse intervention on', 'a reduction in symptomatic hypoglycemia with', 'the plasticity of neuropsychological function in', 'the need for levodopa therapy in', 'the need for erythrocyte transfusion in', 'a history of chronic hepatitis in', 'the improvement in overall survival with', 'the impact of iodide salt on', 'the safety of tranexamic acid before', 'the value of antibiotic prophylaxis in', 'the effectiveness of perineal massage in', 'the importance of iodized salt in', 'the site of perineal repair by', 'the importance of appropriate dosing in', 'the impact of beta-carotene supplementation on', 'the incidence of colorectal cancer over', 'the need for erythrocyte transfusion from', 'the need for careful consideration in', 'the effect of antioxidant supplementation on', 'the progression of carotid atherosclerosis in']"},{"template":": NN NNP JJ NN IN","text":"['- **Design**: Randomized, double-blind trial with', '- **Findings**: No significant difference in', '- **Design**: Randomized, placebo-controlled trial with', '- Results: No significant difference in', '- **Results**: No significant difference between', '- **Outcomes**: No significant difference in', '- **Objective:** Compare computer-tailored feedback with', '- **Conclusion:** No significant difference in', '- **Results:** No overall benefit of', '- **Findings**: No significant reduction in', '- **Results:** No significant advantage in', '- **Design:** Randomized prospective study with', '- **Primary:** No significant reduction in', '- **Conclusion**: No significant difference in', '- **Objective:** Evaluate antibiotic prophylaxis in', '- **Findings:** No significant reduction in', '- **Findings**: No statistical difference in', '- **Findings**: No significant impact on', '- **Results**: No significant reduction in', '- **Design**: Randomized clinical trial with', '- **Results:** No significant difference in', '- **Findings**: No significant benefit of', '- **Findings:** No significant difference in', '- **Results**: No significant difference in', '- **Mortality**: No significant difference in', '- **Outcome**: No significant difference in', '- **Objective:** Evaluate early cessation of', '- **Design:** Randomized, placebo-controlled trial with', '- **Design**: Double-blind placebo-controlled trial with', '- **Design:** Double-blind, placebo-controlled study with']"},{"template":"JJ NN IN CD NNS VBD","text":"['12-week trial with 416 patients showed', 'placebo-controlled trial with 240 infants showed', '8-week study with 24 women found', '6-month study with 28 women found', 'cross-over trial with 10 patients showed', '6-week trial with 194 nonmelancholic depressed', '(mean improvement of 8.7, p <', 'third study with 60 women found', 'placebo-controlled study with 24 children found', 'cross-sectional study with 1378 patients found', '10-week study with 56 women showed', 'placebo-controlled study with 101 patients demonstrated', 'double-blind study with 10 patients used', 'longitudinal study with 300 girls found', '24-week study with 38 women found', 'double-masked trial with 225 participants assessed', 'cluster-randomized trial with 1,275 patients found', 'Primary patency at 2 years was', 'clinical trial with 37 children found', 'sham-controlled trial with 154 participants assessed', 'placebo-controlled trial with 39 women found', 'positive response at 8 weeks maintained', 'Retrospective review of 491 patients showed', 'arterial pH at 6 hours showed', '4-year trial with 2382 participants found', 'multicenter trial with 215 adolescents found', '8-week trial with 315 patients showed', 'prospective analysis of 1030 patients showed', 'sham-controlled trial with 154 participants showed', '8-week study with 29 women found', 'pilot trial with 64 patients found', 'three-year follow-up of 331 women showed', 'placebo-controlled trial with 76 patients found', 'Primary patency at 3 years was', 'placebo-controlled study with 33 women showed', 'double-blind study with 101 volunteers found', '16-week trial with 24 patients showed', 'large study with 576 children found', '13-week trial with 19 patients found', 'double-blind comparison with 80 patients confirmed', 'placebo-controlled trial with 225 children aged', 'pilot program with 45 patients found', 'randomized trial with 58 patients assessed', 'nimodipine (Alsamin) for 9 weeks enhanced', '6-week trial with 265 patients showed', 'randomized trial with 100 patients evaluated', '8-week study with 42 men found', 'diagnostic rule with four features was', 'Prospective study of 621 patients showed', 'clinical trial with 48 women found', 'double-blind trial with 50 women found', '8-week study with 30 women found', 'multi-dose study in 120 patients confirmed', 'double-blind trial with 25 patients showed', 'placebo-controlled study with 69 patients showed', '6-week trial with 22 patients found', 'short-term study with 10 patients found', 'large trial with 554 patients demonstrated', 'dose-finding trial with 190 patients showed', '24-week trial with 69 patients showed', 'large study with 2019 women found', 'placebo-controlled trial with 20 patients found', 'small study with 12 patients found', 'linear growth over six months was']"},{"template":"DT JJ NN IN CD NNS","text":"['a mean age of 74.7 years.', 'A multi-dose study in 120 patients', 'every other day for two years.', 'A double-blind study with 46 patients', 'a median follow-up of 13 months,', 'a small study with 12 women,', 'Another large study with 2019 women', 'An 8-week trial with 315 patients', 'a mean survival of 11.8 months.', 'a two-year period, with 20 patients', 'a single-blind study of 120 children,', 'A pilot trial with 64 patients', 'A 24-week study with 38 women', 'An 8-week study with 45 women', 'An 8-week study with 30 women', 'A double-blind trial with 22 patients', 'A 12-week study with 254 patients', 'An 8-week study with 24 women', 'a mean follow-up of 30.1 months.', 'A double-blind study with 10 patients', 'A 6-week trial with 194 nonmelancholic', 'A 12-week study with 50 patients', 'a similar study with 193 children', 'the surgical group, with four cases', 'a median follow-up of 21 months.', 'A large trial with 554 patients', 'a positive response at 8 weeks', 'a 6-week trial with 16 adults,', 'the screened group, with 32 deaths', 'A 10-week study with 56 women', 'a single-blind study of 94 children,', 'a dose-ranging study with 68 patients', 'A double-blind study with 101 volunteers', 'A diagnostic rule with four features', 'An 8-week study with 42 men', 'an average age of 12.17 years,', 'A placebo-controlled trial with 72 participants', 'A 12-week trial with 246 outpatients', 'A cross-sectional study with 1378 patients', 'A third study with 60 women', 'A prospective study of 51 children', 'a median survival of 9 months', 'Another short-term study with 10 patients', 'A 12-week trial with 416 patients', 'An 8-week study with 29 women', 'A 6-week trial with 265 patients', 'A 7-week trial with 50 patients', 'a 2-year follow-up of 61 patients', 'A 6-month study of 25 patients', 'an average delay of 4.22 months.', 'a randomized study with 16 patients', 'a main analysis over 3 years.', 'A randomized trial with 114 women', 'A prospective analysis of 1030 patients', 'a small-scale study with 14 patients', 'A 12-week trial with 94 patients,', 'A follow-up study of 150 children', 'a mean follow-up of 15.9 months,', 'a randomized study with 50 patients,', 'Another 8-week trial with 135 subjects', 'A multicenter trial on 1650 women', 'A randomized trial with 193 patients', 'A multicenter trial with 215 adolescents', 'a median follow-up of 44 months,', 'A pilot program with 45 patients', 'A 6-week trial with 64 patients']"},{"template":"NNP NNP NNP NNP NNP NNP","text":"[\"(Alzheimer's Disease Cooperative Study):** Vitamin E\", 'Rating Scale (PRRS), Short-Form McGill Pain', 'Oxford Tropical Medicine Research Programme ####', 'Pain Relief Rating Scale (PRRS), Short-Form', 'Typhoid Fever Treatment Studies #### Chloramphenicol', 'Location**: Ho Chi Minh City, Vietnam', \"E (Alzheimer's Disease Cooperative Study):** Vitamin\", 'Neer Mark II Total Shoulder Arthroplasties', 'Smokeless Tobacco Cessation Studies #### Nicotine', 'Scale (PRRS), Short-Form McGill Pain Questionnaire', 'Myopia Progression Interventions #### Topical Atropine', 'Toronto Western Spasmodic Torticollis Rating Scale', 'Tropical Medicine Research Programme #### Copyright', 'L\/min (PMDI), P=0.001 #### Conclusion: Salbutamol', '(Niigata Prefecture, Influenza A (H3N2) Epidemic):**', 'Atherosclerosis Vitamin E Trial):** Vitamin E', '(Mild Cognitive Impairment Study):** Vitamin E', 'Spectacle Lenses (Full Correction, Bifocals, Progressive', 'India, China, South Africa, Brazil, Iran,', 'Bacterial Conjunctivitis #### MOXI-AF (0.5% Moxifloxacin', 'Squamous Intraepithelial Lesions (SIL) #### Study', 'E (Melbourne Atherosclerosis Vitamin E Trial):**', 'Correction, Bifocals, Progressive Addition Lenses) Several', 'Scale, Clinical Global Impression, Mania Scale)', '(Severity, Disability, Pain), Analog Pain Assessment,', 'Tobacco Cessation Studies #### Nicotine Lozenge', 'E (Boston Nursing Home Study):** Vitamin', '(Full Correction, Bifocals, Progressive Addition Lenses)', 'Drug Administration (FDA) Investigational Device Exemption', '(Melbourne Atherosclerosis Vitamin E Trial):** Vitamin', 'Adolescent Smoking Cessation Interventions #### Overview', 'Mahidol University Oxford Tropical Medicine Research', 'Treating Alcohol Dependence #### Overview Naltrexone,', 'Lenses (Full Correction, Bifocals, Progressive Addition', 'Study (Edinburgh, Shanghai, Cape Town)**: Antenatal', 'Relief Rating Scale (PRRS), Short-Form McGill', 'Rating Scale, Clinical Global Impression, Mania', \"Unified Parkinson's Disease Rating Scale (UPDRS)\", 'Psychiatric Rating Scale, Clinical Global Impression,', 'Patient Global Assessments, Sickness Impact Profile.', 'Pakistan, India, China, South Africa, Brazil,', 'Conjunctivitis #### MOXI-AF (0.5% Moxifloxacin Ophthalmic', 'Health Library (RHL) Educational Strategy (Mexico', 'Reproductive Health Library (RHL) Educational Strategy', 'Low-Grade Squamous Intraepithelial Lesions (SIL) ####', 'Exposure (IHT), Applied Muscle Relaxation (AMR),', 'Cessation Studies #### Nicotine Lozenge Study', 'Progression Interventions #### Topical Atropine A', 'E (Mild Cognitive Impairment Study):** Vitamin', 'University Oxford Tropical Medicine Research Programme', '#### MOXI-AF (0.5% Moxifloxacin Ophthalmic Solution)', 'Outcomes:** Pain Relief Rating Scale (PRRS),', 'Disability, Pain), Analog Pain Assessment, Investigator', 'Rheumatoid Arthritis Patients #### Shoulder Arthroplasty', 'Wellcome Trust Mahidol University Oxford Tropical', \"E (Physicians' Health Study II):** Neither\", 'Studies #### Nicotine Lozenge Study A', 'Heart Failure (CHF) Case Management (CM):**', 'Multiple Sclerosis Treatments #### Glatiramer Acetate', 'Sclerosis Treatments #### Glatiramer Acetate (GA)', 'Structured Internet Behavioral Weight Loss Program', 'Very Preterm Infants #### Background Very', '(Boston Nursing Home Study):** Vitamin E', 'Outcome**: Toronto Western Spasmodic Torticollis Rating', 'Trust Mahidol University Oxford Tropical Medicine']"},{"template":"NNP NN IN CD NNS VBD","text":"['A study with 242 patients demonstrated', 'A study with 167 patients found', 'A trial with 80 infants found', 'A study with 150 outpatients found', 'A study with 28 patients found', 'A study with 50 patients found', 'A study with 108 patients found', 'A study with 60 children found', 'A study with 560 adults found', 'A study with 123 patients found', 'A trial with 63 inpatients found', 'A study with 353 children evaluated', 'Scale score at 3 months was', 'A study with 60 patients evaluated', 'A study of 288 students found', 'A study with 80 patients found', 'A study with 65 adults found', 'A study with 200 women found', 'A study with 79 patients found', 'A study of 100 women found', '(15 mg\/day for 3 weeks) did', 'A study with 206 patients found', 'A trial with 1813 women found', '(total dose of 400 microg\/kg) did', 'A study with 210 patients found', 'A study with 217 patients found', 'A study of 63 women found', 'A study with 109 children found', 'A study with 116 neonates found', 'A study of 186 patients found', 'A study with 103 children found', 'A trial with 102 neonates found', 'A study with 175 adults found', 'A study with 110 patients found', 'A study of 67 patients found', 'A study with 33 patients found', 'A trial with 1485 women found', 'III trial with 251 patients showed', 'A study with 114 patients showed', 'A study with 62 patients found', 'A study with 121 patients found', 'A trial with 251 patients showed', 'A study of 60 women found', 'A study of 50 patients found', 'A trial with 100 women found', 'A trial with 200 women found', 'A study with 42 patients found', 'A trial with 200 infants found', 'A trial with 66 women assessed', 'A study with 100 patients found', 'A trial with 300 women found', 'A trial with 396 women showed', 'A trial with 150 infants found', 'II trial with 114 patients found', 'A trial with 90 patients showed', 'A study with 48 eyes found', 'A study with 400 patients showed', 'A study with 190 patients found', 'A study with 28 adults found', 'A study of 50 women found', 'A study with 63 patients found', 'A study with 240 children found']"},{"template":"VBD DT JJ NN IN JJ","text":"['showed a protective effect on upper', 'showed no significant effect of chiropractic', 'was no significant difference in ovarian', 'showed no significant difference in median', 'found a significant difference in interleukin-6', 'was no significant difference in steroid', \"had an 'excess' number of post-operative\", 'showed a significant improvement in nighttime', 'showed a significant decrease in uterine,', 'found no significant difference in neurological', 'experienced a significant increase in mean', 'showed no significant difference in health-related', 'noted a significant reduction in mean', 'tested an Internet-delivered intervention for rural', 'had a low frequency of adverse', 'caused a significant increase in intraocular', 'was no significant difference in early', 'reduced the combined incidence of cerebral', 'was a significant reduction in tonic-clonic', 'was no significant difference in overall', 'were an acceptable alternative for many', 'found no significant reduction in nosocomial', 'was the combined incidence of nonfatal', 'showed no significant effect on neurological', 'was no significant difference in self-reported', 'evaluated a combined regimen of early', 'found no significant effect on night-wetting', 'had a favorable effect on multiple', 'found no significant difference in myopia', 'found no significant difference in cognitive', 'found no significant difference in immediate', 'found no significant benefit of functional', 'was no significant difference in weight', 'showed a significant increase in child', 'highlight the differential efficacy of pharmacological', 'showed a modest reduction in nocturnal', 'showed a significant reduction in wet', 'found no significant difference in anxiety,', 'saw a weight decrease of 4.3-4.5', 'had a limited advantage over cranberry', 'showed a significant reduction in soluble', 'had a \u226520% improvement in pulmonary', 'showed a significant increase in contraceptive', 'found no significant difference in mean', 'saw a significant decline in preclinical', 'showed no significant suppression of urinary', 'was no significant difference in axial', 'showed a non-significant reduction in febrile', 'showed a significant reduction in overweight', 'found a slight increase in contraceptive', 'showed a significant reduction in ovarian', 'showed a significant decrease in 6-keto-PGF1\u03b1', 'found no significant difference between interferon', 'found no significant difference in overall', 'found no significant difference in fever', 'Found a significant improvement in long-term', 'was no significant difference in myopia', 'showed a slight reduction in depressive', 'highlight the mixed effectiveness of various', 'had a non-significant effect among overweight', 'showed no beneficial effect on pulmonary', 'showed a significant reduction in severe', 'showed a significant increase in plasma', 'found no significant difference in incident', 'showed a significant reduction in gadolinium-enhancing']"},{"template":"IN NNS IN JJ JJ NN","text":"['for women with high-risk endometrial carcinoma.', 'in patients with alpha(1)-antitrypsin (alpha(1)-AT) deficiency,', 'on patients with end-stage renal disease', 'in patients with acute maxillary sinusitis.', 'for patients with non-reconstructable critical limb', 'in patients with cystoid macular edema', 'in patients with multivessel coronary artery', 'for patients with advanced colonic cancer.', 'in patients with multiple previous withdrawals.', 'in populations with low dietary calcium', 'on children with acute lymphoblastic leukemia', 'on patients with chronic peripheral arteriopathy', 'in patients with aneurysmal subarachnoid hemorrhage', 'in patients with acute cerebral ischemia.', 'in children with acute exudative pharyngitis', 'For individuals with nonaffective psychotic disorders,', 'for individuals with age-related macular degeneration', 'for patients with refractory cholestatic pruritus.', 'in patients with painful diabetic polyneuropathy.', 'in patients with severe cognitive impairment.', 'among individuals with severe mental illnesses.', 'in patients with acute upper respiratory', 'for persons with serious mental illness.', 'in patients with bulky residual disease', 'in women with polycystic ovary syndrome', 'in patients with severe mental illness.', 'in patients with mild cognitive impairment.', 'in children without prior antibiotic therapy.', 'for people with severe mental illness', 'with reductions in negative affective state', 'in patients with advanced ovarian cancer.', 'for patients with abnormal posterior tongue', 'In patients with first-episode psychosis, maintenance', 'in patients with acute gastrointestinal hemorrhage', 'in patients with acute digestive hemorrhage', 'of patients with malignant ovarian germ', 'in infants with complete unilateral cleft', 'for patients with severe mental illness.', 'in patients with chemosensitive first relapse', 'for patients with trauma, elderly patients,', 'in patients with advanced ovarian cancer', 'in terms of local recurrence-free survival', 'For patients with severe cognitive dysfunction,', 'in patients with acute ischemic stroke.', 'among patients with severe mental illness.', 'for patients with advanced ovarian cancer', 'in patients with end-stage renal disease', 'for patients with refractory partial seizures,', 'for nurses on central venous catheter', 'in patients with polycystic ovary syndrome', 'in patients with advanced colorectal cancer', 'in terms of median age, frequency', 'in patients with acute submassive PE.', 'in patients with chronic steroid-dependent CD.', 'with reductions in severe maternal morbidity', 'in patients with relapsing-remitting multiple sclerosis', 'in patients with multi-vessel coronary artery', 'in children across various African regions.', 'for patients with advanced colorectal cancer', 'in patients with severe, steroid-dependent asthma', 'in children with mild-to-moderate cystic fibrosis', 'in mothers with low psychological resources.']"},{"template":"VBD DT JJ NN IN NN","text":"['found a significant reduction in infection', 'evaluated a task-oriented intervention for arm', 'showed no significant advantage over chloroquine', 'had a shorter duration of hospitalization', 'showed no significant difference for influenza', 'prolonged the first stage of labor.', 'was the combined rate of chorioamnionitis', 'experienced a >50% reduction in seizure', 'found no significant reduction in prednisolone', 'found no significant benefit of phenytoin', 'Found no significant impact on breast', 'had a 90-99% reduction in seizures.', 'was no significant difference in infection', 'found no overall efficacy of borage', 'showed a significant reduction in proteinuria', 'experienced a significant reduction in pruritus', 'was no significant reduction in mortality', 'had a >50% reduction in seizure', 'showed no significant difference in mortality', 'showed no beneficial effect on time', 'found no significant benefit of diphenylhydantoin', 'had a shorter duration of steroid', 'found no significant difference in reepithelialization', 'reduced the required dose of propofol', 'found a favorable effect of borage', 'showed a significant reduction in breast', 'found no significant difference in infection', 'was no significant difference in pain', 'found no significant difference between piracetam', 'completed a full course of patches.', 'showed no significant difference in safety', 'reported an improved sense of well-being', 'found no significant benefit over placebo.', 'had a positive effect on pain', 'showed a dose-proportional increase in exposure', 'was no observed benefit on disease', 'found no significant difference between cranberry', 'showed no significant effect on pain', 'showed a clinical response at week', 'found no significant difference in parasite', 'showed a significant decrease in withdrawal', 'found no significant reduction in recurrent', 'was the significant predictor of infection', 'had a delayed effect on hemolysis', 'showed a positive effect on adiposity', 'had no significant effect on uterine', 'found no significant difference in mortality', 'found no significant difference in efficacy', 'found no significant difference in pain', 'found no significant difference in abrasion', 'showed no significant improvement in survival', 'reported a global impression of improvement', 'was no significant difference in mortality', 'showed no significant difference in attendance', 'found no significant effect of cranberry', 'revealed a significant reduction in mania']"},{"template":"NN IN DT JJ NN NN","text":"['reduction in the sterile water groups.', 'population in an acute hospital setting.', 'osteoporosis, with a well-tolerated safety profile.', 'analysis of a 28-week double-blind trial.', 'education in a general medicine clinic', '**Asenapine**: Over a 26-week period, asenapine', 'section of an implicit memory test.', 'puff) in a three-period crossover study.', 'investigation as a potential maintenance treatment', 'burying of the distal catheter segment', 'care by a geriatric management team', 'functioning between the quetiapine switch group', 'survival in the heparin-plus-alteplase group (P=0.005).', 'blockade with an angiotensin-converting enzyme inhibitor', 'risk of an anti-PF4\/heparin immune response,', 'part of a comprehensive intervention strategy.', 'bypass with a distal vein cuff.', 'end of the first treatment week', 'conditions, with a favorable side effect', 'benefit in the first treatment period.', 'hemiarthroplasty via an anterolateral (McKee) approach.', 'rate with a 14-day primaquine regimen,', 'cimetidine in a double-blind crossover study.', 'practice with a mean therapy time', '(PMDI) with a large volume spacer', 'months, with a two-year survival rate', 'learning in the cognitive intervention group,', 'effect of a visual health intervention', 'hemiarthroplasty via a posterior (Moore) approach,', 'groups, although the intramedullary hip screw', 'sinusitis in the primary care setting.', 'counseling in a public health service', 'validated) of the brief intervention group', 'efficacy beyond the initial treatment phase', '**Outcome**: In the urban practice, health', 'length of the initial hospital stay.', 'commitment (beyond the initial court order)', 'area under the concentration-time curve (AUC)', 'improvement in the visual analog scale', 'improvement in the neuropathy disability score', 'speed in the early therapy group,', 'trial in a veteran retirement home', 'found that a physical activity intervention', 'surgery for an isolated hip fracture', 'difference in the entire study population', 'polymorphism of the mu-opioid receptor gene', 'rate in the intensive therapy group.', '**Efficacy:** Over a 6-month period, ciclesonide', '(CPA) with an oral contraceptive (Group', 'group with no significant side effects.', 'death in the neoadjuvant chemotherapy group', 'closure of the common bile duct', 'therapy in a protected environment (PE).', 'preference for the vigabatrin treatment period', 'assignment in a double-blind, crossover design.', '**Ziprasidone**: In a 1-year study, ziprasidone']"},{"template":"NNP NNP : NN CD NNS","text":"['Radiotherapy (RT)**: - **Participants**: 345 patients', 'Lessons Study**: - **Participants**: 8 children', 'City, Vietnam - **Participants**: 47 patients', 'University (2007)**: - **Participants**: 35 patients', 'Azathioprine Study**: - **Participants**: 569 patients', 'Trial (NCT00628186)** - **Participants**: 100 patients', 'Clinic Study**: - **Participants**: 4000 employees', 'Randomized Trial** - **Participants**: 120 patients', 'Outpatient Commitment:** - **Participants:** 264 individuals', 'Crossover Study**: - **Participants**: 34 patients', 'Kathmandu, Nepal - **Participants**: 844 patients', 'Diabetes Risk**: - **Participants**: 227 subjects', 'Brief Intervention**: - **Participants**: 250 women', 'Vientiane, Laos - **Participants**: 50 adults', '(65+ years)**: - **Design**: 1559 seniors', '(75-84 years)**: - **Design**: 580 subjects', 'Posterior Bite-Blocks**: - **Participants**: 20 patients', 'Capacity Study**: - **Participants**: 16 children', 'Anterior Resection - **Participants**: 171 patients', 'Prednisone Study**: - **Participants**: 64 patients', 'Tumors (1985-1988)**: - **Participants**: 177 cases', 'Prolapse Surgery**: - **Participants**: 109 patients', 'Abdominoperineal Resection - **Participants**: 28 patients', 'Radiotherapy Alone**: - **Participants**: 540 patients', 'IIIB Carcinoma)**: - **Participants**: 45 patients', 'CLASICC Trial - **Participants**: 794 patients', 'Massage Therapy**: - **Participants**: 107 subjects', 'Radiation Therapy**: - **Participants**: 181 patients', 'Porcine Insulin**: - **Participants**: 40 patients', 'Randomized Trial** - **Participants**: 238 patients', 'Physician Practices**: - **Participants**: 930 adults', 'Acute GP**: - **Participants**: 45 patients', 'Long-Course Cefotaxime:** - **Participants:** 90 patients', 'Interbody Fusion:** - **Participants:** 304 patients', 'Cholesterol Screening**: - **Participants**: 6000 employees', 'IV Ciprofloxacin:** - **Participants:** 80 patients', 'Resistance Study**: - **Participants**: 26 patients', 'Carcinoma (T4N0M0)**: - **Participants**: 56 patients', 'Multicenter Trial** - **Participants:** 34 patients', 'Epirubicin, Cyclophosphamide)**: - **Participants**: 156 patients', 'Case Study** - **Participants:** 2 patients', 'Multicenter Study**: - **Participants**: 238 patients', 'Location**: Vietnam - **Participants**: 235 children', 'Gynecologic Surgery**: - **Participants**: 145 patients', 'Low-Dose Cefotaxime:** - **Participants:** 143 patients', 'Circumferential Fusion:** - **Participants:** 67 patients', 'Internal Stents** - **Participants**: 43 patients', 'Non-Surgical Treatment:** - **Participants:** 173 patients', 'IIB Carcinoma)**: - **Participants**: 40 patients', '(CAP) Chemotherapy**: - **Participants**: 385 patients', 'Treatment Programs**: - **Participants**: 563 smokers', 'Adjuvant Exercise**: - **Participants**: 100 patients', 'Program Study**: - **Participants**: 61 children', 'Location**: Nepal - **Participants**: 390 patients', 'Neuropathic Bladder**: - **Participants**: 305 patients', 'Self-Care Education**: - **Participants**: 262 patients', 'Intestine CD:** - **Participants:** 17 children', 'General Practice**: - **Participants**: 309 subjects', 'Cancer (1984-1986)**: - **Participants**: 122 patients', 'Comparative Study**: - **Participants**: 153 patients', 'Fact Sheet**: - **Participants**: 59 patients', 'Treatment Study**: - **Participants**: 290 patients']"},{"template":"DT NN IN JJ JJ NN","text":"['a disease with limited therapeutic progress', 'the efficacy of telephone-delivered motivational interviewing', 'the number of sexual partners, drug', 'The prevention of first esophageal variceal', 'the convenience of once-weekly oral administration.', 'the efficacy of different umbilical cord', 'the effectiveness of various physical therapies,', 'the effectiveness of various collaborative care', 'the need for careful patient selection', 'the efficacy of tidal peritoneal dialysis', 'the need for further extensive research', 'the effectiveness of different therapeutic approaches.', 'the effectiveness of percutaneous needle aspiration', 'The diagnosis of immune heparin-induced thrombocytopenia', 'the efficacy of various antimicrobial prophylaxis', 'a trend of reduced behavioral distress', 'the importance of early postoperative rehabilitation', 'the peritoneum in lateral paramedian incisions.', 'the efficacy of spinal manipulative therapy', 'the efficacy of various cognitive training', 'the effectiveness of chlorhexidine vaginal irrigation', 'the incidence of symptomatic, laboratory-confirmed influenza', 'an increase in supervised physical activity', 'The management of displaced intracapsular hip', 'all groups, with similar neonatal outcomes.', 'the risk of febrile non-hemolytic transfusion', 'the efficacy of various non-invasive tests,', 'the quality of care, mental health', 'the effectiveness of involuntary outpatient commitment', 'the effectiveness of antenatal perineal massage', 'the period of low functional lactase', 'the role of preoperative biliary drainage', 'a decrease in calculated vascular resistance', 'the efficacy of prophylactic intravenous immunoglobulin', 'the efficacy of long-term, low-dose macrolide', 'the efficacy of interferon beta-1a (30', 'the effectiveness of multimodal interventions, education', 'the effectiveness of local antiseptic spray,', 'the effectiveness of different occupational therapy', 'the impact of antenatal phenobarbital (PB)', 'No difference in antibiotic usage, hospital', 'the lack of clear clinical benefit,', 'the presence of fetal red blood', 'the risk of first nosocomial infection', 'the effectiveness of various non-pharmacologic interventions,', 'the effect of weekly endovaginal ultrasound', 'the treatment of advanced gastric cancer.', 'a decrease in out-of-hours primary care', 'this technique with additional individualized velopharyngeal', 'the efficacy of various psychosocial interventions,', 'the impact of sequential high-dose chemotherapy', 'the potential of innovative interventions\u2014auricular acupoint', 'the risk of pelvic inflammatory disease', 'the excretion of other electrolytes, acids,', 'the importance of careful dose management', 'the absence of significant luminal narrowing.', 'the treatment of proximal deep-vein thrombosis', 'the need for further cultural adaptation.', 'the incidence of postoperative central apnea.', 'the value of preoperative biliary drainage.', 'the importance of goal-setting, personalized support,']"},{"template":"DT JJ NNS IN JJ NN","text":"['No significant changes in daily living', 'the surgical outcomes of lens extraction', 'no significant differences in physical function', 'no significant differences in gingival health', 'no significant differences in urinary tract', 'no significant differences in other alcohol', 'no significant differences in spirometric measures,', 'no significant differences in calorie intake', 'Some positive effects on physical activity', 'No significant differences in virologic failure', 'No overall differences between trauma-focused group', 'no significant differences in clinical outcomes.', 'no significant differences in overall complication', 'No significant differences in anemia, thrombocytopenia,', 'No significant differences in parkinsonism, akathisia,', 'no significant differences between nurse intervention', 'no significant differences in cognitive effects,', 'no adverse effects on neonatal adaptation', 'no significant differences in total bed', 'No significant differences in urinary tract', 'no significant changes in inflammatory mediators,', 'No significant differences in implant stability,', 'some superior effects in specific areas.', 'No significant differences in marginal bone', 'no significant differences between systematic detection', 'no significant differences in infant care', 'no significant differences in hemostatic effects,', 'no significant differences in myopia progression', 'No significant differences in implant integration', 'the long-term effects of permanent vena', 'the potential benefits of specialized care', 'no significant differences in patient morbidity', 'no adverse effects on cardiac structure', 'no significant differences in glycemic control', 'no significant improvements in neonatal outcomes.', 'no major issues in patient recruitment', 'No differential effects on sustained attention.', 'no significant differences in falls, hospitalization,', 'the comparative outcomes of primary closure', 'no significant differences in fetal outcomes.', 'No significant differences in cataract progression', 'no significant changes in audiologic tests.', 'No significant differences in other health', 'The combined regimen of early gonadotropin', 'the long-term effects of potassium-enriched salt', 'no significant differences in health, depression,', 'no significant differences in intraoperative, radiologic,', 'no significant differences in self-esteem, body', 'the potential benefits of various discharge', 'no significant differences in neurological scores,', 'No significant differences in complications, hospital', 'No significant differences in other side', 'no significant differences in overall mortality', 'no significant changes in academic achievement', 'No significant differences in pulmonary function', 'the therapeutic options for chronic schizophrenia,', 'no significant differences in postoperative liver', 'no significant differences in hospital stay']"},{"template":"NNP : NN CD NNS IN","text":"['Practices**: - **Participants**: 930 adults with', 'Study**: - **Participants**: 32 patients with', 'Study**: - **Participants**: 8 children with', 'Exercise**: - **Participants**: 100 patients with', 'D):** - **Participants:** 90 eyes of', 'Programs**: - **Participants**: 563 smokers in', 'Study**: - **Participants**: 26 patients with', 'Study** - **Participants:** 2 patients with', 'Azithromycin - **Participants**: 241 patients with', 'Ofloxacin - **Participants**: 88 patients with', 'Study**: - **Participants**: 569 patients in', 'Chloramphenicol - **Participants**: 60 patients with', 'Relaxation**: - **Participants**: 24 adults with', 'Chemotherapy**: - **Participants**: 385 patients with', 'Ciprofloxacin - **Participants**: 42 patients with', 'Therapy**: - **Participants**: 181 patients with', 'Sheet**: - **Participants**: 59 patients with', 'Study**: - **Participants**: 153 patients with', 'GP**: - **Participants**: 45 patients with', 'Vietnam - **Participants**: 47 patients with', 'Study**: - **Participants**: 238 patients with', 'Insulin**: - **Participants**: 40 patients with', 'Prednisone:** - **Participants:** 55 children with', 'Study**: - **Participants**: 16 children with', 'Ciprofloxacin:** - **Participants:** 80 patients with', 'Practice**: - **Participants**: 309 subjects with', 'Hypercholesterolemia**: - **Participants**: 135 subjects with', 'Ciprofloxacin - **Participants**: 123 adults with', 'Risk**: - **Participants**: 227 subjects at', 'Cyclophosphamide)**: - **Participants**: 156 patients with', 'Exercise**: - **Participants**: 109 patients in', 'Alone**: - **Participants**: 540 patients with', 'Carcinoma)**: - **Participants**: 40 patients without', 'Cefotaxime:** - **Participants:** 143 patients with', 'Study**: - **Participants**: 34 patients with', 'Fluoroscopy**: - **Participants**: 53 patients with', 'Study**: - **Participants**: 452 patients in', 'Study**: - **Participants**: 290 patients with', 'Vietnam - **Participants**: 235 children with', 'BPH**: - **Participants**: 40 men with', 'Hydrocortisone**: - **Participants**: 73 patients with', 'Adults - **Participants**: 107 adults with', 'Therapy**: - **Participants**: 107 subjects with', 'Carcinoma)**: - **Participants**: 45 patients without', 'Cefotaxime:** - **Participants:** 90 patients with', 'Netherlands)**: - **Participants**: 358 patients with', 'Bladder**: - **Participants**: 305 patients with', 'Naftopidil**: - **Participants**: 185 patients with', 'Therapy**: - **Participants**: 146 patients with', 'CD:** - **Participants:** 17 children with', 'Ceftriaxone:** - **Participants:** 60 patients with', 'Laos - **Participants**: 50 adults with', 'ES**: - **Participants**: 121 patients with', 'Children - **Participants**: 108 children with', 'Cotrimoxazole - **Participants**: 42 patients with', 'HGPIN**: - **Participants**: 40 men with', 'Study**: - **Participants**: 64 patients in', '(RT)**: - **Participants**: 345 patients with', 'Steroids:** - **Participants:** 24 children with']"},{"template":"JJ NN IN JJ JJ NN","text":"['primary canine with cervical-pull headgear (EHG),', 'combined regimen of early follicular phase', 'significant effect of chiropractic spinal manipulation', 'promising activity, with improved overall survival', '(0.3 mg) before planned surgical induction.', 'combined graft of autolysed antigen-extracted allogeneic', \"'excess' number of post-operative cardiorespiratory complications,\", 'combined endpoint of nonfatal ischemic stroke,', '14-fold rise for South European origin', 'small rise in serum total bilirubin', 'surgical approach for laparoscopic radical nephrectomy.', 'secondary prevention of major vascular events.', 'hCG-triggered ovulation during natural intercourse-advised cycles.', 'low-contact treatment, with significant clinical improvement', 'significant difference in disease-specific overall survival', 'antioxidant supplementation on free radical activity', 'Significant increase in pedometer-determined physical activity', 'low incidence of serious adverse events.', 'significant difference in overall diabetic control', 'hemorrhoidectomy (SH) with various conventional hemorrhoidectomy', 'macular edema after branch retinal vein', 'extensive disease, with large metastatic lesions.', 'positive reactions, with minimal negative side', 'preterm delivery among HIV-infected drug-using women.', 'lifestyle intervention on diet, physical activity,', 'further research with larger, double-blind studies.', 'high risk of major adverse cardiac', 'combined incidence of nonfatal stroke, pulmonary', 'significant reduction in major depressive episodes,', 'overall effect of ascorbic acid, vitamin', 'patient satisfaction with different contraceptive counseling', 'significant reduction in overall crystal formation', 'circumferential fusion by multiple clinical criteria.', 'Similar efficacy for nalidixic acid-sensitive strains.', 'postoperative period after third molar surgery.', 'artificial rupture of membranes, vaginal examinations,', 'significant difference in peak postoperative liver', 'first episode of primary spontaneous pneumothorax.', 'significant difference in mean cervical dilation', 'significant benefit of functional posted foot', 'computer-tailored feedback with human e-mail counseling.', 'significant difference in non-fatal influenza infection', 'ovarian stimulation with recombinant follicle-stimulating hormone', 'follow-up support into routine general practice', 'overall survival in high-risk endometrial cancer', 'natural progression of traumatic intracerebral hemorrhage', 'prognostic factor for local recurrence-free survival', 'viral replication in chronic HIV-1-infected patients,', 'early intervention with custom rigid foot', 'severe asthma on high-dose inhaled steroids.', 'postoperative pain after third molar surgery.', 'functional improvement for various foot conditions,', 'digestive tract with aerobic gram-negative bacilli', 'school-based intervention among rural high school', 'maternal mortality without significant adverse effects.']"},{"template":"JJ NNS IN JJ NN CC","text":"['significant differences in physical function or', 'significant changes in academic achievement or', 'prostaglandin-based methods for cervical ripening and', 'functioning improvements among olanzapine, risperidone, and', 'significant improvements in neurocognitive functioning and', 'significant reductions in affective instability and', 'frequent episodes of perioperative hypertension and', 'significant differences in hospital stay or', 'significant differences in calorie intake or', 'significant differences in cataract progression or', 'significant differences in overall mortality or', 'significant differences in glycemic control or', 'significant improvements in postural control and', 'certain outcomes like relapse-free survival and', 'significant differences in parkinsonism, akathisia, or', 'depressed patients with chronic pain, and', 'significant changes in postural performance or', 'similar improvements in pulmonary function and', 'major issues in patient recruitment or', 'significant benefits in postural control and', 'significant differences in virologic failure or', 'significant improvements in postural performance and', 'significant differences in infant care or', 'anticonvulsant therapies for severe pre-eclampsia and', 'significant improvements in aerobic capacity and', 'surgical outcomes of lens extraction and', 'improved activities of daily living and', 'significant differences in intraoperative, radiologic, or', 'significant improvements in glycemic control but', 'significant improvements in adherence, self-efficacy, and', 'adverse effects on cardiac structure or', 'eligible patients with locally recurrent or', 'significant differences in falls, hospitalization, or', 'significant improvements in functional capacity and', 'High rates of proximal migration and', 'significant improvements in clinical resolution and', 'similar improvements in clinical status and', 'significant differences in implant integration or', 'significant improvements in depression, suicidality, and', 'significant differences in pulmonary function or', 'significant reductions in postoperative stay and', 'significant differences between systematic detection and', 'antipsychotic effects on paranoid, hallucinatory-desintegrative, and', 'significant differences in patient morbidity or', 'various methods of cervical ripening and', 'Non-invasive tests like myocardial scintigraphy and', 'similar rates of abdominal pain and', 'final stages of oocyte maturation and', 'positive effects on mental development and', 'significant improvements in psychosocial functioning and', 'significant increases in mandibular length and', 'significant differences in health, depression, or', 'marginal improvements in child maltreatment and', 'analgesic requirements between peritoneal closure and', 'few restrictions on patient selection and', 'additional benefits in functional performance and', 'significant reductions in overweight incidence and', 'significant improvements in indoor mobility and', 'significant differences in anemia, thrombocytopenia, or', 'Alternative treatments like human milk and']"},{"template":"JJ NN NN IN CD NNS","text":"['double-blind, crossover trial with 37 patients.', 'single-blind crossover trial with 10 patients', 'randomized, double-blind study with 400 schoolchildren', '(5-ASA) (3 g\/day) over 30 weeks.', '8-week, single-blind study with 76 patients.', '24-week crossover study with 18 patients', '48-week crossover study with 11 patients', '4-week double-blind study with 404 patients.', '>50% seizure reduction at 3 months', 'placebo-controlled crossover study with 24 subjects.', '24-week crossover trial with 14 patients', 'double-blind, crossover study with 12 patients.', 'twice-daily bladder irrigation over 8 weeks.', 'monthly website advice over 4 months.', 'double-blind crossover trial with 48 patients,', '33-week crossover trial with 24 subjects', 'double-blind, parallel study with 115 patients.', 'retrospective cohort study of 887 women', 'nighttime asthma symptoms, with 14 patients', 'medicine-controlled multicenter trial with 216 children.', 'veteran retirement home with 1981 participants', 'placebo-controlled cross-over study with 21 patients.', 'double-blind, crossover study with 18 patients,', 'double-blind, crossover trial with 33 patients.', 'sham-controlled pilot study with 33 patients', 'clinical feasibility trial with 40 patients.', 'degradable polyurethaneurea (Artelon), in 15 patients', 'nickel-titanium alloy wire over 6 weeks.', '2-mile run time\/score at 12 weeks,', '4-week, double-blind study with 253 patients.', 'positive pressure ventilation at 5 minutes', 'multicenter, double-blind study with 281 patients', 'isolated hip fracture within 48 hours.', 'large multicenter trial with 2416 infants', '24-hour blood pressure by 6\/4 mm', 'double-blind case-control study with 64 patients.', 'double-blind crossover study with 24 patients', 'daily weight gain in five patients,', 'double-blind, crossover comparison with 30 patients.', 'concentration-time curve (AUC) at 24 hours', 'double-blind, parallel-group study over 20 weeks.', 'double-blind, cross-over study with 15 patients.', 'double-blind, crossover comparison with 13 patients.', 'pulmonary function (FEV1) after six weeks', 'small crossover trial with 23 women', 'triple cross-over study with 57 patients.', 'double-blind crossover study with 12 patients', 'single crossover study with nine patients', '24-week crossover trial with 12 patients', 'placebo-controlled crossover study with 15 children', 'double-blind, randomized study of 300 children', 'double-blind, randomized study with 45 patients', 'placebo-controlled pilot study with 26 children', 'placebo-controlled crossover study with 15 patients.', 'large multicenter trial with 3526 patients', 'Prospective double-blind study with 120 children.', 'median symptom score, by 50% (P', 'placebo-controlled multicenter trial with 150 patients.', 'randomized, double-blind study with 60 children', 'double-blind, crossover trial with 15 patients', 'subsequent randomized study of 50 patients,']"},{"template":"IN DT NN IN JJ NN","text":"['Assess the use of free nicotine', 'on the role of local heat', 'Additionally, the incidence of hospital-acquired pressure', 'in the treatment of chronic schizophrenia', 'without the need for radiographic evaluation.', 'in the progress of labor, time', 'in the absence of nonnutritive sucking.', 'on the management of preterm labor', 'in the prevention of cardiovascular events,', 'that the use of surgical face', 'in the pathophysiology of systemic sclerosis.', 'in the number of cleaved embryos.', 'for the treatment of discogenic pain', 'on the severity of cognitive impairment', 'at the site of perineal repair', 'at the start of ovarian stimulation', 'in the frequency of asthma exacerbations,', 'in both groups, with superior satisfaction', 'although the impact on overall mortality', 'across a range of medical conditions.', 'Assess the influence of e-coach support', 'with a history of severe pre-eclampsia', 'than a cause of early weaning.', 'Therefore, the necessity of early endoscopic', 'by the lack of pick-up order', 'with no improvement in six-month survival', 'that the use of cervical length', 'for the treatment of chronic osteomyelitis', 'for the management of bipolar disorder', 'whether the addition of thyrotropin-releasing hormone', 'for a reduction in levodopa dosage', 'despite the lack of statistical significance.', 'of the peritoneum for gynecological procedures.', 'patients, the prevalence of myocardial ischemia', 'with no deterioration in pulmonary function.', 'In a study with stabilized patients,', 'in the form of folic acid,', 'with the use of cervical-pull headgear.', 'by the time of definitive restoration.', 'in the treatment of acute gallstone', 'although the decrease in serum tryptase', 'in the number of attacks, intensity,', 'with a history of febrile transfusion', 'in the treatment of unresectable stage', 'with a follow-up of 5-8 years.', '**Conclusion**: The combination of anticholinergic (ipratropium', 'of some degree of neurobehavioral plasticity', 'at the time of skin incision', 'that the administration of sodium bicarbonate', 'with no difference in extrapyramidal symptoms.', 'with a combination of selenium, antioxidants,', 'in the treatment of amoebic liver', 'in the treatment of traumatic corneal', 'with a diagnosis of psychotic illness', 'that a combination of patient counseling,', 'on the method of iodine delivery', 'Assess the impact of iodide salt']"},{"template":"NN NN IN DT JJ NN","text":"['pain conditions, with a favorable side', 'inhaler (PMDI) with a large volume', 'reaching, load through the affected foot,', 'respiratory monitoring for all high-risk infants.', 'top-quality embryos in the flare-up group.', 'methotrexate (MTX) as a steroid-sparing agent', 'velopharyngeal surgery (either a pharyngeal flap', 'treatment (one on the 7-day regimen,', 'placebo group over a 6-week follow-up.', 'enacarbil (GEn) in the prophylactic treatment', 'cost-utility analysis from the second study', 'recurrence rate with a 14-day primaquine', 'care group, with the occupational intervention', 'induction therapy in a protected environment', 'placebo group, with no significant difference.', 'cancer mortality in the invited groups.', 'dropout rate in the intensive therapy', 'cholesterol levels, with a dose-related effect.', 'Affective state before the painful stimulus', 'year failing by the final follow-up.', 'behavior change over the long term', 'flow rate over a one-month period.', 'cholesterol reduction in the dietitian group.', 'pain reduction at the 6-month follow-up.', 'patient population in an acute hospital', 'concise summary of the key findings:', 'hemorrhoidal disease in the long term', 'prednisone group at the 1-month mark.', 'peak analgesia with a similar duration', 'force production through the affected leg.', 'lung tissue in the alpha(1)-AT group', 'heart failure in the high-volume group,', 'platelet count from the postoperative peak', 'acitretin group with no significant side', 'control study in a 1000-bed hospital.', 'cancellation rate in the long protocol.', 'cure rate), with the 50-mg dose', 'pregnancy rate in the long protocol.', 'gait speed in the early therapy', 'treatment effect on the primary endpoint', 'mist inhaler, versus a pressurized MDI.', 'acetate (CPA) with an oral contraceptive', 'pain reduction in the sterile water', 'overgrowth post-gingivectomy, with a 6-7% difference', 'neck pain at a 12-month follow-up.', 'treatment groups, with no significant difference', 'hormone (recFSH) during the luteal phase', 'fertilization rate in the flare-up group']"},{"template":"DT JJ NNS VBD VBN IN","text":"['no significant differences were observed in', 'no significant improvements were observed in', 'No significant changes were observed at', 'No significant differences were observed between', 'no such changes were observed in', 'no significant differences were observed between', 'No significant differences were observed in', 'no significant differences were found between', 'No significant changes were observed in', 'No significant improvements were observed in', 'No adverse effects were observed in', 'no significant differences were found in', 'No significant differences were found in', 'No significant differences were observed at', 'no significant differences were detected in', 'No significant differences were found between', 'No significant differences were found for', 'No adverse events were reported with']"},{"template":"NN CC NN IN JJ NN","text":"['disorder, and alcoholism with antisocial personality', 'depression and anxiety in primary care.', 'safety and efficacy of interferon beta-1b', 'intensity and duration of follow-up support', 'effectiveness and safety of manual aspiration', 'admission and treatment in mental health', 'efficacy and feasibility in general practice', 'progression or survival in primary sclerosing', 'hospital, or satisfaction with psychiatric services.', 'tolerability, and efficacy of low-dose atorvastatin', 'drainage and laparotomy with bowel resection', 'symptoms, but improvement in negative symptoms.', 'increment and progression in various age', 'pain and effectiveness of buffered versus', 'response and deterioration of metabolic control.', 'safety, and feasibility of hyperbaric oxygen', 'safety, and tolerability in Chinese patients.', 'cefuroxime and piperacillin\/tazobactam, though transient diarrhea', 'incidence and severity of acute respiratory', 'efficacy and safety of shorter, combination', 'benefit or harm of beta-carotene supplementation', 'health and well-being of elderly individuals,', 'venlafaxine and imipramine for painful polyneuropathy.', 'levels, and satisfaction during cesarean delivery', 'preeclampsia and eclampsia in pregnant women.', 'use, and prevention of mother-to-child transmission', 'safety and effectiveness of weekly fluconazole', 'tissue, and cessation of ulcer discharge', 'preeclampsia and eclampsia, with various administration', 'cancer, and cancer of unknown primary', 'well-being, and reduction in abdominal pain', 'prevention or treatment of age-related cataracts.', 'tension and normalization of cervical proprioception.', 'incidence or progression of age-related cataracts.', 'efficacy and safety of tranexamic acid', 'intervention and design for future research.', 'survival and freedom from myocardial infarction', 'use, and hospitalization after certain chemotherapy', 'nortriptyline and amitriptyline for postherpetic neuralgia.', 'efficacy and safety of alternate-day prednisone', 'acetaminophen, and placebo across various pain', 'artemether and quinine, with similar mortality', 'distress, and use of antiretroviral therapies.', 'efficacy and safety of different medications.', 'closure and excision with secondary healing.', 'pre-eclampsia and eclampsia in pregnant women.', 'safety, and immunogenicity in diabetic patients.', 'incidence and progression of age-related cataracts.', 'engagement and retention in medical care', 'safety, and tolerability of oral versus', 'incidence and duration of febrile neutropenia,', 'scores, and reduction in polyp size', 'life and survival in descriptive analyses,', 'relief and restoration of cervical mobility', 'duration and severity of acute diarrhea', 'efficacy and toxicity of concurrent chemoradiotherapy', 'onset and duration of sensory block,']"},{"template":"JJ JJ NN IN CD NNS","text":"['open-label, long-term study with 36 patients.', '5-week double-blind trial with 28 participants', 'double-blind, placebo-controlled trial with 76 patients', 'Double-blind, placebo-controlled study with 44 patients.', 'double-blind, placebo-controlled study with 33 women', 'double-blind, placebo-controlled study with 60 patients.', 'double-blind, placebo-controlled study with 101 patients', 'double-blind, placebo-controlled trial with 22 subjects.', 'single-blind randomized study of 34 children', 'open dose-finding trial with 190 patients', 'double-blind, placebo-controlled study with 49 patients.', 'twice weekly group over 16 weeks.', 'Double-blind, placebo-controlled study with 77 patients.', 'double-blind, placebo-controlled study with 272 patients.', 'median gestational age of 26.6 weeks', '10-week, double-blind trial with 652 patients', 'mean arterial pH at 6 hours', 'double-blind, placebo-controlled trial with 222 children.', 'double-blind, placebo-controlled trial with 150 mg\/day', 'randomized, double-blind trial with 167 patients', 'double-blind, placebo-controlled trial with 72 patients.', 'double-blind clinical trial with 67 patients', 'double-blind, placebo-controlled trial with 20 patients', 'Double-blind, placebo-controlled trial with 135 patients.', 'placebo-controlled, double-masked trial with 225 participants', 'double-blind, placebo-controlled trial with 139 patients.', '12-week double-blind trial with 42 participants', 'double-blind, placebo-controlled study with 320 patients.', 'double-blind, placebo-controlled study with 28 patients.', 'prospective clinical trial with 12 subjects', 'double-blind, placebo-controlled trial with 41 subjects.', 'double-blind, placebo-controlled study with 69 patients', 'twice weekly group over 12 weeks.', '6-week double-blind trial with 67 patients', 'double-blind, 10-week trial with 145 patients.', '16-week, double-blind trial with 87 patients.', 'weekly, oral methotrexate over 2 years.', 'placebo-controlled, double-blind trial with 252 adults.', 'double-blind, placebo-controlled trial with 375 patients.', '3-week, double-blind trial with 248 patients.', 'double-blind, placebo-controlled trial with 225 children', 'prospective clinical trial with 31 patients.', 'double-blind, placebo-controlled trial with 224 patients.', 'Double-blind, double-dummy trial with 981 subjects.', 'single-blind, sham-controlled trial with 154 participants', 'double-blind, placebo-controlled trial with 31 patients.', 'double-blind, placebo-controlled trial with 344 patients.', '(full occlusal, palatal) in 63 subjects', 'stable-dosed interferon-\u03b2 (IFN\u03b2) in 118 patients', 'double-blind, placebo-controlled trial with 135 adults', 'double-blind, placebo-controlled study with 40 patients.', 'double-blind, placebo-controlled trial with 34 subjects.', 'randomized, placebo-controlled study with 39 patients.', 'double-blind, placebo-controlled trial with 37 women.', 'randomized clinical trial with 33 elders', 'double-blind, placebo-controlled study with 338 patients.']"},{"template":"DT NN IN JJ NN NN","text":"['the risk of hypertensive disorders, preeclampsia,', 'the safety of high-dose atorvastatin (40', 'a combination of selenium, antioxidants, amino', 'the importance of clinic features, provider', 'a reduction in homologous blood use', 'a reduction in impaired brain flow', 'the efficacy of prophylactic indomethacin therapy', 'the treatment of acute gallstone pancreatitis', 'the efficacy of spinal cord stimulation', 'the duration of general illness, sore', 'the necessity of early endoscopic intervention', 'the benefit of concentrated risk reduction', 'The activation of latent tuberculosis infection', 'the form of folic acid, methylfolate,', 'the effect of placental cord drainage', 'the management of bipolar disorder (BD).', 'the use of improved water containers,', 'the impact of postnatal health education', 'the impact of gonadotropin-releasing hormone analog', 'the impact of secondary cytoreductive surgery', 'a role in compulsive drinking behavior', 'the need for compulsory inpatient care.', 'the impact of mammographic breast cancer', 'the effectiveness of various child abuse', 'no effect on cardiovascular endpoints, consistent', 'the effect on maternal bone density', 'the effectiveness of various water treatment', 'the influence of e-coach support type', 'the responsiveness of systemic blood pressure', 'The role of early endoscopic intervention', 'the incidence of sudden infant death', 'a history of febrile transfusion reactions.', 'the type of surgery, age, gender,', 'the effectiveness of transcutaneous nerve stimulation', 'the effectiveness of sacral nerve stimulation', 'the need for rescue medication (albuterol).', 'the addition of adhesive zinc oxide', 'the need for individualized treatment plans.', 'the need for additional oxytocic injections,', 'The efficacy of isosorbide mononitrate (IMN)', 'The choice of umbilical cord care', 'the efficacy of different iron chelation', 'the effectiveness of fecal occult blood', 'the efficacy of early endoscopic intervention', 'The occurrence of intermenstrual bleeding (IMB)', 'the need for homologous blood transfusions.', 'The treatment of pilonidal sinus disease', 'the incidence of chronic lung disease,', 'the efficacy of early amitriptyline treatment', 'No correlation with plasma drug concentrations.', 'the risk of fetal alcohol effects.', 'the risk of sustained disability progression', 'the effectiveness of computer-assisted instruction (CAI)', 'the addition of thyrotropin-releasing hormone (TRH)', 'the recurrence of gingival overgrowth post-gingivectomy,', 'the need for personalized treatment approaches.', 'the decrease of eicosapentaenoic acid (EPA)']"},{"template":"NNP : NN NNP NNP VBD","text":"['Surgery**: - **Study Design**: Prospective, randomized,', 'Ambulation - **Study Design**: Prospective randomized', 'Therapy - **Study Design**: Randomized controlled', 'Leukemia**: - **Study Design**: Prospective, randomized', '(Postpartum)**: - **Study Design**: Prospective, mixed', '(Antepartum)**: - **Study Design**: Prospective, randomized,', 'Systems**: - **Study Design**: Multicenter randomized', 'Care**: - **Study Design**: Block randomized', 'Systems**: - **Study Design**: Prospective controlled', 'Gel - **Study Design**: Double-blind randomized', 'Programs - **Study Design**: Randomized controlled', 'Findings - **Preschool Children**: ADCs were', 'Insertion**: - **Study Design**: Double-blind, randomized', 'Values:** - **GLP Group:** BCVA (logMAR)', 'Disorder**: - **Study Design**: Randomized, masked', 'Anesthetics**: - **Study Design**: Prospective, randomized,', 'Workload**: - **Study Design**: Randomized controlled', 'Catheterization**: - **Study Design**: Blinded, randomized', 'Blockade**: - **Study Design**: Prospective, randomized,', '(IPC)**: - **Study Design**: Randomized, controlled', 'Populations - **Preschool Children**: Studies included', 'Infliximab - **Study Design**: Multiple randomized,', 'Benefit**: - **Study Design**: Randomized controlled', '(Antepartum)**: - **Study Design**: Prospective, randomized', 'Tasks**: - **Study Design**: Randomized controlled', 'Replacement - **Study Population**: Various uncemented', 'Theatre**: - **Study Design**: Double-blind, randomized', 'Disorders**: - **Study Design**: Randomized, controlled', 'OCD**: - **Study Design**: Double-blind, controlled', 'Surgeries**: - **Study Design**: Double-blind, randomized', 'Adalimumab - **Study Design**: Follow-on randomized', 'Study)**: - **Study Design**: Open-label, randomized', 'Management**: - **Study Design**: Multiple interrupted', 'Placebo**: - **Study Design**: Randomized controlled', 'Acetaminophen**: - **Study Design**: Randomized controlled', 'DuraSite - **Study Design**: Prospective, randomized,', 'Ibuprofen**: - **Study Design**: Double-blind controlled', 'Lacerations**: - **Study Design**: Prospective, randomized,', 'Training - **Study Design**: Randomized controlled', 'Heparin**: - **Study Design**: Randomized, prospective,', 'Placement**: - **Study Design**: Double-blind, randomized', 'Systems**: - **Study Design**: Prospective randomized', 'Falls**: - **Study Design**: Randomized controlled', 'Systems**: - **Study Design**: Single-center randomized', 'Study**: - **Design**: Phase II, randomized,', 'Falling**: - **Study Design**: Randomized controlled', 'Blockage**: - **Study Design**: Multisite randomized', 'Catheterization**: - **Study Design**: Double-blind, randomized', 'Stimulation - **Study Design**: Double-blind, stratified', 'Retraining - **Study Design**: Randomized controlled', 'Reduction**: - **Study Design**: Multi-institutional, interrupted']"},{"template":"IN JJ NN IN JJ NN","text":"['for chronic osteomyelitis with prolonged therapy.', 'in myopia progression between full correction', 'of intraoperative hypothermia during cerebral aneurysm', 'for intractable epilepsy across various age', 'of superior efficacy in glycemic control.', 'of careful monitoring for potential side', 'as 24-hour therapy for mild preeclampsia,', 'of sensory block, with significant prolongation', 'of carotid atherosclerosis in chronic smokers.', 'for palatal closure in submucous cleft', 'of sodium bicarbonate during neonatal resuscitation', 'on postoperative morbidity in open colonic', 'with significant improvement in intraosseous canine', 'of iodide salt on thyroid size', 'on mortality, duration of mechanical ventilation,', 'with monoclonal gammopathy of undetermined significance', 'between full correction for continuous use', 'during short-term catheterization after urological procedures.', 'on night-wetting frequency in enuretic children.', 'of spermatogenic suppression with acceptable side', 'in vibratory detection threshold, motor-nerve conduction', 'with standard care in colonic resection.', 'of spontaneous ovulation versus hCG-triggered ovulation', 'for asthmatic children, while high-intensity training', 'for chronic pain in spinal cord', 'of iodinated salt on goitre prevalence', 'than intramuscular betamethasone for antepartum treatment', 'that long-term use of oral protein', 'of routine drainage in certain surgeries.', 'for weight loss in male shift', 'for single-tooth replacement in esthetic areas.', 'in upper-extremity function without significant toxicity.', 'that daily consumption of concentrated cranberry', 'of antibiotic treatment for pulmonary exacerbations.', 'of occupational intervention with clinical care', 'at high risk of pulmonary embolism', 'for internal fixation of reconstructable fractures.', 'for primary prophylaxis of variceal bleeding,', 'of potassium-enriched salt on cardiovascular disease', 'for diabetic polyneuropathy, with similar efficacy', 'for long-term treatment in unselected patients.', 'with inadequate response in previous cycles.', 'that pelvic radiotherapy after radical surgery', 'with severe pruritus of non-dermatological origin.', 'for transplacental passage of fetal blood', 'on weight retention among pregnant women.', 'for acute treatment of pediatric anxiety', 'for first-trimester abortions, with similar complication', 'for mild preeclampsia, with chronic hypertension', 'that further investigation of interferon beta-1b', 'of postoperative bacteremia in primary closure', 'at high risk for neurodevelopmental problems,', 'in chronic rhinosinusitis with nasal polyps.', 'of peritoneal closure in abdominal surgeries:', 'than in-person support for long-term weight']"},{"template":"IN DT NN IN CD NNS","text":"['in a study of 130 patients', 'In a trial with 78 patients', 'after an average of 18 months', 'In a study with 20 patients,', 'In a study with 25 patients,', 'In a study with 92 females', 'In a trial with 101 infants', 'In a study with 51 women,', 'In a study of 54 boys,', 'at a dose of 1 mg\/kg', 'At the end of 4 weeks,', 'In a study with 36 patients,', 'In a study with 20 women,', 'below the introitus for 30 seconds', 'In a study with 24 patients,', 'by an average of 27 mm', 'In a study with 263 women,', 'In a study with 200 women,', 'In a study of 45 patients,', 'between the groups, with 21.6 days', 'In a study with 100 women,', 'In a study of 33 women', 'In a trial with 306 parturients,', 'In a study of 21 women', 'In a study with 44 women,', 'In a trial with 40 infants,', 'In a study with 26 women,', 'In a study of 33 women,', 'In a study of 42 patients', 'for an average of 9.7 years.', 'In a study with 30 women,', 'by the end of 2 weeks', 'In a trial with 55 women,', 'In a study with 28 women,', 'at a dose of 15 mg', 'In a study with 60 patients,', 'In a study with 73 patients', 'at a dose of 0.6 mg\/kg', 'In a study with 120 women,', 'In a study with 85 patients,', 'into the home over three months', 'In a study with 75 women', 'In a study with 152 women,', 'In a study of 53 infants', 'In a study of 28 women', 'In a trial with 267 patients,', 'In a study of 50 women,', 'In a trial with 160 women,', 'In a study with 106 women,', 'In a study of 23 patients,', 'with the need for 550 patients', 'before the second, while 37 patients', 'with a minimum of 10 treatments', 'In a study with 32 women,', 'In a subgroup of 10 patients']"},{"template":"IN JJ NNS IN JJ NN","text":"['with optical causes of low vision.', 'of different analgesics for post-episiotomy pain', 'among HIV-infected persons in rural areas.', 'in cirrhotic patients with portal hypertension.', 'into significant improvements in overall survival.', 'with significant implications for public health', 'for internet-based interventions with enhanced engagement', 'on multiple aspects of patient care,', 'of different treatments for multiple sclerosis.', 'of different treatments on neurological conditions.', 'with small deficits in physical functioning.', 'over pharmacological approaches for sustained management', \"with child coping, while parents' behavior\", 'of prostaglandin-based methods for cervical ripening', 'for individual contacts against laboratory-confirmed influenza.', 'of multiple strategies for optimal health', 'without significant changes in glomerular filtration', 'with mixed results from various studies.', 'on clinical outcomes across different studies.', 'at aftercare sessions for male alcohol', 'in elderly patients with rheumatoid arthritis', 'with \u226412 months of prior zidovudine', 'of trophic ulcers in leprosy patients,', 'if high doses of fish oil', 'of different treatments for hepatocellular carcinoma', 'with significant improvements in indoor mobility', 'in remote areas with limited healthcare', 'of specific bacteria in upper respiratory', 'with various types of spinal fusion', 'for fall-fracture patients from private homes,', 'in depressed patients with chronic pain,', 'of various medications on menstrual blood', 'by socio-economic criteria in future studies.', 'as many episodes of unprotected sex', 'of elderly residents in long-term care', 'in certain subtypes of major depression,', 'that other factors besides delayed resorption', 'among HIV-positive patients with multiple partners.', 'in significant reductions in postoperative stay', 'with conventional restorations in primary molars.', 'on pulmonary parameters despite improved reflux', 'with significant improvements in clinical resolution', 'with sustained reductions at 1-year follow-up.', 'in pregnant women with unfavorable cervices.', 'on biochemical indicators in alcohol-dependent patients.', 'among elderly residents in long-term care', 'with potential benefits from additional postoperative', 'for dental caries in high-risk groups,', 'of young patients with borderline hypertension', 'in preterm infants with perforated necrotizing', 'that single doses of racemic ketoprofen', 'in malnourished patients with generalized malignancy.', 'with few restrictions on patient selection', 'for trophic ulcers in leprosy patients:']"},{"template":"NN IN JJ JJ NN NN","text":"['efficacy of spinal manipulative therapy (SMT)', 'efficacy of different umbilical cord care', 'effectiveness of multimodal interventions, education programs,', 'regimen of early follicular phase gonadotropin', 'effectiveness of various collaborative care models,', 'difference in non-fatal influenza infection rates.', 'prevention of first esophageal variceal hemorrhage', 'impact of antenatal phenobarbital (PB) therapy', '(HSCT) with conventional aggressive chemotherapy (Dexa-BEAM)', 'impact on rheumatologic clinical status varies,', 'decrease in out-of-hours primary care contacts.', 'Combination of cognitive behavioral therapy (CBT)', 'quality of life, physical fitness, medication', 'efficacy of prophylactic intravenous immunoglobulin (IVIG)', 'program for multiple alcohol-related traffic offenders.', 'propranolol, with endoscopic variceal ligation (EVL).', 'potential of innovative interventions\u2014auricular acupoint stimulation', 'graft of autolysed antigen-extracted allogeneic bone', 'baclofen on acute symptomatic alcohol withdrawal', 'increase in tear-film lipid layer thickness', 'fall of free radical activity marker', 'rupture of membranes, vaginal examinations, episiotomy,', 'administration of recombinant human erythropoietin (rHuEPO)', '(rHCG) with urinary human chorionic gonadotropin', 'mg of spironolactone daily (triple blockade),', 'technique with additional individualized velopharyngeal surgery', 'severity of neonatal intracranial hemorrhage (ICH)', '(OC), with similar long-term oncologic outcomes.', 'reactions, with minimal negative side effects.', 'efficacy of tidal peritoneal dialysis (TPD)', 'period of low functional lactase activity', 'satisfaction with different contraceptive counseling methods.', 'amitriptyline on trigeminal neuralgia, tension headache,', 'stimulation with recombinant follicle-stimulating hormone (rFSH)', 'difference in peak postoperative liver enzyme', 'regeneration in severe periodontal bone loss', '(SH) with various conventional hemorrhoidectomy techniques,', 'difference in antibiotic usage, hospital days,', 'diagnosis of immune heparin-induced thrombocytopenia (HIT)', 'safety of inhaled long-acting bronchodilator salmeterol', 'treatment of proximal deep-vein thrombosis (DVT).', 'impact of sequential high-dose chemotherapy (SHDCT)', 'progression among interferon beta-1b (250 microg,', 'supplement on weight, lean body mass', '(ART) for advanced maternal age (AMA)', 'safety of recombinant human erythropoietin (r-HuEPO)', 'edema after branch retinal vein occlusion', 'effectiveness of local antiseptic spray, antibiotics,', 'quality of life, physical functioning, efficacy', 'venlafaxine for atypical facial pain (AFP).', 'flow in acute cerebral ischemia patients.', 'reduction in incorrect urinary catheter care', 'quality of care, mental health outcomes,', 'option for carious primary molar teeth.']"},{"template":"JJ NNP IN NNP NNP :","text":"['Conventional Amoxicillin in Female Adolescents**: -', '**Single-Embryo Transfer in Younger Women**: -', '**Psycho-behavioral Intervention for African-American Women**: -', '**Immediate Restoration in Esthetic Zones:** -', '**Two-Step Intervention for Older Women**: -', '**Collaborative Care for Latino Patients**: -', '**Divalproex Sodium for Impulsive Aggression**: -', '**Preemptive Analgesia in Tooth Extraction**: -', '**Collaborative Care vs. Consult-Liaison Care**: -', '**Collaborative Care for Anxiety Disorders**: -', '**IV Ferumoxytol in Hemodialysis Patients**: -', '**Collaborative Care for Panic Disorder**: -', '**Educational Program for VAP Prevention**: -', '**Collaborative Care for Postnatal Depression**: -', '**Endovascular Cooling in Ischemic Stroke**: -', '**Virtual Reality for Lumbar Puncture**: -', '**Follow-Up Study on Outpatient Commitment:** -', '**Collaborative Care with Clinical Pharmacists**: -', '**College Women with Acute UTI**: -', '**Long-Term Effect of Depression Intervention**: -', '**Preoperative Ibuprofen in Orthodontic Pain**: -', '**Loteprednol Etabonate vs. Dexamethasone Study**: -', '**Task-Oriented Intervention for Arm Function**: -', '**Collaborative Care for Acute Depression**: -', '**Aztreonam Lysine for Inhalation (AZLI)**: -', '**Dietary Advice in General Practice**: -', '**Collaborative Care for Post-CABG Depression**: -', '**Active Distraction for Immunization Pain**: -', '**Task-Oriented Intervention for Walking Competence**: -', 'Clinical Trial on Brief Intervention**: -', '**Vancomycin Prophylaxis in Neutropenic Patients**: -', '**HIV Prevention for Adolescent Mothers**: -', '**Disc Prosthesis vs. Non-Surgical Treatment:** -', '**Collaborative Care for Cardiac Patients**: -', '**Electromyographic Activity with Off-the-Shelf Orthotics**: -', '**Collaborative Care for Cancer Patients**: -', '**Comparative Study of Functional Appliances**: -', '**VAP Reduction in Surgical ICU**: -', '**Clinical Trial on Postoperative Bacteremia**: -', '**Long-Term Impact of Tobacco Marketing**: -', '**QI Teams for Depression Improvement**: -', '**PEARLS Program for Older Adults**: -', '**Lifestyle Intervention for Diabetes Risk**: -', 'Biofeedback-Assisted Relaxation for Combat-Related PTSD**: -', '**Short-term Efficacy of CPT Regimens**: -', 'Intermittent Clamping in Cirrhotic Patients -', '**Oral Ciprofloxacin after IV Ciprofloxacin:** -', '**Cross-Over Trial in Dialysis Patients**: -', '**Telephone-Based CBT for Latino Patients**: -', 'Ovarian Hyperstimulation in Poor Responders** -', '**Collaborative Care for Depressed Adolescents**: -', '**Collaborative Care for Older Adults**: -', '**VAP Reduction through Compliance Auditing**: -', '**Cognitive Therapy for Relapse Prevention**: -']"}]